plxs-20240928
0000785786
September 28
2024
FY
false
http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold
http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold
http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold
http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense
http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense
http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
http://www.plexus.com/20240928#LongTermDebtAndFinanceLeaseObligationsCurrent
http://www.plexus.com/20240928#LongTermDebtAndFinanceLeaseObligationsCurrent
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
http://www.plexus.com/20240928#LongTermDebtAndFinanceLeaseObligations
http://www.plexus.com/20240928#LongTermDebtAndFinanceLeaseObligations
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
plxs:numberOfEmployees
plxs:numberOfFacilities
xbrli:pure
plxs:segment
0000785786
2023-10-01
2024-09-28
0000785786
2024-03-30
0000785786
2024-11-11
0000785786
2022-10-02
2023-09-30
0000785786
2021-10-03
2022-10-01
0000785786
2024-09-28
0000785786
2023-09-30
0000785786
us-gaap:CommonStockMember
2023-09-30
0000785786
us-gaap:CommonStockMember
2022-10-01
0000785786
us-gaap:CommonStockMember
2021-10-02
0000785786
us-gaap:CommonStockMember
2023-10-01
2024-09-28
0000785786
us-gaap:CommonStockMember
2022-10-02
2023-09-30
0000785786
us-gaap:CommonStockMember
2021-10-03
2022-10-01
0000785786
us-gaap:CommonStockMember
2024-09-28
0000785786
2022-10-01
0000785786
2021-10-02
0000785786
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0000785786
us-gaap:AdditionalPaidInCapitalMember
2022-10-01
0000785786
us-gaap:AdditionalPaidInCapitalMember
2021-10-02
0000785786
us-gaap:AdditionalPaidInCapitalMember
2023-10-01
2024-09-28
0000785786
us-gaap:AdditionalPaidInCapitalMember
2022-10-02
2023-09-30
0000785786
us-gaap:AdditionalPaidInCapitalMember
2021-10-03
2022-10-01
0000785786
us-gaap:AdditionalPaidInCapitalMember
2024-09-28
0000785786
us-gaap:TreasuryStockCommonMember
2023-09-30
0000785786
us-gaap:TreasuryStockCommonMember
2022-10-01
0000785786
us-gaap:TreasuryStockCommonMember
2021-10-02
0000785786
us-gaap:TreasuryStockCommonMember
2023-10-01
2024-09-28
0000785786
us-gaap:TreasuryStockCommonMember
2022-10-02
2023-09-30
0000785786
us-gaap:TreasuryStockCommonMember
2021-10-03
2022-10-01
0000785786
us-gaap:TreasuryStockCommonMember
2024-09-28
0000785786
us-gaap:RetainedEarningsMember
2023-09-30
0000785786
us-gaap:RetainedEarningsMember
2022-10-01
0000785786
us-gaap:RetainedEarningsMember
2021-10-02
0000785786
us-gaap:RetainedEarningsMember
2023-10-01
2024-09-28
0000785786
us-gaap:RetainedEarningsMember
2022-10-02
2023-09-30
0000785786
us-gaap:RetainedEarningsMember
2021-10-03
2022-10-01
0000785786
us-gaap:RetainedEarningsMember
2024-09-28
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-09-30
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-10-01
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-02
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-10-01
2024-09-28
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-10-02
2023-09-30
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-03
2022-10-01
0000785786
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-28
0000785786
srt:MinimumMember
us-gaap:BuildingAndBuildingImprovementsMember
2024-09-28
0000785786
srt:MaximumMember
us-gaap:BuildingAndBuildingImprovementsMember
2024-09-28
0000785786
srt:MinimumMember
us-gaap:MachineryAndEquipmentMember
2024-09-28
0000785786
srt:MaximumMember
us-gaap:MachineryAndEquipmentMember
2024-09-28
0000785786
srt:MinimumMember
plxs:ComputerEquipmentandSoftwareMember
2024-09-28
0000785786
srt:MaximumMember
plxs:ComputerEquipmentandSoftwareMember
2024-09-28
0000785786
plxs:EngineeringDesignandDevelopmentServicesMember
2022-10-02
2023-09-30
0000785786
plxs:EngineeringDesignandDevelopmentServicesMember
2023-10-01
2024-09-28
0000785786
plxs:EngineeringDesignandDevelopmentServicesMember
2021-10-03
2022-10-01
0000785786
us-gaap:InventoriesMember
2024-09-28
0000785786
us-gaap:InventoriesMember
2023-09-30
0000785786
us-gaap:LandBuildingsAndImprovementsMember
2024-09-28
0000785786
us-gaap:LandBuildingsAndImprovementsMember
2023-09-30
0000785786
us-gaap:MachineryAndEquipmentMember
2024-09-28
0000785786
us-gaap:MachineryAndEquipmentMember
2023-09-30
0000785786
plxs:ComputerEquipmentandSoftwareMember
2024-09-28
0000785786
plxs:ComputerEquipmentandSoftwareMember
2023-09-30
0000785786
us-gaap:ConstructionInProgressMember
2024-09-28
0000785786
us-gaap:ConstructionInProgressMember
2023-09-30
0000785786
us-gaap:BuildingAndBuildingImprovementsMember
2024-09-28
0000785786
us-gaap:BuildingAndBuildingImprovementsMember
2023-09-30
0000785786
plxs:A4.05SeniorNotesMember
us-gaap:SeniorNotesMember
2024-09-28
0000785786
plxs:A4.05SeniorNotesMember
us-gaap:SeniorNotesMember
2023-09-30
0000785786
plxs:A4.22SeniorNotesMember
us-gaap:SeniorNotesMember
2023-09-30
0000785786
plxs:A4.22SeniorNotesMember
us-gaap:SeniorNotesMember
2024-09-28
0000785786
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2024-09-28
0000785786
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2023-09-30
0000785786
us-gaap:SeniorNotesMember
2023-09-30
0000785786
us-gaap:SeniorNotesMember
2024-09-28
0000785786
us-gaap:RevolvingCreditFacilityMember
2023-10-01
2024-09-28
0000785786
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2019-05-14
0000785786
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2022-06-09
0000785786
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2023-10-01
2024-09-28
0000785786
plxs:FinanceLeaseObligationsMember
2023-09-30
0000785786
plxs:FinanceLeaseObligationsMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
plxs:OtherAccruedLiabilitiesCurrentMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:DesignatedAsHedgingInstrumentMember
plxs:OtherAccruedLiabilitiesCurrentMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
plxs:OtherAccruedLiabilitiesCurrentMember
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
plxs:OtherAccruedLiabilitiesCurrentMember
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2023-10-01
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2022-10-02
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2021-10-03
2022-10-01
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2021-10-03
2022-10-01
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2022-10-02
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2023-10-01
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2021-10-03
2022-10-01
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-10-01
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-10-02
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
us-gaap:OtherNonoperatingIncomeExpenseMember
2023-10-01
2024-09-28
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
us-gaap:OtherNonoperatingIncomeExpenseMember
2022-10-02
2023-09-30
0000785786
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
us-gaap:OtherNonoperatingIncomeExpenseMember
2021-10-03
2022-10-01
0000785786
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeForwardMember
2024-09-28
0000785786
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2024-09-28
0000785786
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2024-09-28
0000785786
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2024-09-28
0000785786
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeForwardMember
2023-09-30
0000785786
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2023-09-30
0000785786
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2023-09-30
0000785786
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2023-09-30
0000785786
plxs:IncomeTaxMethodChangeMember
2023-10-01
2024-09-28
0000785786
plxs:IncomeTaxWitholdingMember
2023-10-01
2024-09-28
0000785786
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:StateAndLocalJurisdictionMember
2024-09-28
0000785786
us-gaap:ForeignCountryMember
2024-09-28
0000785786
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OtherNoncurrentLiabilitiesMember
2024-09-28
0000785786
plxs:DeferredIncomeTaxAssetsMember
2024-09-28
0000785786
us-gaap:StockCompensationPlanMember
2023-10-01
2024-09-28
0000785786
us-gaap:StockCompensationPlanMember
2021-10-03
2022-10-01
0000785786
us-gaap:StockCompensationPlanMember
2022-10-02
2023-09-30
0000785786
srt:MinimumMember
2023-10-01
2024-09-28
0000785786
srt:MaximumMember
2023-10-01
2024-09-28
0000785786
plxs:A2024OmnibusIncentivePlanMember
2024-09-28
0000785786
us-gaap:RestrictedStockUnitsRSUMember
plxs:A2024OmnibusIncentivePlanMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
plxs:A2024OmnibusIncentivePlanMember
2023-10-01
2024-09-28
0000785786
plxs:A2024OmnibusIncentivePlanMember
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2023-10-01
2024-09-28
0000785786
plxs:A2024OmnibusIncentivePlanMember
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
plxs:SP400Member
srt:MinimumMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
plxs:SP400Member
srt:MaximumMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
srt:MinimumMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
srt:MaximumMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
srt:MinimumMember
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
srt:MaximumMember
2024-09-28
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2021-10-02
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2021-10-03
2022-10-01
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2022-10-01
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2022-10-02
2023-09-30
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2023-09-30
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2023-10-01
2024-09-28
0000785786
plxs:RestrictedStockUnitsandPerformanceSharesMember
2024-09-28
0000785786
us-gaap:RestrictedStockUnitsRSUMember
2024-09-28
0000785786
us-gaap:RestrictedStockUnitsRSUMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2023-10-01
2024-09-28
0000785786
us-gaap:PerformanceSharesMember
2022-10-02
2023-09-30
0000785786
us-gaap:PerformanceSharesMember
2021-10-03
2022-10-01
0000785786
us-gaap:PerformanceSharesMember
2024-09-28
0000785786
us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember
2023-10-01
2024-09-28
0000785786
us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember
2022-10-02
2023-09-30
0000785786
us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember
2021-10-03
2022-10-01
0000785786
us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember
2024-09-28
0000785786
us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember
2023-09-30
0000785786
plxs:ArbitrationChargeTotalCashOutlayMember
2022-10-02
2023-09-30
0000785786
plxs:ArbitrationChargeMember
2022-10-02
2023-09-30
0000785786
plxs:ArbitrationChargeMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:IntersegmentEliminationMember
2023-10-01
2024-09-28
0000785786
us-gaap:IntersegmentEliminationMember
2022-10-02
2023-09-30
0000785786
us-gaap:IntersegmentEliminationMember
2021-10-03
2022-10-01
0000785786
us-gaap:CorporateNonSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:CorporateNonSegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:CorporateNonSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2023-09-30
0000785786
plxs:CorporateAndReconcilingItemsMember
2024-09-28
0000785786
plxs:CorporateAndReconcilingItemsMember
2023-09-30
0000785786
country:US
2023-10-01
2024-09-28
0000785786
country:US
2022-10-02
2023-09-30
0000785786
country:US
2021-10-03
2022-10-01
0000785786
country:MY
2023-10-01
2024-09-28
0000785786
country:MY
2022-10-02
2023-09-30
0000785786
country:MY
2021-10-03
2022-10-01
0000785786
country:MX
2023-10-01
2024-09-28
0000785786
country:MX
2022-10-02
2023-09-30
0000785786
country:MX
2021-10-03
2022-10-01
0000785786
country:RO
2023-10-01
2024-09-28
0000785786
country:RO
2022-10-02
2023-09-30
0000785786
country:RO
2021-10-03
2022-10-01
0000785786
country:CN
2023-10-01
2024-09-28
0000785786
country:CN
2022-10-02
2023-09-30
0000785786
country:CN
2021-10-03
2022-10-01
0000785786
country:GB
2023-10-01
2024-09-28
0000785786
country:GB
2022-10-02
2023-09-30
0000785786
country:GB
2021-10-03
2022-10-01
0000785786
country:TH
2023-10-01
2024-09-28
0000785786
country:TH
2022-10-02
2023-09-30
0000785786
country:TH
2021-10-03
2022-10-01
0000785786
country:DE
2023-10-01
2024-09-28
0000785786
country:DE
2022-10-02
2023-09-30
0000785786
country:DE
2021-10-03
2022-10-01
0000785786
country:US
2024-09-28
0000785786
country:US
2023-09-30
0000785786
country:MY
2024-09-28
0000785786
country:MY
2023-09-30
0000785786
country:MX
2024-09-28
0000785786
country:MX
2023-09-30
0000785786
country:RO
2024-09-28
0000785786
country:RO
2023-09-30
0000785786
country:TH
2024-09-28
0000785786
country:TH
2023-09-30
0000785786
country:CN
2024-09-28
0000785786
country:CN
2023-09-30
0000785786
country:PL
2024-09-28
0000785786
country:PL
2023-09-30
0000785786
country:GB
2024-09-28
0000785786
country:GB
2023-09-30
0000785786
plxs:OtherForeignEntitiesMember
2024-09-28
0000785786
plxs:OtherForeignEntitiesMember
2023-09-30
0000785786
us-gaap:CorporateNonSegmentMember
2024-09-28
0000785786
us-gaap:CorporateNonSegmentMember
2023-09-30
0000785786
plxs:GEHCMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2022-10-02
2023-09-30
0000785786
plxs:GEMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2021-10-03
2022-10-01
0000785786
plxs:A2023StockRepurchaseProgramMember
2022-08-18
0000785786
plxs:A2023StockRepurchaseProgramMember
2023-10-01
2024-09-28
0000785786
plxs:A2023StockRepurchaseProgramMember
2022-10-02
2023-09-30
0000785786
plxs:A2024StockRepurchaseProgramMember
2024-01-16
0000785786
plxs:A2024StockRepurchaseProgramMember
2023-10-01
2024-09-28
0000785786
plxs:A2025StockRepurchaseProgramMember
2024-08-14
0000785786
plxs:A2025StockRepurchaseProgramMember
2023-10-01
2024-09-28
0000785786
plxs:A2025StockRepurchaseProgramMember
2024-09-28
0000785786
plxs:MUFGMember
2024-09-28
0000785786
plxs:HSBCMember
2024-09-28
0000785786
plxs:MUFGMember
2023-10-01
2024-09-28
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:AerospaceDefenseMember
2023-10-01
2024-09-28
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:HealthcareLifeSciencesMember
2023-10-01
2024-09-28
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
plxs:IndustrialMember
2023-10-01
2024-09-28
0000785786
us-gaap:OperatingSegmentsMember
2023-10-01
2024-09-28
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AmericasSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AsiaPacificSegmentMember
2023-10-01
2024-09-28
0000785786
us-gaap:IntersegmentEliminationMember
plxs:EMEASegmentMember
2023-10-01
2024-09-28
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:AerospaceDefenseMember
2022-10-02
2023-09-30
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:HealthcareLifeSciencesMember
2022-10-02
2023-09-30
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
plxs:IndustrialMember
2022-10-02
2023-09-30
0000785786
us-gaap:OperatingSegmentsMember
2022-10-02
2023-09-30
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AsiaPacificSegmentMember
2022-10-02
2023-09-30
0000785786
us-gaap:IntersegmentEliminationMember
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
plxs:AmericasSegmentMember
2022-10-02
2023-09-30
0000785786
plxs:EMEASegmentMember
2022-10-02
2023-09-30
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:AerospaceDefenseMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:AerospaceDefenseMember
2021-10-03
2022-10-01
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:HealthcareLifeSciencesMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:HealthcareLifeSciencesMember
2021-10-03
2022-10-01
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:IndustrialMember
us-gaap:OperatingSegmentsMember
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
plxs:IndustrialMember
2021-10-03
2022-10-01
0000785786
us-gaap:OperatingSegmentsMember
2021-10-03
2022-10-01
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:IntersegmentEliminationMember
plxs:AsiaPacificSegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:IntersegmentEliminationMember
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
plxs:AmericasSegmentMember
2021-10-03
2022-10-01
0000785786
plxs:EMEASegmentMember
2021-10-03
2022-10-01
0000785786
us-gaap:TransferredOverTimeMember
2023-10-01
2024-09-28
0000785786
us-gaap:TransferredOverTimeMember
2022-10-02
2023-09-30
0000785786
us-gaap:TransferredOverTimeMember
2021-10-03
2022-10-01
0000785786
us-gaap:EmployeeSeveranceMember
2022-10-02
2023-09-30
0000785786
us-gaap:RestructuringChargesMember
2023-10-01
2024-09-28
0000785786
us-gaap:RestructuringChargesMember
2022-10-02
2023-09-30
0000785786
us-gaap:RestructuringChargesMember
2021-10-03
2022-10-01
0000785786
us-gaap:EmployeeSeveranceMember
2021-10-02
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2021-10-02
0000785786
plxs:ArbitrationChargeMember
2021-10-02
0000785786
us-gaap:EmployeeSeveranceMember
2021-10-03
2022-10-01
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2021-10-03
2022-10-01
0000785786
plxs:ArbitrationChargeMember
2021-10-03
2022-10-01
0000785786
us-gaap:EmployeeSeveranceMember
2022-10-01
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2022-10-01
0000785786
plxs:ArbitrationChargeMember
2022-10-01
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2022-10-02
2023-09-30
0000785786
us-gaap:EmployeeSeveranceMember
2023-09-30
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2023-09-30
0000785786
plxs:ArbitrationChargeMember
2023-09-30
0000785786
us-gaap:EmployeeSeveranceMember
2023-10-01
2024-09-28
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2023-10-01
2024-09-28
0000785786
us-gaap:EmployeeSeveranceMember
2024-09-28
0000785786
us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain
2024-09-28
0000785786
plxs:ArbitrationChargeMember
2024-09-28
0000785786
2024-06-30
2024-09-28
0000785786
plxs:ToddP.KelseyMember
2024-06-30
2024-09-28
0000785786
plxs:ToddP.KelseyMember
2024-09-28
0000785786
us-gaap:AllowanceForCreditLossMember
2023-09-30
0000785786
us-gaap:AllowanceForCreditLossMember
2023-10-01
2024-09-28
0000785786
us-gaap:AllowanceForCreditLossMember
2024-09-28
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2023-09-30
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2023-10-01
2024-09-28
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2024-09-28
0000785786
us-gaap:AllowanceForCreditLossMember
2022-10-01
0000785786
us-gaap:AllowanceForCreditLossMember
2022-10-02
2023-09-30
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2022-10-01
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2022-10-02
2023-09-30
0000785786
us-gaap:AllowanceForCreditLossMember
2021-10-02
0000785786
us-gaap:AllowanceForCreditLossMember
2021-10-03
2022-10-01
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2021-10-02
0000785786
us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember
2021-10-03
2022-10-01
Table of Contents
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
____________________________________________________________________________________________________________________________________
FORM 
10-K

____________________________________________________________________________________________________________________________________
(Mark One)
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended 
September 28, 2024

OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission File Number 
001-14423

____________________________________________________________________________________________________________________________________
PLEXUS CORP.

(Exact name of registrant as specified in charter)
____________________________________________________________________________________________________________________________________
Wisconsin
39-1344447
(State or other jurisdiction of incorporation)

(I.R.S. Employer Identification No.)
One Plexus Way

Neenah
, 
Wisconsin

54957

(Address of principal executive offices) (Zip Code) 
Telephone Number (
920
) 
969-6000

(Registrant’s telephone number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.01 par value
PLXS
The Nasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act:  None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     
Yes

ý
    No  
¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes 
o 
No

x

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    
Yes

x
    No  
o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    
Yes

x
    No  
o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Table of Contents
Large accelerated filer
x
Accelerated filer
☐
Non-accelerated filer  
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 
☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 
☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  
☐
    No  
☒

As of March 30, 2024, 27,469,730, shares of common stock were outstanding, and the aggregate market value of the shares of common stock (based upon the $94.82 closing price of the registrant's common stock on the last trading day of its fiscal second quarter, as reported on the Nasdaq Global Select Market) held by non-affiliates (excludes 561,696 shares reported as beneficially owned by directors and executive officers – does not constitute an admission as to affiliate status) was approximately $
2.6
 billion.
As of November 11, 2024, there were 
27,092,389
 shares of common stock outstanding.    
DOCUMENTS INCORPORATED BY REFERENCE:
Parts of Registrant’s Proxy Statement for the 
2025
 Annual Meeting of Shareholders are incorporated by reference into Part III of this Report.

Table of Contents
PLEXUS CORP.
TABLE OF CONTENTS
Form 10-K for the Fiscal Year Ended
September 28, 2024 

PART I
2
ITEM 1. BUSINESS
2
ITEM 1A. RISK FACTORS
11
ITEM 1B. UNRESOLVED SEC STAFF COMMENTS
23
ITEM 1C. CYBERSECURITY
23
ITEM 2. PROPERTIES
25
ITEM 3. LEGAL PROCEEDINGS
25
ITEM 4. MINE SAFETY DISCLOSURES
25
PART II
26
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
26
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
28
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
39
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
40
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
71
ITEM 9A. CONTROLS AND PROCEDURES
71
ITEM 9B. OTHER INFORMATION
72
ITEM 9C. FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
72
PART III
72
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
72
ITEM 11. EXECUTIVE COMPENSATION
73
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
73
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
74
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
74
PART IV
75
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
75
ITEM 16. FORM 10-K SUMMARY
79
SIGNATURES
81
Table of Contents
"SAFE HARBOR" CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:
The statements contained in this Form 10-K that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings.
In addition, see Risk Factors in Part I, Item 1A and Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 for a further discussion of some of the factors that could affect future results.
*    *    *
1
Table of Contents
PART I
ITEM 1.    BUSINESS
Overview
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions.    
Our Vision, Mission and Strategy
Our vision is to help create the products that build a better world. Our mission is to be the leader in highly complex products and demanding regulatory environments. Our strategy to fulfill our vision and mission is consistent and can be summarized in four parts:  
•
Market Focus
 – We engineer innovative solutions for customers in growth markets featuring highly complex products and demanding regulatory environments.
•
Superior Execution –
 We are dedicated partners to our customers, committed to achieving zero defects and perfect delivery through operational excellence. 
•
Passion Meets Purpose
 – We are united as a team.  We are guided by our values. We do the right thing to support our team members, communities and customers. 
•
Discipline by Design
 – We hold ourselves accountable to delivering shareholder value through consistent application of a disciplined financial model.  
Built on a foundation of innovation, we are relentless in our pursuit of excellence, aligning our team members, operations, systems of oversight and financial metrics to create a high performance, accountable organization with an engaged workforce deeply passionate about helping to create the products that build a better world. 
Financial Model 
Our financial model aligns with our business strategy. Our primary long-term goal is to achieve a 9-12% compounded annual revenue growth rate while earning a return on invested capital ("ROIC") of 15%, which would significantly exceed our weighted average cost of capital ("WACC") and represent positive economic return. Economic return is the amount by which our ROIC exceeds our WACC, and we believe it is a fundamental driver of shareholder value. We review our internal calculation of WACC annually; for fiscal 2024, our WACC was 8.2%. 
For more information regarding ROIC and economic return, which are non-GAAP financial measures, refer to "Management’s Discussion and Analysis of Financial Condition - Results of Operations - Return on Invested Capital ("ROIC") and economic return" in Part II, Item 7. For additional information on our use of non-GAAP financial measures, see Exhibit 99.1 to this annual report on Form 10-K, which exhibit is incorporated herein by reference.
Solutions
With integrated solutions throughout the product lifecycle, our team strives to create innovative and optimized paths to deliver products to the market, keep products in the market longer and help manage the product lifecycle sustainably and responsibly.

•
Design and Development
 – Using standard tools and processes throughout our six design centers worldwide, we leverage the latest technology and state-of-the-art design automation methodologies to provide comprehensive new product development and product commercialization solutions. The breadth of our capabilities across the product lifecycle enables us to integrate supply chain, manufacturing and service expertise into our designs, resulting in products developed with the full product lifecycle in mind.
•
Supply Chain Solutions
 – Delivering an optimal supply chain strategy is more than simply getting a product where it needs to be on time. Our supply chain experts engage in all of Plexus’ integrated solutions to identify opportunities for supply chain optimization. We help manage the full supply chain to minimize cost, mitigate risk and provide a flexible, scalable and resilient solution for our customers.  
2
Table of Contents
•
New Product Introduction
 – When introducing a new product, we understand our customers need to move quickly. We have a dedicated team focused on decreasing time to market and transitioning products to full volume manufacturing, through a full suite of integrated new product introduction services, such as design for excellence, product lifecycle assessment, specialized design of test solutions and rapid prototyping. 
•
Manufacturing
 – Our approach to manufacturing focuses on innovation, continuous improvement and superior quality and delivery. With a global footprint and scalable operations, we aim to tailor our manufacturing environment to meet each customer’s needs worldwide. As we strive for perfect delivery and zero defects, exceptional quality begins with each individual member of our team, which we advance through our Quality Begins with Me program. Our capabilities and our commitment to superior execution position us to support the complex technology and regulatory needs of the industries we serve, providing customers with dependable and flexible manufacturing solutions.
•
Sustaining Services
 –

We are committed to protecting our customers' brand reputation, supporting the success of each product in the market and extending a product's useful life through repair, refurbishment, remanufacturing (at the direction of our customers) and service parts planning. From influencing a product's design for serviceability, which creates early access for lifecycle extension services and repair, to aftermarket and end-of-life treatment, such as spare parts management, depot repair and part recovery services, we take a proactive and circular approach to service to help keep products in the market. 
Through these integrated solutions, we proactively tackle tough challenges throughout the product lifecycle. We provide most of our solutions on a turnkey basis, under which we procure and warehouse all materials required for product assembly. We provide select solutions on a consignment basis, meaning our customers supply the necessary materials, while Plexus provides the labor and other services required for product assembly. Other than certain test equipment, manufacturing equipment and software used for internal operations, we do not design or manufacture our own proprietary products.
Operations 
Plexus is a Wisconsin-headquartered corporation operating from 26 active facilities, totaling approximately 5.0 million square feet. Our facilities are strategically located to support the design, manufacturing and service needs of customers' global supply chains in our targeted market sectors.
Customers and Market Sectors Served
We specialize in serving customers in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial market sectors. Plexus serves a diverse customer landscape that includes industry-leading, branded product companies, along with other technology pioneering start-ups and emerging companies that may or may not maintain manufacturing capabilities. During fiscal 2024, we served approximately 190 customers. No customer accounted for over 10% of our sales in fiscal 2024. GE Healthcare Technologies, Inc. ("GEHC") accounted for 10.3% of our net sales during fiscal 2023, while General Electric ("GE") accounted for 12.9% of our net sales during fiscal 2022. During fiscal 2023, GE completed the separation of its healthcare business, GEHC, as a stand-alone company. No other customer accounted for 10.0% or more of our net sales in any of the last three fiscal years. Many of our large customers, including GEHC and GE, contract with us through multiple independent divisions, subsidiaries, production facilities or locations. We believe that in most cases our sales to any one such division, subsidiary, facility or location are independent of sales to others.
The distribution of our net sales by market sectors for the indicated fiscal years is shown in the following table:
Industry
2024
2023
2022
Aerospace/Defense
18%
14%
13%
Healthcare/Life Sciences
39%
44%
41%
Industrial
43%
42%
46%
Total net sales
100%
100%
100%
Although our current business development focus is based on our targeted market sectors of Aerospace/Defense, Healthcare/Life Sciences, and Industrial, we evaluate our financial performance and allocate our resources geographically (see Note 11 "Reportable Segments, Geographic Information and Major Customers" in Notes to Consolidated Financial Statements regarding our reportable segments). Plexus offers an array of solutions for customers in each market sector and, aside from the specific go-to-market teams, generally we do not dedicate operational equipment, personnel, facilities or other resources to particular market sectors, nor do we internally track our costs and resources per market sector.
3
Table of Contents
Go-to-Market Strategy
Each market sector has a market sector vice president, as well as market sector senior director roles, who together oversee and provide leadership to business development and customer management teams, supply chain, engineering and manufacturing subject matter experts and market sector specialists. These teams maintain expertise related to each market sector and execute sector strategies aligned to that market’s unique delivery, quality and regulatory requirements.
Our market sector teams help to develop Plexus’ strategy for growth with a particular emphasis on expanding the value-add solutions we offer customers. Our sales and marketing efforts focus on expanding our engagements with existing customers as well as targeting new customers. 
Materials and Suppliers
We typically purchase raw materials, including printed circuit boards and electronic components, from a wide variety of manufacturers and their authorized distributors. Under certain circumstances, we will purchase materials from independent distributors, customers or competitors. Many of these raw materials are unique to the designed assembly. By customer agreement, we purchase materials according to customer forecast and supplier lead-times. 
The key electronic components we purchase include: advanced semiconductors, diodes, power management modules, microcontrollers, memory modules, interconnects, inductors, resistors, capacitors, power supplies and cable and wire. Volatile demand (in quantity or mix), material shortages, extended lead-times and subsequent allocations by our suppliers are an inherent risk within the electronics industry and have remained an issue, particularly for semiconductors during fiscal 2024. We discuss the causes, implications, and potential implications of volatile demand and material shortages more fully in "Risk Factors" in Part I, Item 1A herein. 
We also purchase non-electronic, typically custom engineered components such as molded/formed plastics, sheet metal fabrications, aluminum extrusions, robotics, motors, vision sensors, motion/actuation, fluidics, displays, die castings and various other hardware and fastener components. These materials are sourced from Plexus' preferred suppliers and customer directed suppliers. Altogether, purchased materials range from “off the shelf” to highly customized and vary widely in terms of market availability and price. Through our engineering product development engagements and through the quoting of new business, Plexus can influence the selection of new product materials, and therefore the selection of suppliers who outperform their peers.  
Amidst a highly dynamic set of supply markets, Plexus' global supply chain management organization works to mitigate potential risks and ensure a steady flow of materials at competitive prices. We pursue these goals through supply chain solutions developed in collaboration with our customers and our suppliers, a commitment to strong supplier partnerships, use of proprietary risk management tools and aggressive management of supplier commitments. 
Competition
Plexus operates in a highly competitive market, with a goal to be best-in-class at meeting the unique needs of our customers. A number of competitors may provide services similar to Plexus. Others may be more established in certain industry sectors, or have greater financial, manufacturing or marketing resources. Smaller competitors compete mainly in specific sectors and within limited geographic areas. Plexus also competes with in-house capabilities of current and potential customers. Plexus maintains awareness and knowledge of our competitors' capabilities in order to remain highly competitive within our target markets. Refer to the discussion in "Risk Factors" in Part I, Item 1A herein for further details on market competition.
We believe our ability to provide a full range of services that complement the entire product lifecycle across a global footprint provides a business advantage. Relative to our competition, overriding factors such as lower manufacturing volumes, production flexibility, unique fulfillment requirements and complex regulatory and quality requirements typically result in higher investments in inventory and selling and administrative costs for us. The cost variance from our competitors is especially evident relative to those that provide electronics manufacturing services for high-volume, less complex products, with less stringent requirements (e.g., consumer electronics).
Sustainability & Social Impact
Our vision is to help create the products that build a better world, yet the opportunity and responsibility we have to build a better world goes far beyond the products we help to create. We are committed to elevating the standards of business conduct through the integration of sustainable and responsible business practices into our enduring strategy. This integrated approach and related goals enable us to address important environmental and social issues material to the long-term success of our business. This commitment is made public through our membership with organizations such as the U.N. Global Compact ("UNGC"), including alignment to the U.N. Sustainable Development Goals, and the Responsible Business Alliance ("RBA"). 
4
Table of Contents
In service to our vision, we continue to evolve our solutions to better service our customers in light of changing market demands. This includes the opportunity we have to help deliver more sustainable and responsible products to the market. We continue to expand our product lifecycle capabilities in response to this heightened focus, as we seek to design more environmentally sustainable products, improve our production practices, assess and deploy product life extension and part recovery strategies, and enable a more sustainable, responsible supply chain for our customers. In 2024, we were a finalist in Scotland's Centre for Engineering, Education & Development's "Net Zero Hero" award for our product lifecycle assessment services. These services help our customers estimate and uncover factors that may impact the global warming potential of their products.  
We are focused on our own operational impact, as well, seeking to reduce our emissions, waste, water and use of natural resources, transition to renewable energy and reusable resources, and optimize our operations through adoption of new technologies and automation. Our commitment to reducing our environmental impact is captured in our Climate Policy, which helps to guide our objectives and offers structure to aid in prioritizing our efforts.

In fiscal 2024, we pursued a third consecutive year-over-year emissions intensity reduction goal, achieving an absolute Scope 1 and Scope 2 emissions reduction following two consecutive years of Scope 1 and Scope 2 emissions intensity reductions across our global operations. Further in fiscal 2024, we participated in the UNGC's Climate Ambition Accelerator program as we seek to advance our energy transition strategy and develop longer-term aspirations in support of international climate initiatives. 
Beyond our four walls, we seek to collaborate and integrate with our local communities and find opportunities to partner throughout our value chain. Community involvement, volunteering and charitable giving are important to ensure we are investing and promoting positive impacts in the communities in which we operate and where our team members live. Within each community where we have a physical location, we provide donations to local charities that enhance innovation, promote technology-related educational programs (e.g., STEM) and preserve the quality of life. Plexus also offers eight hours of paid, volunteer time off for team members who want to give back through community engagement events. In addition to local impacts realized through our team member volunteer efforts, the Plexus Community Foundation donated nearly $1.1 million in fiscal 2024, bringing its total giving to $11.0 million since 2004.
We are committed to driving greater transparency around our sustainable and responsible business practices through the publication of an annual sustainability report. More detailed information about Plexus’ efforts and progress can be found in that report located at https://www.plexus.com/en-us/corporate-social-responsibility. The information in the sustainability report and on Plexus’ website is not a part of this Annual Report on Form 10-K and is not incorporated by reference.
Refer to the discussion in "Risk Factors" in Part I, Item 1A herein for further details of environmental physical and transition risks, as well as the legal and regulatory landscape related to environmental matters, including climate change, that could adversely affect our business, results of operations, and financial condition.
Human Capital Management 
People are the heart of what we do and who we are. How we engage and empower our team members is critical to how we deliver value and create sustained growth for our shareholders. We realize our success depends on the well-being and inclusive engagement of each individual on our team. As a responsible employer, we are committed to global standards of employment, which we effect through our Code of Conduct and Business Ethics ("Code of Conduct"), our Human Rights Policy and other labor and employment policies and through our commitment to the UNGC Sustainable Development Goals and the RBA. We also realize in order to attract and retain talented individuals we must provide our team members the ability to do meaningful work, personally and professionally develop, and create diverse and memorable experiences. 
5
Table of Contents
Purpose and Culture
We recognize a great culture is foundational to the success of our vision to help create the products that build a better world. We are proud of our culture and the recognition we have received over the years as a great place to work. In 2024, HR Asia awarded Plexus the Best Company to Work for in Asia (Malaysia Chapter), as well as the HR Asia Diversity, Equity, & Inclusion Award. In building a great culture, we embrace our five values:
•
Growing our People 
– We foster a culture of trust, courage and growth, empowering every team member to realize their full potential. 
•
Building Belonging
 – We build an inclusive environment, valuing each team member, embracing diversity and promoting teamwork to achieve extraordinary outcomes together. 
•
Innovating Responsibly
 – We innovate and leverage technology, guided by a clear strategy, to boldly drive positive change and promote a sustainable future.
•
Delivering Excellence
 – We commit to exceptional quality and perfect delivery by standardizing, scaling and continuously improving.  
•
Creating Customer Success
 – We exceed customer expectations and forge relationships built on trust, candor and shared successes.
Commitment to Our Values and Ethical Business Practices
Along with our values, we act in accordance with our Code of Conduct, which creates expectations and provides guidance for all team members, representatives and partners of Plexus to make the right decisions. Our Code of Conduct includes topics such as corruption, discrimination, harassment, privacy, appropriate use of company assets, protecting confidential information and reporting Code of Conduct violations. It is used to reinforce our passion for operating in a fair, honest, responsible and ethical manner and articulates our responsibilities as a trusted leader in the business community. The Code of Conduct also emphasizes the importance of having an inclusive, welcoming environment in which all team members feel empowered to do what is right and are expected to voice concerns should violations of the Code of Conduct be observed. All team members are required to complete training on the Code of Conduct biennially.
Our commitment to being a responsible employer is reinforced through our membership with the RBA. Since 2014, our RBA membership reinforces the critical business standards required of Plexus, our team members and business partners related to human rights, environmental, health and safety, labor and business ethics. As an active member of RBA, we abide by their global standards, which may exceed minimum legal requirements, regarding the treatment of workers. Being a member of the RBA means we help collectively influence our broader business ecosystem by propagating and maintaining sustainable and responsible business practices. 
Human Rights
At the core of our value system is a fundamental respect for human rights. Our Human Rights Policy formalizes Plexus' commitment to respect human rights and embodies internationally-recognized principles and the laws of the countries in which we operate. 
We prohibit discrimination and harassment, recruiting fees imposed on our workers, the use of child labor, forced labor or labor that results from human trafficking, and the unreasonable restriction of movement or travel of workers. We support reasonable working hours and time off, fair wages, access to basic liberties (including clean sanitation facilities and potable water), freedom of association, the humane treatment of all workers and fair and honest business practices. Our Human Rights Policy supports the RBA Code of Conduct labor standards framework, and reinforces our statement in support of the California Transparency in Supply Chains Act and the UK Modern Slavery Act. Our Human Rights Policy was created by a cross-functional team appointed to conduct regular policy and impact mapping, as outlined by the UNGC, to facilitate continuous improvement and commitment to our standards. 
Talent Development & Acquisition
With people at the heart of what we do and who we are, we create, implement and accelerate development opportunities for our team members in order to enable business growth, enhance our culture, drive leadership accountability and inspire purposeful engagement. Our commitment to holistic talent management means that we expect and reward high performance and address underperformance with urgency, candor and empathy. We engage in regular talent reviews to calibrate on the performance and potential of our teammates, development opportunities, career pathing and the strength of our succession plans. During these reviews, we also assess retention rates and the diversity composition of our leaders and leadership pipeline. Competency-based training, leadership development programs and online learning promote a learning culture and provide ongoing development for team members at all levels. We also have established a formal mentoring program that aids in the development and retention of 
6
Table of Contents
talent. While our goal is to develop our own talent, we recruit new graduate and experienced talent by valuing potential and personality traits that align with our values, as well as direct and transferable experiences.
Employee Engagement
At every facility, in every region and at all levels, we strive to continuously improve the engagement of our team members.  We survey employee engagement annually through our employee net promoter score and we identify strengths and act on areas of opportunity to enhance our work environment and increase employee satisfaction. In 2024, we received responses from 100% of our team members through the survey resulting in an industry leading net promoter score.
Diversity and Inclusion
At Plexus, diversity and inclusion ("D&I") does not simply mean representation. It means maximizing and optimizing the human experience and enabling access to the best possible talent for Plexus. We have adopted the following D&I statement at Plexus, which is directly incorporated into our Code of Conduct: 
"Our people create our best Plexus. Ingrained in our culture of inclusion is the philosophy that each individual offers diverse perspectives, backgrounds and experiences that create great outcomes when we are united as a team. We respect our people and embrace our differences. We welcome everyone and value the ideas generated by our collective uniqueness. We aspire that all of our people reach their full potential."
Our organizational approach to D&I at Plexus includes the following:
•
D&I Integration Plan
 – We have established defined actions aligned to value-driven outcomes as we further integrate diversity and inclusion into our strategy, business operations and culture. 
•
D&I Committee and Board Oversight
 – To oversee strategic objectives and to ensure appropriate accountabilities exist to support our efforts, D&I is incorporated into our executive Sustainable & Responsible Business Practices Committee, made up of key members of executive management, including our Chief Executive Officer. In addition, the Compensation and Leadership Development Committee of our Board of Directors reviews our human capital management strategy, including D&I initiatives and progress to cultivate an optimized workforce and inclusive culture.  
•
Employee Resource Groups
 – Our ERGs are voluntary, employee-driven, executive-sponsored groups organized around common interests and legitimate business purposes. Plexus' current ERGs include:
◦
Plexus Pride
 – Plexus Pride is focused on supporting the needs of the LGTBQIA+ community by creating greater awareness of the challenges and uniqueness of this demographic. They aim to provide educational, networking and development opportunities for all Plexus team members.
◦
Plexus Veterans Network
 – The goal of the Plexus Veterans Network is to enhance Plexus’s ability to hire, develop and support U.S. veterans across the organization to improve business outcomes. The network facilitates veteran outreach, camaraderie and mentorship opportunities around the veterans’ community.
◦
Plexus Women in Network
 – Plexus Women in Network has a mission to champion the advancement of women in their professional and personal development through various career and life changes. This ERG aims to contribute to more women in elevated roles and increased diversity in leadership positions across Plexus.
◦
Plexus Young Professionals 
– Plexus Young Professionals focuses on creating an environment that fosters collaboration and development for the young professionals at Plexus. This group desires to enhance talent development and retention, create an environment that fosters networking and sponsorship for career growth and provide community engagement opportunities. 
◦
UnusPlexus
 – UnusPlexus’ purpose is to celebrate the different cultures and diversity within Plexus. The group plays a key role in embodying the D&I mission at Plexus, and through its tenets of communication, cultural celebration and community outreach, creates impactful experiences across Plexus.
These groups are directly supported by executive-level leadership and management engages regularly in support of ERG programming. Plexus supports further expansion and enhancement efforts of existing ERGs as well as employee-driven creation of new ERGs.
7
Table of Contents
•
Training
 – Plexus has invested in D&I leadership training on the value of diversity and how best to foster an inclusive culture, including trainings related to foundations of D&I, unconscious bias and hiring. 
•
Broadening our Talent Pool 
– Our talent acquisition teams continuously seek to widen the funnel of talent seeking to join Plexus. Efforts are customized by geography based on current workforce dynamics. This includes partnerships with organizations such as the Society of Women Engineering ("SWE"), Women in Electronics, and recruiting from new universities and industry groups across many disciplines. 
Employee Benefits & Programs
Plexus has a number of policies and benefits in place to support the unique needs and overall well-being of our team members and their families, including competitive health and welfare plans, a flexible workplace, paid parental leave and a Plexus wellness program to ensure our team members have access to the resources they need to lead healthy, balanced lives. For our team members, this includes access to our Employee Assistance Program ("EAP") - or similar program depending on the country of employment - that provides confidential support for stress management and mental health, including counseling and resources for team members and their households. In 2024, Plexus was proud to be recognized as one of the Greatest Workplaces for Mental Wellbeing by Newsweek magazine.
Compensation
We employ a "pay for performance" approach, emphasizing a direct correlation between performance and rewards and empowering team members to steer their own professional destinies. Leaders are provided with the flexibility to recognize exceptional individual contributions through customized elements of pay such as base salary, cash incentives and equity (company stock) compensation. Short and long-term incentive pay is designed to be competitive, improve employee retention, reward team members for performance supporting our strategic objectives and align team members with the interests of shareholders to deliver both short-term and long-term results. Approximately 20.4% and 3.0% of our team members participate in our short and long-term incentive programs, respectively. Further, we support financial well-being through external fiduciary advisors that can help team members with topics ranging from retirement investing and paying off debt to general money matters.
Our compensation guidelines and pay structures are adapted to reflect market dynamics and currency exchange rate fluctuations, ensuring alignment with regional trends, pay range segments and applicable experience. A risk assessment on our compensation plans and strategy is performed annually, including a market pay analysis to ensure we are competitive with local market practices where we operate. We provide the results of this risk assessment and a summary of all global total rewards programs to the Compensation and Leadership Development Committee of our Board of Directors on an annual basis. These practices not only facilitate a clear and transparent understanding of our compensation philosophy among team members but also ensure internal fairness and external market competitiveness.
A pay equity tool was introduced within the United States in fiscal 2024 to automate our process for ensuring equity within our compensation framework and to allow for enhanced transparency with our team members. We will expand the usage of this tool outside the United States in fiscal 2025. This tool analyzes various factors such as job roles, job levels, qualifications, performance and industry benchmarks. Through the integration of this tool into our compensation process, we streamline and simplify our proactive approach to prevent pay disparities before they start.
Worker Health and Safety
Protecting our team and those within our communities is paramount as we strive to be the safest place for our team members outside of their home. We are committed to complying with applicable laws and take an adaptive and proactive approach to ensure we conduct all of our operations across the globe safely and responsibly. We maintain a method of evaluating environmental, health and safety ("EHS") performance for continual improvement and we are committed to providing a workplace that promotes the health and safety of all who walk through our doors. 
Our Corporate Policy for Quality, Environmental, Health & Safety and Social Responsibility Management sets forth our EHS policy statement, which includes our commitment to: maintain, evaluate and continuously improve our global EHS management system; provide processes for consultation and participation of team members to reduce safety risks; and maintain compliance with applicable environmental and occupational health and safety laws and other requirements. These requirements are related to topics such as: monitoring, tracking and reporting of air and water emissions; tracking and disposing of wastes generated from our manufacturing process; and evaluating and mitigating employee health and safety risks in our facilities.
8
Table of Contents
Sixteen of our 17 manufacturing facilities are certified to ISO 14001 Environmental Management and three of 17 are certified to ISO 45001 Occupational Health and Safety Management standards. All of our manufacturing facilities, regardless of formal certification, abide by global policies and processes that align with both of these standards. Our facility in Kelso, Scotland is certified to the ISO 50001 Energy Management system, which requires the development and implementation of a comprehensive energy management system that helps the site achieve continual improvement of energy performance, including efficiency, security, use and consumption.
Our site teams are trained on these requirements and certifications to these standards are audited and renewed annually in alignment with ISO standards. Further, we provide education and training for every team member on important environmental and safety topics applicable to their role, leveraging a risk-based approach to training to ensure our team members have the knowledge they need to keep themselves and their peers safe and the environment healthy. To help drive best practices and enhance our environmental and safety performance, we employ a global team of over 50 EHS professionals who help to develop and deploy standard policies and procedures to protect our team members and to enable safe and sustainable operations. These roles are integrated into operational teams and process reviews to ensure appropriate consideration of potential safety concerns and environmental consequences of our operating procedures.
Human Capital Management Governance
Our Chief Human Resources Officer ("CHRO") directs our human capital management strategy and provides an update to the Compensation and Leadership Development Committee of our Board of Directors quarterly. This update may include, among other topics, talent attraction, development and retention; succession planning, including successor candidates for key management roles; corporate culture; D&I; compensation practices; training; and progress to advance initiatives. Management also updates the Board of Directors regularly on employee-related policies, trends and efforts intended to protect our team members and to preserve our corporate culture, such as those related to EHS and Ethics Hotline reporting. 
Employee Data
Of our over 20,000 team members, 50.4% are female, 49.5% are male and 0.1% choose not to identify. The majority of our workforce, 56.8%, is located in our APAC region, while 29.6% and 13.6% of our team members are located in our AMER and EMEA regions, respectively. Approximately 240 of our team members in the United Kingdom are covered by union agreements. These union agreements are typically renewed at the beginning of each year, although in a few cases these agreements may last two or more years. Our global team members outside the United Kingdom are not covered by union agreements. We have no history of labor disputes at any of our facilities, and we believe that our employee relationships are positive and stable. Given the quick response times required by our customers, we seek to maintain flexibility to scale our operations as necessary to maximize efficiency. To do so, we use skilled temporary labor in addition to our full-time employees.
Intellectual Property
We own various service marks that we use in our business, which are registered in the trademark offices of the United States and other countries. We develop and maintain trade secrets but do not generally seek to protect trade secrets through patents. We do not have any material copyrights.
Information Technology
Our core solutions for manufacturing facilities include a single-instance enterprise resource planning (“ERP”) system in addition to product data management and advanced planning and scheduling systems, along with consistent solutions for warehouse management and manufacturing execution that support our global operations. This consistency augments our other management information systems, allowing us to standardize the translation of data from multiple production facilities into operational and financial information required by the business. The related software licenses are of a general commercial character on terms customary for these types of agreements.
In addition to our core solutions, we are committed to investing in new platform technologies, such as advanced manufacturing execution systems, process automation, warehouse automation, artificial intelligence, realtime vision and anomaly detection systems and collaboration tools. These investments are aimed at enhancing productivity, optimizing operational efficiency, and driving differentiation in a competitive landscape. Refer to the discussion in "Cybersecurity" in Part I, Item 1C herein for details on our cybersecurity risk management strategy and governance.
9
Table of Contents
Compliance with Laws and Regulations
As a global public company that designs, manufactures and services highly complex products in demanding regulatory environments, our operations are subject to a variety of laws, regulations and compliance obligations. We strive to implement robust internal controls, quality management systems and management systems of compliance that govern our internal actions and mitigate our risk of non-compliance. We also make efforts to identify non-compliance concerns through internal and external audits, risk assessments as well as an ethics hotline reporting system. Plexus is also committed to supporting product safety and environmental compliance regulations as may be required by our customers. This support may include customized operational processes or collecting data or compliance information on parts or production materials to meet certain laws, regulations or end market requirements, such as the Restrictions on Hazardous Substances ("RoHS") 2011/65/EU, Waste Electrical and Electronic Equipment ("WEEE") 2012/19/EU directives and Registration, Evaluation, Authorization and restriction of Chemicals ("REACH") EC 1907/2006 EU directive.
Regulatory Requirements
All Plexus manufacturing and engineering facilities are certified to a baseline Quality Management System standard per ISO9001:2015. We have capabilities to assemble finished medical devices meeting the U.S. Food and Drug Administration’s (“FDA”) Quality Systems Regulation requirements and similar regulatory requirements in other countries. 
We have additional certifications and/or registrations held by certain facilities in the following regions:
AMER
APAC
EMEA
Medical Standard ISO 13485:2016
X
X
X
21 CFR Part 820 (FDA) (Finished Medical)
X
X
X
JMGP accreditation
X
X
X
GMP-Korea certification
X
ANVISA accreditation
X
X
X
NPMA (National Medical Products Administration) registration
X
ISO 14001(environmental management)
X
X
X
ISO 45001 (occupational health and safety)
X
X
ANSI/ESD (Electrostatic Discharge Control Program) S20.20
X
X
ITAR (International Traffic and Arms Regulation) self-declaration
X
Aerospace Standard AS9100
X
X
X
NADCAP certification
X
X
X
FAR 145 certification (FAA repair station)
X
EASA repair approval
X
ATEX/IECEx certification
X
IRIS certification (Railway)
X
ISO 50001:2011 (energy management)
X
Bureau of Indian Standards (BIS)
X
TL9000 (telecommunications)
X
Refer to the discussion in "Risk Factors" in Part I, Item 1A herein for further details on legal and regulatory obligations that could adversely affect our business, results of operation and financial conditions.
Additional Information
Our global headquarters is located at One Plexus Way, Neenah, Wisconsin, 54957. Plexus maintains a website at www.plexus.com. As soon as is reasonably practical, after we electronically file or furnish all reports to the Securities and Exchange Commission ("SEC"), we provide online copies of such reports, free of charge. These reports include: Proxy Statements, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Specialized Disclosure Reports on Form SD and amendments to those reports. These reports are also accessible at the SEC's website at www.sec.gov. Our Code of Conduct is also posted on our website. You may access these SEC reports and the Code of Conduct by following the links under "Investors" at our website.
10
Table of Contents
ITEM 1A.    RISK FACTORS
Material risk factors to our business and financial performance are those that may impact our strategy, which is centered around four strategic pillars: 
Market Focus, Superior Execution, Passion Meets Purpose 
and
 Discipline by Design
. This section lays out a number of material risks that may impact those strategic pillars. Other sections of this report also include risks that may impact our strategic business objectives and affect our financial performance. The risks included herein and elsewhere in this report are not exhaustive. In addition, due to the dynamic nature of our business, new risks may emerge from time to time and it is not possible for management to predict or assess the impact of all such risks on our business.

Risks impacting our Market Focus
The end markets we serve require technologically advanced products and such markets may be impacted by a number of factors that could adversely impact our customers’ demand.
Factors affecting the technology-dependent end markets that we serve could adversely affect our customers and, as a result, Plexus. These factors include:
•
customers’ ability or inability to adapt to rapidly changing technologies, such as artificial intelligence, and evolving industry standards that can result in short product life-cycles or product obsolescence
•
customers’ ability or inability to develop and market their products, some of which are new and untested
•
the potential failure of our customers’ products to gain widespread commercial acceptance, and
•
the availability of the components required to manufacture and service our customers' products.
Even if our customers successfully respond to these market challenges, their responses, including any consequential changes we must make in our business relationships, services offered, or to our operations, can affect our production cycles, working capital levels and results of operations.
Our customers do not make long-term commitments to us and may cancel or change their production requirements, which may strain resources and negatively impact our revenue, working capital levels and our operating results.
We generally do not obtain firm, long-term purchase commitments from our customers, and frequently do not have visibility as to their future demand for our services. Customers also cancel, change or delay design, manufacturing or sustaining services demand and schedules, or fail to meet their forecasts for a number of reasons beyond our control. Customer expectations can change rapidly, requiring us to take on additional commitments or risks. In addition, customers may fail to meet their commitments to us or our expectations. Cancellations, reductions or delays by a significant customer, or by a group of customers, could seriously harm our operating results and negatively affect our working capital levels. Such cancellations, reductions or delays have occurred from time to time and may continue to occur in the future. This risk continues to be heightened by potential volatility in end-market demand for our customers' products or our services as a result of external factors such as the current inflationary environment, global conflicts, regulatory change and general economic uncertainty.
In addition, we make significant decisions based on our estimates of customers’ demand, including determining the levels of business that we will seek and accept, production schedules, component procurement commitments, working capital management, facility and capacity requirements, facility footprint planning, personnel needs and other resource requirements. The short-term nature of our customers’ commitments and the possibility of rapid changes in demand for their products affect our ability to accurately estimate their future requirements. Because certain of our operating expenses are fixed in the short or long term, a reduction in customer demand can harm our operating results. 
Rapid increases in customer demand may stress personnel and other capacity resources. We may not have sufficient resources, including personnel and components, at any given time to meet all of our customers’ demands or to meet the requirements of a specific program, which could result in a loss of business from such customers. Rapid decreases in customer demand may result in operational inefficiencies and excess inventory, which could harm our gross profit margins and results of operations.
The need for us to correctly anticipate component needs is amplified in times of shortages. A tight component supply and other factors discussed above, can increase the difficulties and cost of anticipating changing demand. Moreover, because our margins vary across customers and specific programs, a reduction in revenue with higher margin customers or programs will have a more significant adverse effect on our operating results.
11
Table of Contents
Increased competition may result in reduced demand or reduced prices for our services.
Our industry is highly competitive. We compete against numerous providers with global operations, as well as those which operate on only a local or regional basis. In addition, current and prospective customers continually evaluate the merits of designing, manufacturing and servicing products internally and may choose to design, manufacture or service products (including products or product types that we currently design, manufacture or service for them) themselves rather than outsource such activities. Consolidations and other changes in our industry may result in a changing competitive landscape.
Our competitors may:
•
respond more quickly than us to advancements in technology, such as artificial intelligence
•
be faster to develop new business models or otherwise adapt to evolving customer requirements and expectations
•
have greater name recognition, critical mass and geographic and market presence generally or within specific technologies or subsectors
•
be better able to identify and take advantage of acquisition opportunities
•
have lower internal cost structures
•
have greater direct buying power with component suppliers and distributors
•
devote greater resources to the development, promotion and sale of their services and execution of their strategy
•
be better positioned to compete on price for their services
•
have technological expertise, capabilities and/or resources that are greater than ours
•
have excess capacity, and be better able to utilize such excess capacity
•
be better positioned to add additional resources, and
•
be willing or able to make sales or provide services at lower margins than we do.
Our manufacturing processes are generally not subject to significant proprietary protection, and companies with greater resources or a greater market presence may enter our market or otherwise become increasingly competitive. Increased competition could result in significant price reductions, reduced sales and margins, or loss of market share.
The majority of our net sales come from a relatively small number of customers and a limited number of market sectors; if we lose a major customer or program or if there are challenges in those market sectors, then our net sales and operating results could decline significantly.
Our 10 largest customers accounted for 47.8% and 49.6% of our net sales in fiscal 2024 and 2023, respectively. During fiscal 2023, there was one customer that represented 10.0% or more of our net sales. 
Our major customers may vary from period to period, and our major customers may not continue to purchase services from us at current levels, or at all, particularly given the volatile or temporary nature of certain programs. In any given period, a higher portion of our sales may be concentrated with customers or projects with relatively lower margins, which could adversely affect our results. We have experienced from time to time, and in the future may experience, significant disengagements with customers or of programs, adverse changes in customer supply chain strategies and the end-of-life of significant programs. Especially given our discrete number of customers, the loss of, or significant reductions in net sales to, any of our major customers or our failure to make appropriate choices as to the customers we serve could seriously harm our business and results of operations.
In addition, we focus our sales efforts on customers in only a few market sectors, as identified in Part I, Item 1, herein. Each of these sectors is subject to macroeconomic conditions as well as trends and conditions that are sector specific. Any weakness in our customers’ end markets could affect our business and results of operations. Economic, business or regulatory conditions that affect the sector, or our failure to choose to do business in appropriate subsectors, can particularly impact us. For instance, sales in the Healthcare/Life Sciences sector are substantially affected by trends in the healthcare industry, such as government reimbursement rates and uncertainties relating to the U.S. healthcare sector generally. In addition, the Healthcare/Life Sciences sector is affected by health crises and trends. The semiconductor industry has historically been subject to significant cyclicality and volatility. Changing export regulations, increasing sanctions or other trade barriers may limit our ability to use or produce certain technologies or products in China or sell certain components or products that are ultimately destined to China. Further, potential reductions in U.S. government agency spending, including those due to budget cuts or other political developments or issues, could affect opportunities in all of our market sectors. 
We rely on timely and regular payments from our customers, and the inability or failure of our major customers to meet their obligations to us or their bankruptcy, insolvency or liquidation may adversely affect our business, financial condition and results of operations. We also have receivables factoring agreements in place; therefore, deterioration in the payment experience with or credit quality of our customers with respect to which we factor receivables, or issues with the banking counterparties to 
12
Table of Contents
our factoring agreements, could have a material adverse effect on our financial condition and results of operations if we are unable to factor such receivables. 
From time to time, our customers have been affected by merger, acquisition, divestiture and spin-off activity. While these transactions may present us with opportunities to capture new business, they also create the risk that these customers will partially reduce their purchases or completely disengage from us as a result of transitioning such business to our competitors or their internal operations.
We and our customers are subject to increasingly extensive government regulations, legal requirements and industry standards; a failure to comply with current and future regulations, requirements and standards could have an adverse effect on our business, customer relationships, reputation and profitability.
We and our customers are subject to extensive government regulation, legal requirements and industry standards (as well as customer-specific standards) relating to the products we design, manufacture and service as well as how we conduct our business. This includes regulations and standards relating to labor and employment practices, workplace health and safety, operating practices and quality systems, the environment, sourcing and global trade practices, usage of emerging technologies, data privacy and protection, ethics, financial reporting, the market sectors we support and many other facets of our operations. The regulatory climate in the U.S. and other countries has become increasingly complex and fragmented, and regulatory enforcement activity has increased in recent periods. Rulings of the U.S. Supreme Court and other courts may affect the regulatory environment. Regulatory changes and restrictions can be announced with little or no advance notice. A failure to comply with laws, regulations or standards applicable to our business can result in, among other consequences, fines, injunctions, civil penalties, criminal prosecution, recall or seizure of devices, total or partial suspension of production, including debarment, and could have an adverse effect on our reputation, customer relationships, profitability and results of operations. 
Our Healthcare/Life Sciences sector is subject to statutes and regulations covering the design, development, testing, manufacturing, labeling and servicing of medical devices and the reporting of certain information regarding their safety, including regulations by the Food and Drug Administration and similar regulations in other countries. We also design, manufacture and service products for certain industries, including certain applications where the U.S. government is the end customer, that face significant regulation by the Department of Defense, Department of State, Department of Commerce, Federal Aviation Authority and other governmental agencies in the U.S. as well as in other countries, and also under the Federal Acquisition Regulation. In addition, whenever we pursue business in new sectors and subsectors, or our customers pursue new technologies or markets, we need to navigate the potentially heavy regulatory and legislative burdens of such sectors, as well as standards of quality systems, technologies or markets. Failure to navigate these regulatory obligations and burdens could impact our operating results as well as cause reputational damage.
The regulatory climate can itself affect the demand for our services. For example, government reimbursement rates and other regulations, the financial health of healthcare providers, and changes in how healthcare systems are structured, and how medical devices are taxed, could affect the willingness and ability of end customers to purchase the products of our customers in the Healthcare/Life Sciences sector as well as impact our margins.
Our customers are also required to comply with various government regulations, legal requirements and industry standards, including many of the industry-specific regulations discussed above. Our customers’ failure to comply could affect their businesses or reputation, which in turn would affect our sales to them and pose potential reputational risk to us. In addition, if our customers are required by regulation or other requirements to make changes to their products or in their product lines, these changes could significantly disrupt particular programs we have in place for these customers and create inefficiencies in our business. Failure of our customers to identify or flow down any such requirements to us could result in production of non-compliant product, which could restrict their ability to sell such products, thus affecting our sales to them.
13
Table of Contents
We may fail to identify acquisition targets, successfully complete future acquisitions, successfully integrate acquired operations or recognize the anticipated benefits of an acquisition, which could adversely affect our operating results.
If we pursue new capabilities or geographies to enable growth through acquisitions, such activities would involve significant risks that could have a material adverse effect on us. These include operating risks such as the inability to successfully identify acquisition targets or, once a target is identified, to successfully negotiate and close an acquisition; to integrate businesses, systems and personnel; to navigate potential impacts on customer programs and relationships; and to realize anticipated synergies or economies of scale. They also include strategic risks such as the diversion of management time and attention from other business activities and opportunities and financial risks such as the use of cash or incurrence of additional debt and interest expense as consideration for the acquisition and to fund the activities required to pursue acquisitions, the potential volatility or weakness in our stock price as a result of the announcement of such transactions, the incurrence of large write-offs or write-downs as a result of the acquisition and other potential financial impacts. 
Risks impacting our Superior Execution
Plexus is a multinational corporation and operating in multiple countries exposes us to increased risks, including adverse local developments and currency risks.
We have operations in many countries. Operations outside of the U.S. in the aggregate represent a majority of our net sales and operating income, with a particular concentration in Malaysia. In addition, although we have repatriated a substantial amount of cash since the enactment of the U.S. Tax Cuts and Jobs Act (“U.S. Tax Reform”) in 2017, a significant amount of our cash balances remain held outside of the U.S., with a particular concentration in Malaysia and China. We support customers operating in various countries and purchase a significant number of components manufactured in various countries. These international aspects of our operations, which are likely to increase over time, including with any introduction of facilities in new locations, subject us to risks that could materially impact our operations and operating results, such as the following:
•
economic, political or civil instability
•
civil or international conflicts and war, including the risk of escalation in the Russia-Ukraine war, conflict in the Middle East, escalating tensions between China and Taiwan as well as China and the U.S.
•
transportation delays or interruptions
•
exchange rate fluctuations
•
potential disruptions or restrictions on our ability to access cash amounts held outside of the U.S.
•
changes in labor markets, such as government-mandated wage increases, increases to minimum wage requirements, changes in union-related laws, regulations or practices, limitations on immigration or the free movement of labor or restrictions on the use of migrant workers, and difficulties in appropriately staffing and managing personnel in diverse cultures and increased public scrutiny on labor practices
•
customers shifting parts of their manufacturing and supply chains to different countries, including re-shoring, which may impact footprint needs and create operational disruption due to transition efforts
•
compliance with laws, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and the European Union’s (EU's) General Data Protection Regulation (the “GDPR”), applicable to companies with global operations
•
changing global trade regulations, particularly relating to advanced semiconductors and chip-manufacturing equipment, which may limit the ability to ship certain components or product to customers in China, support certain programs in our China operations, and source the components necessary to manufacture customer product in China
•
changes in the taxation of earnings in the U.S. and in other countries
•
reputational risks related to, among other factors, varying standards and practices among countries
•
changes in duty rates
•
significant natural disasters and other events or factors impacting local infrastructure
•
the effects of other international political developments, such as tariffs, embargoes, sanctions, boycotts, trade wars, energy disruptions, trade agreements and changes in trade policies, including those which may be affected by the U.S. and other countries’ political reactions to those actions, and
•
other regulatory and legal requirements and industry standards, and changes thereto.
As our international operations continue to expand, our failure to appropriately address foreign currency transactions or the currency exposures associated with assets and liabilities denominated in non-functional currencies could adversely affect our consolidated financial condition, results of operations and cash flows. In addition, developments affecting particular countries can adversely affect our ability to access cash or other assets held in such countries.
14
Table of Contents
A significant portion of our operations is currently located in the APAC region, particularly in Malaysia. The concentration of our operations, workforce, assets and profitability in that region exposes us to adverse developments, economic, political or otherwise, in those countries.
Changes in policies or trade agreements by or changes in elected officials of the U.S. or other governments could negatively affect our operating results due to trade wars, changes in duties, tariffs or taxes, currency exchange rate fluctuations, higher costs of compliance, or limitations on currency or fund transfers, as well as government-imposed restrictions on producing certain products in, or shipping them to, specific countries. Our current facilities in Mexico operate under the Mexican Maquiladora (“IMMEX”) program. This program provides for reduced tariffs and eased import regulations. We could be adversely affected by changes in the IMMEX program or our failure to comply with its requirements. 
Additionally, continued uncertainty regarding commercial dealings, tariffs, export regulations and other trade protection measures between the U.S. and China, heightened by escalating geopolitical tensions, may affect our ability to do business in China, may impact the cost of our products originating in China and may impact the demand for our products manufactured in China in the event our customers reduce or eliminate their operations in China. These actions could also affect the cost and/or availability of materials or components that we procure from suppliers in China, as well as create disruptions, delays, shortages or increased costs within our global supply chain. Government-imposed restrictions on where we or our customers can produce certain types of products or source components or with whom we can conduct business, such as named companies or industries identified in the 2021 National Defense Authorization Act, outbound investment restrictions, and trade regulations limiting advanced semiconductors and chip-manufacturing equipment, could limit our ability to sell or manufacture products or services in China, or source components from certain companies or geographies. These factors can negatively affect our operating results and financial position, including reducing our revenues and profitability as a result of having to minimize engagements in China, requiring us to shift such production to other potentially higher-cost locations, or increasing the cost of sourcing components.
Further, the extent to which the conflict between Russia and Ukraine, conflict in the Middle East or the escalating tensions between China and Taiwan or China and the U.S. may impact our business or results of operations will depend on future developments, including the severity and duration of any conflicts, their impact on global supply chains and their impact on regional and global economic conditions including the ability of our customers or suppliers to do business in those or surrounding countries and the inflationary effects of such conflicts on our profitability. These tensions have resulted in, and may continue to cause, global disruptions creating significant volatility in financial markets and the global economy. 
We experience component shortages, delays, price fluctuations and supplier quality concerns.
We generally do not have long-term supply agreements. We have experienced from time to time, and may in the future experience, significant component shortages and longer lead-times due to supplier capacity constraints. Supply chain constraints and delays can be caused by world events, such as government policies, tariffs, trade wars, trade disputes and trade protection measures, terrorism, armed conflict, natural disasters, natural resource availability, economic recession, increased demand due to economic growth or technological advancements, preferential allocations, transportation challenges, and other localized events. Further, we rely on a limited number of suppliers for many of the components used in the assembly process and, in some cases, may be required to use suppliers that are the sole provider of a particular component. Such suppliers may encounter quality problems, labor disputes or shortages, financial difficulties or business continuity issues that could preclude them from delivering components timely or at all. Supply shortages and delays in deliveries of components may result in delayed manufacturing or servicing of products, which reduces our revenue and operating profit for the periods affected. Additionally, a delay in obtaining a particular component may result in other components for the related program being held for longer periods of time, increasing working capital, risking inventory obsolescence and negatively impacting our cash flow.
In addition, components that are delivered to us may not meet our specifications or other quality criteria. Certain components provided to us may be counterfeit or violate the intellectual property rights of others. The need to obtain replacement components may negatively affect our operations and operating results. The inadvertent use of any such components may also give rise to liability claims. Further, the commitments made to us by our suppliers, and the terms applicable to such relationships, may not match all the commitments we make to, and the terms of our arrangements with, our customers, and such variations may lead us to incur additional expense or liability and/or cause other disruptions to our business.
Component supply shortages and delays in deliveries, along with other factors such as tariffs, trade disputes or embargoes, inflation, and rising energy and transportation costs, can also result in increased pricing. While many of our customers permit quarterly or other periodic adjustments to pricing based on changes in component prices and other factors, we have in the past and may continue to bear the risk of price increases that occur between any such repricing or, if such repricing is not permitted, during the balance of the term of the particular customer contract. In addition, these repricing or pricing recoveries have been 
15
Table of Contents
and may continue to be dilutive to our operating margin. Conversely, as a result of our pricing strategies and practices, component price reductions have contributed positively to our operating results in the past. Our inability to continue to benefit from such reductions in the future could adversely affect our operating results, cash flows and inventory levels, which could increase as a result of higher component prices or the negative effects of inflation on customer end-market demand.
Due to the highly competitive nature of our industry, an inability to obtain sufficient inventory of quality components on a timely basis and for a reasonable price, could also harm relationships with our customers and lead to loss of business to our competitors.
Our services involve other inventory risk.
Most of our services are provided on a turnkey basis, under which we purchase some, or all, of the required materials and components based on customer forecasts or orders. Although, in general, our commercial contracts with our customers obligate our customers to ultimately purchase inventory ordered to support their forecasts or orders, we generally finance these purchases initially. In addition, suppliers at times require us to purchase materials and components in minimum order quantities that may exceed customer requirements. A customer’s cancellation, delay or reduction of forecasts or orders can also result in excess inventory or additional expense to us. Engineering changes by a customer or a product’s end-of-life may result in obsolete materials or components. While we attempt to cancel, return or otherwise mitigate excess and obsolete inventory, require customers to reimburse us for these items and/or price our services to address related risks, we may not actually be reimbursed timely or in full, be able to collect on these obligations or adequately reflect such risks in our pricing. In addition to increasing inventory in certain instances to support new program ramps, we may also increase inventory if we experience component shortages or longer lead-times for certain components in order to maintain a high level of customer service. In such situations, we may procure components earlier, which leads to an increase in inventory in the short term and may lead to increased excess or obsolete inventory in the future. Excess or obsolete inventory, the need to acquire increasing amounts of inventory due to shortages, customer demand or otherwise, or other failures to manage our working capital, could adversely affect our operating results, including our return on invested capital.
In addition, we provide managed inventory programs for some of our customers under which we hold and manage finished goods or work-in-process inventories. These managed inventory programs may result in higher inventory levels, further reduce our inventory turns and increase our financial exposure with such customers. In addition, our inventory may be held at a customer’s facility or warehouse, or elsewhere in a location outside of our control, which may increase the risk of loss. Even though our customers generally have contractual obligations to purchase such inventories from us, we remain subject to customers’ credit risks as well as the risk of potential customer default and the need to enforce those obligations.
An inability to successfully manage the procurement, development, implementation or execution of information systems, or to adequately maintain these systems and their security, as well as to protect data and other confidential information, may adversely affect our business and reputation.
As a global company with a complex business model, we are heavily dependent on our information systems to support our customers’ requirements and to successfully manage our business. Any inability to successfully manage the procurement, development, implementation, execution or maintenance of our information systems, including matters related to system and data security, cybersecurity, privacy, reliability, compliance, performance and access, as well as any inability of these systems to fulfill their intended purpose within our business, could have an adverse effect on our business. We periodically make strategic investments in enterprise-wide systems, as prior systems reach end-of-life, to enable global scalability or to add capability. Implementing new technology on this scale is complex and can create operational disruption if the implementation fails to meet our expectations.
In the ordinary course of business, we collect and store sensitive data and information, including our proprietary and regulated business information and that of our customers, suppliers and business partners, as well as personally identifiable information about our employees. Our information systems, like those of other companies, are susceptible to malicious damage, intrusions and outages due to, among other events, viruses, cyber threats, industrial espionage (internal or external), hacking, break-ins and similar events, other breaches of security, natural disasters, power loss or telecommunications failures. Due to the intellectual property we maintain on our systems related to high technology components, sub-components, manufacturing processes and our customers’ products, we are a likely target from various external cyber threats, such as lone attackers, nation states seeking to gain access to such intellectual property, as well as both unintentional and malicious internal threats. In addition, lone and organized crime elements have been known to extort money by encrypting their victims’ data (ransomware) and/or utilizing their victims’ resources for unauthorized mining of cryptocurrency. The reliance on third-party vendors in a complex supply chain can further introduce cybersecurity risks, as unmitigated vendor vulnerabilities or compromise can increase the attack surface for malicious actors.
16
Table of Contents
The increasing sophistication of cyberattacks requires us to continually evaluate the threat landscape and new technologies and processes intended to detect and prevent these attacks. There can be no assurance that the security measures and systems configurations we choose to implement will be sufficient to protect the data we manage. Any theft or misuse of information resulting from a security breach or cyberattack could result in, among other things, interruption to our operations, loss of significant and/or sensitive information, litigation by affected parties, financial obligations resulting from such theft or misuse, higher insurance premiums, governmental investigations, fines and penalties, negative reactions from current and potential future customers, and reputational damage, any of which could adversely affect our financial results.

Also, the time and funds spent on monitoring and mitigating our exposure and responding to breaches or attempted breaches, including the training of employees, the purchase of protective technologies and the hiring of additional employees and consultants to assist in these efforts could adversely affect our financial results.

This risk is enhanced as a result of the increasing sophistication of threat actors, including through the use of artificial intelligence, and an increase in our remote workforce due to evolving flexible workplace practices, for example by reason of utilizing home networks that may lack encryption or secure password protection, virtual meeting/conference security concerns and an increase of phishing/cyberattacks around our remote workforce's digital resources.
Moreover, we are subject to increasing 
data privacy, handling, and protection requirements and customer expectations due to the nature of their end products, including those related to the Export Administration Regulations, International Traffic in Arms Regulation, Federal Acquisition Regulation, Defense Federal Acquisition Regulation Supplement and Cybersecurity Maturity Model Certification
. Any operational failure or breach of security from increasingly sophisticated cyber threats could lead to the loss or disclosure of our or our customers’ financial, product or other confidential information, result in adverse regulatory or other legal actions and have a material adverse effect on our business and reputation. In addition, we must comply with increasingly complex and rigorous regulatory standards enacted to protect business and personal data, globally. GDPR and similar legislation in jurisdictions in which we operate continue to evolve imposing additional obligations on companies regarding the handling and protection of personal data and provide certain individual privacy rights to persons whose data is processed and stored. Compliance with existing, proposed and recently enacted laws and regulations can be costly. Failure to comply with these regulatory standards could subject us to legal and reputational risks. Misuse of or failure to protect personal information could also result in violation of data privacy laws and regulations, proceedings against us by governmental entities or others, fines and penalties, damage to our reputation and credibility and could have a negative impact on our business and results of operations.
We have a complex business model and are subject to rapidly changing technology requirements; our failure to properly manage or execute on that model and those requirements could adversely affect our operations, financial results and reputation.
Our business model focuses on products and services that are highly complex and subject to demanding regulatory requirements. Our customers’ products typically require significant production and supply-chain flexibility necessitating optimized solutions across an integrated global platform. The products we design, manufacture and service are also typically complex, heavily regulated and require complicated configuration management and direct order fulfillment capabilities to global end customers. 
Our business model requires working capital, management and technical personnel, and the development and maintenance of systems and procedures to manage diverse design, manufacturing, regulatory and sustaining services requirements for multiple programs of varying sizes simultaneously, including in multiple locations and geographies. We also depend on securing and ramping new customers and programs as well as transitioning production for new customers and programs, which creates added complexities related to managing the start-up risks of such projects, especially for companies that did not previously outsource such activities.
The complexity of our model, which encompasses a broad range of services including design and development, supply chain solutions, new product introduction, manufacturing and sustaining services, often results in complex and challenging contractual obligations and unique customer requirements. In addition, program complexity and associated customer expectations have increased in recent years with respect to certain capabilities, commitments, allocation of risk and compliance with third-party standards, requiring extraordinary measures to ensure operational execution and compliance within unique, non-standard engagements. If we fail to meet those obligations, or are otherwise unable to execute on our commitments or unsuccessfully mitigate such risks, then it could result in claims against us, regulatory violations, or adversely affect our reputation and our ability to obtain future business, as well as impair our ability to enforce our rights (including those related to payment) under those contracts. A failure to adequately understand unique customer requirements may also impact our ability to estimate and ultimately recover associated costs, adversely affecting our financial results.
17
Table of Contents
Many of our customers' markets are characterized by rapidly changing technology and evolving process developments. Our internal processes are also subject to these factors. The sustained success of our business will depend upon our continued ability to:
•
attract and retain qualified engineering and technical personnel, especially in times of tight labor markets 
•
choose, maintain and enhance appropriate technological and service capabilities
•
successfully manage the implementation and execution of information systems
•
develop and market services that meet changing customer needs
•
effectively and efficiently execute our services and perform to our customers’ expectations, and
•
successfully anticipate, or respond to, technological changes on a cost-effective and timely basis.
Although we believe that our operations utilize the technologies, equipment and processes that are currently required by our customers, we cannot be certain that we will maintain or develop the capabilities required by our customers in the future. The emergence or advancement in technologies, such as artificial intelligence, industry standards or customer requirements may render our technical personnel, equipment, inventory or processes obsolete or noncompetitive. In addition, we may have to acquire new skills, technologies and equipment to remain competitive, as well as offer new or additional services, all of which may require significant expense or capital investment that could reduce our liquidity and negatively affect our operating results. Our failure to anticipate and adapt to our customers’ changing technological needs and requirements, or to perform to their expectations or standards, as well as our need to maintain our personnel and other resources during times of fluctuating demand, could have an adverse effect on our business.
Physical risks, including natural disasters and weather events caused by global climate change, breaches of physical security and other events outside our control, and the ineffective management of such events, may harm our business.
Some of our facilities are located in areas that may be impacted by natural disasters including tornadoes, hurricanes, earthquakes, water shortages, tsunamis or floods. Further, there continues to be concern that global climate change is impacting the frequency and severity of these natural disasters. All facilities are subject to other potential natural or man-made disasters such as those related to weather events or global climate change, fires, acts of terrorism or war, breaches of security, theft or espionage, workplace violence and failures of utilities. If such an event was to occur and we did not have an effective business continuity plan in place, our business could be harmed due to the event itself or due to our inability to effectively manage the effects of the particular event, with the impact of the event potentially magnified in areas where we have multiple facilities in close proximity. For example, we maintain significant production capacity in Penang, Malaysia, and an event in that geography could materially hinder our production capabilities. Potential harms include the loss of business continuity, financial risk, the loss of business data and damage to infrastructure. These natural disasters and physical climate risks could also disrupt our operations by impacting the availability and cost of materials within our supply chain, and could also increase insurance and other operating costs. These factors may impact our decisions to construct new facilities or maintain existing facilities in areas most prone to physical climate risks, such as our facilities in Malaysia that are at or near sea level.
In addition, some of our facilities possess certifications or unique equipment necessary to work on specialized products that our other locations lack. If work is disrupted at one of these facilities, it may be impractical or we may be unable to transfer such specialized work to another facility without significant costs and delays. Thus, any disruption in operations at a facility possessing specialized certifications or equipment could adversely affect our ability to provide products and services to our customers, and potentially have a negative effect on our relationships and financial results. While we maintain business continuity plans, including data system recovery protocols, to enable us to maintain operations following a natural disaster or other event that may be disruptive to our business, we cannot ensure these responses will fully mitigate or protect us from all disruptions. While we also carry insurance coverage for a variety of property, casualty and other risks, insurance coverage, as well as our other risk mitigation efforts, may be inadequate, not cost-effective or unavailable, either in general or for particular types of events.
Although we have implemented policies and procedures with respect to physical security, we remain at risk of unauthorized access to our facilities and the possible unauthorized use or theft of inventory, information or other physical assets. If unauthorized persons gain physical access to our facilities, or our physical assets or information are stolen, damaged or used in an unauthorized manner (whether through outside theft or industrial espionage), we could be subject to, among other consequences, interruption in our operations, negative publicity, governmental inquiry and oversight, loss of government contracts, litigation by affected parties or other future financial obligations related to the loss, misuse or theft of our or our customers’ data, inventory or physical assets, any of which could have a material adverse effect on our reputation and results of operations.
18
Table of Contents
There may be problems with the products we design, manufacture or service that could result in liability claims against us, reduced demand for our services and damage to our reputation.
We design, manufacture and service products to our customers’ specifications, many of which are highly complex and subject to demanding regulatory environments for market sectors that generally have higher risk profiles for liability claims. Further, the services we provide to our customers continue to expand to encompass full product development, product commercialization, manufacturing, and sustaining services. As we assume more responsibility across the product lifecycle, our customers’ expectations have and may continue to extend beyond what has historically been expected of electronics manufacturing service providers, such as expectations related to environmental sustainability and heightened regulatory compliance support, including as it relates to product composition such as the Restrictions on Hazardous Substances ("RoHS") 2011/65/EU directive, the Registration, Evaluation, Authorization and restriction of Chemicals ("REACh") EC 1907/2006 EU directive, and emerging regulations pertaining to per- and polyfluoroalkyl substances ("PFAS"). These dynamics increase the risks inherent in those engagements. Despite our quality control and quality assurance efforts, problems may occur, or may be alleged, in the execution of these services. Whether or not we are responsible, problems in the products we create, whether real or alleged, whether caused by faulty customer specifications, product design, manufacturing processes, servicing, a component defect or otherwise, may result in delayed shipments to customers or reduced or canceled customer orders or liability claims. If these problems were to occur in large quantities or too frequently, our business reputation may also be tarnished. In addition, such problems may result in liability claims against us, whether or not we are responsible. These potential claims may be initiated through various means, such as our contractual commitments, strict liability or other claims raised by third parties, and may include damages for the recall of a product, injury to person(s) or property, or other theories of liability.
Even if customers or third parties, such as component suppliers, are responsible for defects, they may not, or may not be able to, assume responsibility for any such costs or required payments to us. While we seek to secure contractual protection and/or to insure against many of these risks, we may not have practical recourse against certain third parties, and contractual protections, insurance coverage or supplier warranties, as well as our other risk mitigation efforts, may be inadequate, not cost-effective or unavailable, either in general or for particular types of products or issues. We occasionally incur costs defending claims, we may be unsuccessful in defending against claims and incur financial liabilities, and any such disputes could adversely affect our business relationships.
A failure to comply with customer-driven policies and standards, and third-party certification requirements or standards could adversely affect our business and reputation.
In addition to government regulations and industry standards, our customers may require us to comply with their own or third-party quality standards, commercial terms, or other business policies or standards, which may be more restrictive than current laws and regulations as well as our pre-existing policies and/or terms with our suppliers, before they commence, or continue, doing business with us. Such policies or standards may be customer-driven, established by the market sectors in which we operate or imposed by third-party organizations.
Our compliance with these heightened and/or additional policies, standards and third-party certification requirements, and managing a supply chain in accordance therewith, could be costly, and our failure to comply could adversely affect our operations, customer relationships, reputation and profitability. In addition, our adoption of these standards could adversely affect our cost competitiveness, ability to provide customers with required service levels and ability to attract and retain employees in jurisdictions where these standards vary from prevailing local customs and practices. In certain circumstances, to meet the requirements or standards of our customers we may be obligated to select certain suppliers or make other sourcing choices, and we may bear responsibility for adverse outcomes even if these matters are as the result of third-party actions or outside of our control.
Intellectual property infringement claims against our customers or us could harm our business.
Although our manufacturing processes are generally not subject to significant proprietary protection, our services may and our customers' products do involve the creation and use of intellectual property rights, which subject us and our customers to the risk of claims of intellectual property infringement from third parties. In addition, our customers may require that we indemnify them against the risk of intellectual property infringement. If any claims are brought against us or our customers for infringement, whether or not these have merit, then we could be required to expend significant resources in defense of those claims. In the event of an infringement claim, we may be required to spend a significant amount of money to develop non-infringing alternatives or obtain licenses. We may not be successful in developing alternatives or obtaining licenses on reasonable terms or at all. Infringement by our customers could cause them to discontinue production of some of their products, potentially with little or no notice, which may reduce our net sales to them and disrupt our production.
19
Table of Contents
Additionally, if third parties on whom we rely for products or services, such as component suppliers, are responsible for an infringement (including through the supply of counterfeit parts), we may or may not be able to hold them responsible and we may incur costs in defending claims or providing remedies. Such infringements may also cause our customers to abruptly discontinue selling the impacted products, which would adversely affect our net sales of those products and could affect our customer relationships more broadly. Similarly, claims affecting our suppliers could cause those suppliers to discontinue selling materials and components upon which we rely.
Risks impacting our Passion Meets Purpose
We depend on our workforce, and the inability to attract, develop and retain personnel or an increase in personnel costs or other personnel disruptions may harm our business.
If we fail to attract, develop and retain sufficient qualified personnel, including key leadership positions and highly skilled technical roles, our operations and, consequently, our financial results, could be adversely affected. A number of factors may adversely affect labor availability in one or more of our locations, including wage pressure and changing wage requirements, restrictions on immigration or labor mobility, local competition, high employment rates, high turnover rates and local labor laws. These labor-related issues and labor shortages are pronounced, and we expect these conditions to persist. 
We have also experienced inflationary or other general personnel cost increases due to economic conditions and government-mandated wage increases. Further, increases in turnover rates can lead to decreased efficiency and increased costs in our operations, such as increased overtime to meet demand, increased wage rates to attract and retain employees, and costs associated with recruiting training replacement personnel. If we are unable to offset these labor cost increases through price increases, growth or operational efficiencies, labor cost increases could have a material adverse effect on our operating results and cash flows. 
We also depend on good relationships with our workforce. Monitoring employee engagement and maintaining a healthy workplace culture based on our core values is important to developing these good relationships and retaining a committed workforce. A failure to foster a strong, healthy culture, or a failure to adopt or maintain policies and practices that enhance our workplace culture or competitiveness, such as those related to diversity and inclusion, workplace flexibility or other employee benefits, could adversely impact our ability to attract, develop and retain personnel and could substantially affect our operations and financial results. Further, dissatisfied employees may be more likely to seek union organization, which could disrupt our business, increase the risk of a labor strike and adversely impact our operations, financial results, and reputation.
From time to time, there are changes and developments, such as retirements, promotions, transitions, disability, death and other terminations of service, that affect our executive officers and other key employees, including those that are unexpected or occur simultaneously. Transitions or other changes in responsibilities among officers and key employees without having identified and ready successors for these critical roles, particularly when such changes are unanticipated, unplanned or not executed effectively, inherently can cause disruptions to our business and operations, as well as harm our reputation, which could have an effect on our results. Further, as we grow in size and complexity, a failure to effectively develop personnel and plan for the succession of critical roles may result in shortfalls in the talent and skills required to execute effectively and grow our business, which could affect our operations and financial results.    
Evolving expectations on environmental, social and governance ("ESG") matters, including global climate change, by various stakeholders could negatively affect our business.
Customer, investor and employee expectations relating to ESG have been rapidly evolving and increasing.

In addition, governmental and non-governmental organizations are enhancing or advancing requirements specific to ESG matters. Specifically, certain stakeholders are beginning to request or require disclosures on ESG topics such as greenhouse gas emissions, human capital matters and specific ESG-risk management practices, and we expect this trend to continue and be amplified by existing and potential legislation, such as the Corporate Sustainability Reporting Directive in the European Union and the U.S. Securities and Exchange Commission ("SEC") climate rules. A failure to adequately meet stakeholder expectations and reporting requirements may result in noncompliance with any imposed regulations, the loss of business, reputational impacts, an inability to attract and retain customers, and an inability to attract and retain talent.  In addition, our adoption of certain standards, related reporting requirements, or mandated compliance to certain requirements could necessitate additional investments that could impact our profitability. 
Further, increased public awareness and concern regarding global climate change may result in new or enhanced requirements and/or stakeholder expectations to reduce or mitigate the effects of greenhouse gas emissions and transition to low-carbon alternatives, driven by policy and regulations, low-carbon technology advancement and shifting consumer sentiment and societal preferences. These transition risks could negatively impact our financial condition and results of operations including 
20
Table of Contents
by means of carbon pricing mechanisms, investments in lower greenhouse gas emissions technology, increased cost of raw materials and mandates on and regulation of existing products and services.

In addition, the economic and market uncertainty created by transitioning to low-carbon alternatives could result in reduced demand or product obsolescence for certain of our customers’ products and/or price modifications for our customers’ products and the resources needed to produce them.

This could in turn put pressure on our costs and result in reduced profit margin associated with certain of our customer programs, or loss of customer programs that we may not be able to replace. 
Risks impacting our Discipline By Design
Challenges associated with the engagement of new customers or programs, the provision of new services, or start-up costs and inefficiencies related to new, recent or transferred programs could affect our operations and financial results.
Our engagement with new customers, as well as the addition of new programs or types of services for existing customers, can present challenges in addition to opportunities. We must initially determine whether it would be in our interests from a business perspective to pursue a particular potential new customer, program or service, including evaluating whether the customer, program or service fits with our value proposition as well as its potential end-market success. If we make the decision to proceed, we need to ensure that our terms of engagement, including our pricing and other contractual provisions, appropriately reflect the strategic nature of the customer, anticipated costs, risks and rewards. The failure to make prudent engagement decisions or to establish appropriate terms of engagement could adversely affect our profitability and margins.
Also, there are inherent risks associated with the timing and ultimate realization of anticipated revenue and profitability from a new program or service; these factors can sometimes extend for a significant period. Some new programs or services require us to devote significant capital and personnel resources to new technologies and competencies. We may not meet customer expectations, which could damage our relationships with the affected customers and impact our ability to deliver conforming product or services on a timely basis. Further, the success of new programs may depend heavily on factors such as product reliability, market acceptance, regulatory approvals or economic conditions. The failure of a new program to meet expectations on these factors, or our inability to effectively execute on a new program’s or service’s requirements, could result in lost financial opportunities and adversely affect our results of operations.
In recent years, ramping new programs has been a key contributor to our revenue growth. The management of resources in connection with the establishment of new or recent programs and customer relationships and the need to estimate required resources in advance of production can adversely affect our gross and operating margins and level of working capital. These factors are particularly evident in the early stages of the life-cycle of new programs, which typically lack a track record of order volume and timing as well as production efficiencies in the early stages. We typically manage multiple new programs at any given time; therefore, we are exposed to these factors in varying magnitudes. 
The effects of these start-up costs and inefficiencies can also occur when we transfer programs between locations and geographies. We conduct these transfers on a regular basis to meet customer needs, seek long-term efficiencies or respond to market conditions, as well as due to facility openings and closures. Although we try to recover costs from our customers and minimize the potential losses arising from transitioning customer programs between our facilities and geographies, we may not be successful and there are inherent risks that such transitions can result in operational inefficiencies and the disruption of programs and customer relationships.
While these factors tend to affect new, recent or transferred programs, they can also impact more mature or maturing programs and customer relationships, especially programs where end-market demand can be somewhat volatile.
Failure to manage periods of growth or contraction may seriously harm our business.
Our industry frequently sees periods of expansion and contraction. We regularly contend with these issues and must carefully manage our business to meet changing customer and market requirements. If we fail to manage these growth and contraction decisions effectively, or fail to realize the anticipated benefits of these decisions, we can find ourselves with either excess or insufficient resources and our business, as well as our profitability, may suffer. Expansion and consolidation, including the transfer of operations to new or other facilities or due to acquisitions, can inherently include additional costs and start-up inefficiencies. For example, we are expanding our operations by constructing an additional manufacturing facility in Penang, Malaysia, to support our growth in the Asia-Pacific region. In addition, we may expand our operations in new geographical areas where currently we do not operate. If we are unable to effectively manage this or other expansions or consolidations, or 
21
Table of Contents
related anticipated net sales are not realized, our operating results could be adversely affected. Other risks of current or future expansions, acquisitions and consolidations include:
•
the inability to successfully integrate additional facilities or incremental capacity and to realize anticipated efficiencies, economies of scale or other value
•
challenges faced as a result of transitioning programs
•
incurrence of restructuring costs or other charges that may be insufficient or may not have their intended effects
•
additional fixed or other costs, or selling and administrative expenses, which may not be fully absorbed by new business
•
a reduction of our return on invested capital, including as a result of excess inventory or excess capacity at new facilities, as well as the increased costs associated with opening new facilities
•
difficulties in the timing of expansions, including delays in the implementation of construction and manufacturing plans
•
diversion of management's attention from other business areas during the planning and implementation of expansions
•
strain placed on our operational, financial and other systems and resources, and
•
inability to locate sufficient customers, employees or management talent to support the expansion.
Periods of contraction or reduced net sales, or other factors affecting particular sites, create other challenges. We must determine whether facilities remain viable, whether staffing levels need to be reduced and how to respond to changing levels of customer demand. While maintaining excess capacity or higher levels of employment entail short-term costs, reductions in capacity or employment could impair our ability to respond to new opportunities and programs, market improvements or to maintain customer relationships. Our decisions to reduce costs and capacity can affect our short-term and long-term results. When we make decisions to reduce capacity or to close facilities, we frequently incur restructuring costs. In Fiscal 2024, we closed an engineering facility in Darmstadt, Germany and a manufacturing facility in Portland, Oregon, and we incurred restructuring costs associated with both closures. 
In addition, to meet our customers' needs, particularly when the production requirements of certain products are site-specific, to achieve increased efficiencies or to address factors affecting specific locations, such as tariffs and trade disputes, we sometimes require additional capacity in one location while reducing capacity in another. Since customers’ needs and market conditions can vary and change rapidly, we may find ourselves in a situation where we simultaneously experience the effects of contraction in one location and expansion in another location. We may also encounter situations where our lack of a physical presence in certain locations may limit or foreclose opportunities.
Changes in tax laws, potential tax disputes, negative or unforeseen tax consequences or further developments affecting our deferred tax assets could adversely affect our results.
Our effective tax rate is highly dependent upon the geographic mix of earnings across the jurisdictions where we operate. Changes in tax laws or tax rates in those jurisdictions, including, but not limited to, as a result of actions by the U.S. (including additional guidance and interpretations related to U.S. Tax Reform or potential passage of tax regulation changes under the U.S. presidential administration) or other countries, could continue to have a material impact on our operating results. Among other things, we have been, and are expected to continue to be, affected by the global intangible low-taxed income provisions added by U.S. Tax Reform and related new tax legislation, interpretations and guidance. Our effective tax rate may also be impacted by tax holidays and other various tax credits granted by local taxing authorities. In addition, the implementation of U.S. Tax Reform has required the use of estimates, which may be refined in future periods. All incentives, including a tax holiday granted to our Malaysian subsidiary, are subject to certain terms and conditions, which could be unfavorably altered by the local taxing authorities or changes to U.S. tax policy. We would experience adverse tax consequences if we are found to not be in compliance.
A global minimum tax has been, or is anticipated to be, implemented in many of the countries in which Plexus operates. We anticipate this will materially and unfavorably impact our existing tax holidays and effective tax rate although to what extent is difficult to estimate without final rules and regulations. As of September 28, 2024, we expect those impacts to begin in fiscal 2026 and carry forward.
Our taxable income in any jurisdiction is dependent upon the local taxing authority’s acceptance of our operational and intercompany transfer pricing practices as being at “arm’s length.” Due to inconsistencies among jurisdictions in the application of the arm’s length standard, our transfer pricing methods may be challenged and, if not upheld, could increase our income tax expense. Risks associated with transfer pricing adjustments are further highlighted by the global initiative from the Organization for Economic Cooperation and Development called the Base Erosion and Profit Shifting ("BEPS") project. The BEPS project is challenging longstanding international tax norms regarding the taxation of profits from cross-border business. 
22
Table of Contents
Given the scope of our international operations and the fluid and uncertain nature of how the BEPS project might ultimately lead to future legislation, it is difficult to assess how any changes in tax laws would impact our income tax expense.
We review the probability of the realization of our net deferred tax assets each period based on forecasts of taxable income by jurisdiction. This review uses historical results, projected future operating results based upon approved business plans, eligible carryforward periods, tax planning opportunities and other relevant considerations. Adverse changes in the profitability and financial outlook in each of our jurisdictions may require the creation of an additional valuation allowance to reduce our net deferred tax assets. Such changes could result in material non-cash expenses in the period in which the changes are made.
We may fail to secure or maintain necessary additional financing or capital.
Although we have credit facilities, we cannot be certain that our existing credit arrangements will provide all of the financing capacity that we will need in the future or that we will be able to change the credit facilities or revise covenants, if necessary, to accommodate changes or developments in our business and operations and/or increased working capital needs. In addition, if we do not comply with the covenants under our credit facility, our ability to borrow under that facility would be adversely affected. In addition, it is possible that counterparties to our financial agreements, including our credit facility and receivables factoring programs, may not be willing or able to meet their obligations, either due to instability in the global financial markets or otherwise, which could, among other impacts, increase the duration of our cash collection cycle. While we currently believe we have ample liquidity to manage the financial impact of current economic conditions, we can give no assurance that this will continue to be the case if the impact of current or worsening economic conditions is prolonged. 
Our future success may depend on our ability to obtain additional financing and capital to support possible future growth and future initiatives including additional investments in our business. In addition, we also have receivables factoring programs. Many of our borrowings are at variable interest rates and therefore our interest expense is subject to increase if rates increase. Persistent inflation, especially in Europe and the U.S., has led central banks to hold higher interest rates throughout fiscal 2024 to dampen inflation. These interest rates directly impact the amount of interest we pay on our variable rate obligations and continued or sustained increases in interest rates could negatively impact our business.
We may seek to raise capital by issuing additional common stock, other equity securities or debt securities, modifying our existing credit facilities or obtaining new facilities, or through a combination of these methods. We may not be able to obtain capital when we want or need it, particularly in light of ongoing volatility in the capital markets, and capital may not be available on satisfactory terms. If we issue additional equity securities or convertible securities to raise capital, it may be dilutive to shareholders’ ownership interests; we also may not be able to offer our securities on attractive or acceptable terms in the event of volatility or weakness in our stock price. Furthermore, any additional financing may have terms and conditions that adversely affect our business, such as restrictive financial or operating covenants, and our ability to meet any current or future financing covenants will largely depend on our financial performance, which in turn will be subject to general economic conditions and financial, business and other factors.
ITEM 1B.    UNRESOLVED SEC STAFF COMMENTS
None.
ITEM 1C.    CYBERSECURITY
Information Technology & Security Risk Management
Information security and data privacy risk management, including cybersecurity, is integrated into and aligns with our Enterprise Risk Management ("ERM") processes. Our information protection and privacy program incorporates administrative, technical and physical safeguards, and incorporates various cybersecurity and internal control frameworks to protect information assets, manage data privacy and ensure compliance with laws and industry standards. We leverage the National Institute of Security and Technology ("NIST") Cybersecurity Framework ("CSF"), among others, to provide a strategic and adaptable approach to managing evolving cyber risks. This framework assists in assessing and improving our security posture by identifying vulnerabilities and prioritizing investments or improvements.
We maintain a cybersecurity incident response plan to assist in the assessment and management of cybersecurity incidents. The plan includes tactical playbooks and crisis response procedures based on incident severity and materiality impact. These crisis response procedures include escalation to the Audit Committee and the full Board of Directors, where appropriate. Our incident response plan is periodically tested through tabletop exercises, the results of which are reported to the Audit Committee.
23
Table of Contents
Cybersecurity Governance & Oversight
Our Chief Information & Technology Officer ("CITO"), who reports directly to the President and Chief Executive Officer ("CEO"), directs our global information technology vision and long-term strategies. Under the direction of the CITO, the Director of Cybersecurity leads our enterprise-wide cybersecurity program and oversees a dedicated global cybersecurity team that monitors, assesses and mitigates material risks from various cybersecurity threats. This team leads critical efforts to drive readiness, awareness and learning across the organization, including management of a 24x7x365 Cybersecurity Operations Center for detection and response capabilities; maintaining a cybersecurity awareness learning management system; and third party assessments and audits, penetration tests and "red team" assessments to evaluate the effectiveness of cybersecurity controls and identify areas of cybersecurity risk.
The Director of Cybersecurity is a seasoned cybersecurity expert with over 18 years of cybersecurity experience combined within the United States Department of Defense and Electronic Manufacturing Services industry. The Company's Director of Cybersecurity holds industry-recognized cybersecurity certifications, a Bachelor of Science degree in Cybersecurity and a Master of Science degree in Cybersecurity Management and Policy.
Our executive-level Security Steering Committee provides oversight of cybersecurity, data governance and privacy programs. This Committee is made up of select executives including the General Counsel, Chief Administrative Officer and Secretary ("CAO"); Chief Operating Officer; and CITO. The Security Steering Committee provides oversight and ensures program alignment to Plexus' strategic goals. The committee serves to provide awareness and guidance to prioritization, organizational alignment and enablement of resources to minimize risk to Plexus' operations, brand and reputation. The Security Steering Committee, through the Director of Cybersecurity and the CITO, reports to a broader Information Technology ("IT") Steering Committee, which includes the President and CEO and Chief Financial Officer. 
On at least an annual basis, and on topical information security matters more frequently as determined by the Board of Directors or management, the Audit Committee reviews the effectiveness of IT risk governance and management, including those relating to business continuity, cybersecurity, malware, regulatory compliance and data management. These reviews also include reviewing the appropriateness of resources (people and financial) devoted to information technology requirements. The CITO and Director of Cybersecurity also brief the Audit Committee quarterly on cybersecurity matters, including specific risks, mitigation plans, risk management and governance. The Audit Committee reports to the full Board of Directors on these discussions as appropriate. 
Further, the Board of Directors is briefed periodically (at least annually) on our overall IT strategy, including cybersecurity, to ensure alignment with the business,  review of assets and infrastructure, and trends, key risks and initiatives.
Impact of Cybersecurity Threats
As of the date of this report, we believe that risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have not or are not reasonably likely to materially affect us, including our business strategy, results from operations, or financial condition. Despite our cybersecurity measures, there can be no assurance that we, or the third-parties we interact with, will not experience a cybersecurity incident in the future that will materially affect us. As part of our overall risk mitigation strategy, we maintain insurance coverage that is intended to address certain aspects of cybersecurity risks; however, such insurance may not be sufficient in type or amount to cover us against claims related to cybersecurity breaches, cyberattacks, and other related breaches. Refer to the discussion in "Risk Factors" in Part I, Item 1A herein for further details on cybersecurity and information technology risks that could adversely affect our business, results of operation and financial conditions.
24
Table of Contents
ITEM 2.    PROPERTIES
Our facilities are comprised of an integrated network of manufacturing and engineering centers with our corporate headquarters located in Neenah, Wisconsin. We own or lease facilities with approximately 5.0 million square feet of active capacity. This includes approximately 2.0 million square feet in AMER, approximately 2.5 million square feet in APAC and approximately 0.5 million square feet in EMEA. Our active facilities as of September 28, 2024 are described in the following table:
Location
Type
Size (sq. ft.)
Owned/Leased
AMER
Neenah, Wisconsin
Manufacturing
418,000 
Owned
Guadalajara, Mexico (1)
Manufacturing/Engineering
741,000 
Leased
Nampa, Idaho
Manufacturing
216,000 
Owned    
Appleton, Wisconsin
Manufacturing
205,000 
Owned    
Buffalo Grove, Illinois (1)
Manufacturing
189,000 
Leased    
Neenah, Wisconsin
Global Headquarters
104,000 
Owned    
Neenah, Wisconsin
Engineering
90,000 
Leased    
Raleigh, North Carolina
Engineering
41,000 
Leased    
APAC
Penang, Malaysia (1)
Manufacturing/Engineering
1,530,000 
Owned    
Bangkok, Thailand
Manufacturing
389,000 
Owned
Haining, China (1)
Manufacturing
264,000 
Leased
Xiamen, China (1)
Manufacturing
253,000 
Leased
EMEA
Oradea, Romania
Manufacturing/Engineering
296,000 
Owned
Oradea, Romania
Manufacturing
108,000 
Leased
Livingston, Scotland
Manufacturing/Engineering
62,000 
Leased    
Kelso, Scotland
Manufacturing
57,000 
Owned    

(1)
The facilities in Guadalajara, Mexico; Buffalo Grove, Illinois; Penang, Malaysia; Haining, China; and Xiamen, China include more than one building.
ITEM 3.    LEGAL PROCEEDINGS
Refer to Note 10, "Litigation," for information regarding legal proceedings in which we are involved. 
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.
25
Table of Contents
PART II
ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Performance Graph
Our common stock trades on the Nasdaq Stock Market in the Nasdaq Global Select Market tier (symbol: PLXS).
The following graph compares the cumulative total return on Plexus common stock with the Standard & Poor's MidCap 400 Index ("S&P 400") and the Nasdaq Stock Market Index for Electronic Components Companies ("Nasdaq-Electronic Components"). The values on the graph show the relative performance of an investment of $100 made
 on September 28, 2019 
in Plexus common stock and in each of the indices as of the last business day of the respective fiscal year.
Comparison of Cumulative Total Return
2019
2020
2021
2022
2023
2024
Plexus
$100
$113
$146
$140
$149
$218
Nasdaq-Electronic Components
100
107
145
121
148
200
S&P 400
100
99
140
115
130
162
Shareholders of Record
As of November 11, 2024, we had 325 shareholders of record. 
Dividends
We have not paid any cash dividends in the past. We currently anticipate that in the foreseeable future the majority of earnings will be retained to finance the development of our business through capital expenditures and working capital requirements, as well as execution upon our share repurchase authorizations as management deems appropriate and market conditions may allow. However, our Board of Directors evaluates from time to time potential uses of excess cash, which in the future may include additional share repurchases, a special dividend or recurring dividends. See also Part II, Item 7, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources," for additional discussion of our intentions regarding dividends as well as a description of loan covenants that could restrict our ability to make future dividend payments.
26
Table of Contents
Issuer Purchases of Equity Securities
The following table provides the specified information about the repurchases of shares by us during the three months ended September 28, 2024:
Period
Total number of shares purchased
Average price paid per share
Total number of shares purchased as part of publicly announced plans or programs
Maximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
June 30, 2024 to July 27, 2024
60,094 
$
107.54 
60,094 
$
13,058,922 
July 28, 2024 to August 24, 2024
28,844 
121.16 
28,844 
59,564,264 
August 25, 2024 to September 28, 2024
76,795 
124.80 
76,795 
49,980,101 
165,733 
$
117.91 
165,733 
(1) On January 16, 2024, the Company announced that its Board of Directors had approved a $50.0 million share repurchase authorization (the "2024 Program") that authorizes the Company to repurchase its common stock. 
On August 14, 2024 the Board of Directors approved a share repurchase program (the "2025 Program") that authorizes the Company to repurchase up to $50.0 million of its common stock beginning upon completion of the Company’s 2024 Program.  The 2025 Program commenced upon completion of the 2024 Program, and has no expiration. 
The table above reflects the maximum dollar amount remaining available for purchase under the 2025 Program as of September 28, 2024.
27
Table of Contents
ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
OVERVIEW
Plexus Corp. and its subsidiaries (together "Plexus," the "Company," or "we") help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. Our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial market sectors supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. 
The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to provide an analysis of both short-term results and future prospects from management’s perspective, including an assessment of the financial condition and results of operations, events and uncertainties that are not indicative of future operations and any other financial or statistical data that we believe will enhance the understanding of our company’s financial condition, cash flows and other changes in financial condition and results of operations. The information should be read in conjunction with our consolidated financial statements included herein and "Risk Factors" included in Part I, Item 1A herein.
A discussion regarding our financial condition and results of operations for fiscal 2024 compared to fiscal 2023 is presented below. A discussion regarding our financial condition and results of operations for fiscal 2023 compared to fiscal 2022 is incorporated herein by reference from Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our Annual Report on the Form 10-K for the fiscal year ended September 30, 2023, which was filed with the SEC on November 17, 2023, and is available on the SEC’s website at www.sec.gov as well as our Investor Relations website at www.plexus.com.
Market Pressures Update
We have experienced market-driven inventory corrections and incrementally weaker demand from our customers in our Healthcare/Lifesciences and Industrial market sectors. While we are starting to see improvements, if market softness continues for extended periods, this would impact our operating results in future periods.
We believe our balance sheet is positioned to support the potential future challenges presented by the macroeconomic pressures we are facing. As of September 28, 2024, cash and cash equivalents and restricted cash were $347 million, while debt, finance lease and other financing obligations were $247 million. Borrowings under our credit facility as of September 28, 2024 were $50 million, leaving $450 million of our revolving commitment of $500 million available for use as of September 28, 2024 as well as the ability to expand our revolving commitment to $750 million upon mutual agreement with our banks. Interest expense could increase above current levels due to increased borrowing under our credit facility associated with working capital investments along with the impact of rising interest rates. Refer to Note 4, "Debt, Finance Lease and Other Financing Obligations," in Notes to Consolidated Financial Statements and "Management’s Discussion and Analysis of Liquidity and Capital Resources" in Part II, Item 7 for further information.
28
Table of Contents
RESULTS OF OPERATIONS
Consolidated Performance Summary. 
The following table presents selected consolidated financial data for the indicated fiscal years (dollars in millions, except per share data):
2024
2023
Net sales
$
3,960.8 
$
4,210.3 
Cost of sales
3,582.3 
3,815.8 
Gross profit
378.5 
394.6 
Gross margin
9.6 
%
9.4 
%
Operating income
167.7 
195.8 
Operating margin
4.2 
%
4.7 
%
Other expense
38.2 
34.8 
Income tax expense
17.7 
21.9 
Net income 
111.8 
139.1 
Diluted earnings per share
$
4.01 
$
4.95 
Return on invested capital*
11.8 
%
13.4 
%
Economic return*
3.6 
%
4.4 
%
*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information. 
Net sales.
 Fiscal 2024 net sales decreased $249.5 million, or 5.9%, as compared to fiscal 2023. 
Net sales are analyzed by management by geographic segment, which reflects our reportable segments, and by market sector. Management measures operational performance and allocates resources on a geographic segment basis. Our global business development strategy is based on our targeted market sectors. 
As a percentage of consolidated net sales, net sales attributable to customers representing 10.0% or more of consolidated net sales as well as the percentage of net sales attributable to our ten largest customers for the indicated fiscal years were as follows:

2024
2023
GE Healthcare Technologies, Inc. ("GEHC")
*
10.3%
Top 10 customers
47.8%
49.6%
 * Net sales attributable to the customer were less than 10.0% of consolidated net sales for the period.
A discussion of net sales by reportable segment is presented below for the indicated fiscal years (in millions):
2024
2023
Net sales:
AMER
$
1,323.4 
$
1,558.2 
APAC
2,213.1 
2,358.4 
EMEA
541.6 
403.0 
Elimination of inter-segment sales
(117.3)
(109.3)
Total net sales
$
3,960.8 
$
4,210.3 
AMER. 
Net sales for fiscal 2024 in the AMER segment decreased $234.8 million, or 15.1%, as compared to fiscal 2023. The decrease in net sales was driven by overall net decreased customer end-market demand, inclusive of market-driven inventory corrections at our customers, as well as reductions in inflated component pricing. The decrease was further driven by a decrease of $38.7 million due to disengagements with customers and $35.9 million due to the discontinuation of programs with existing customers. The decrease was partially offset by an increase of $68.8 million due to production ramps of new products for existing customers and $41.4 million due to production ramps for new customers.
29
Table of Contents
APAC. 
Net sales for fiscal 2024 in the APAC segment decreased $145.3 million, or 6.2%, as compared to fiscal 2023. The decrease in net sales was driven by overall net decreased customer end-market demand, inclusive of market-driven inventory corrections at our customers, as well as reductions in inflated component pricing. The decrease was further driven by a decrease of $32.5 million for end-of-life products and $8.5 million due to a disengagement with a customer. The decrease was partially offset by an increase of $20.0 million due to production ramps of new products for existing customers.
EMEA. 
Net sales for fiscal 2024 in the EMEA segment increased $138.6 million, or 34.4%, as compared to fiscal 2023. The increase in net sales was driven by an increase of $89.3 million due to production ramps for new customers, $22.6 million due to production ramps of new products for existing customers and overall net increased customer end-market demand. The increase was partially offset by a decrease of $10.4 million due to the discontinuation of a program with an existing customer and reductions in inflated component pricing. 
Our net sales by market sector for the indicated fiscal years were as follows (in millions):
2024
2023
Net sales:
Aerospace/Defense
$
698.5 
$
579.0 
Healthcare/Life Sciences
1,554.8 
1,874.8 
Industrial
1,707.5 
1,756.5 
Total net sales
$
3,960.8 
$
4,210.3 
Aerospace/Defense
.
 Net sales for fiscal 2024 in the Aerospace/Defense sector increased $119.5 million, or 20.6%, as compared to fiscal 2023. The increase was driven by overall net increased customer end-market demand, an increase of $32.9 million in production ramps for new customers and $19.7 million in production ramps of new products for existing customers. The increase was partially offset by a decrease of $20.7 million due to disengagements with customers.
Healthcare/Life Sciences
.
 Net sales for fiscal 2024 in the Healthcare/Life Sciences sector decreased $320.0 million, or 17.1%, as compared to fiscal 2023. The decrease in net sales was driven by overall net decreased customer end-market demand, inclusive of market-driven inventory corrections at our customers, as well as a reduction in inflated component pricing. The decrease was further driven by a decrease of $31.9 million for end-of-life products. The decrease was partially offset by an increase of $87.4 million in production ramps of new products for existing customers and $14.3 million in production ramps for new customers.
Industrial.
 Net sales for fiscal 2024 in the Industrial sector decreased $49.0 million, or 2.8%, as compared to fiscal 2023. The decrease in net sales was driven by overall net decreased customer end-market demand as well as a reductions in inflated component pricing.  The decrease was further driven by a decrease of $45.9 million due to the discontinuation of programs with existing customers and $24.1 million due to disengagements with customers. The decrease was partially offset by an increase of $83.3 million in production ramps for a new customer.
Cost of sales. 
Cost of sales for fiscal 2024 decreased $233.5 million, or 6.1%, as compared to fiscal 2023. Cost of sales is comprised primarily of material and component costs, labor costs and overhead. In both fiscal 2024 and 2023, approximately 89% of the total cost of sales was variable in nature and fluctuated with sales volumes. Approximately 87% of these costs in both fiscal 2024 and 2023 were related to material and component costs. 
As compared to fiscal 2023, the decrease in cost of sales in fiscal 2024 was primarily driven by the decrease in net sales and a positive shift in customer mix, partially offset by an increase in fixed costs.
Gross profit.
 Gross profit for fiscal 2024 decreased $16.1 million, or 4.1%, as compared to fiscal 2023. Gross margin of 9.6% increased 20 basis points compared to fiscal 2023. The primary drivers of the decrease in gross profit as compared to fiscal 2023 were a decrease in net sales and an increase in fixed costs to support new customer program ramps, partially offset by a positive shift in customer mix, which drove the increase in gross margin. 
Operating income.
 Operating income for fiscal 2024 decreased $28.1 million, or 14.4%, as compared to fiscal 2023. Operating margin of 4.2% decreased 50 basis points compared to fiscal 2023. The primary drivers of the decrease in operating income and operating margin as compared to fiscal 2023 was the result of the decrease in gross profit and an increase of $14.9 million in S&A, partially offset by a decrease of $2.8 million in restructuring and other charges. The increase in S&A was primarily due to an increase of $9.0 million in stock-based compensation expense primarily due to $5.1 million of accelerated stock-based compensation expense related to executive retirement agreements. The increase in S&A was further driven by a net increase in compensation costs and an increase in information technology and professional service expenses. The restructuring and other charges for fiscal 2024 consisted of employee severance costs associated with a reduction in the Company's workforce as well 
30
Table of Contents
as closure costs associated with sites in the Company's AMER and EMEA regions, offset by insurance proceeds received in an arbitration decision regarding a contractual matter that took place in the Company's EMEA region in fiscal 2023. The restructuring and other charges for fiscal 2023 consisted of severance from the reduction of the Company's workforce, a lease agreement termination and an arbitration decision regarding a contractual matter that occurred in the Company's EMEA region.
A discussion of operating income by reportable segment for the indicated fiscal years is presented below (in millions):
2024
2023
Operating income:
AMER
$
39.6 
$
79.7 
APAC
289.3 
289.6 
EMEA
13.4 
1.6 
Corporate and other costs
(174.6)
(175.1)
Total operating income
$
167.7 
$
195.8 
AMER. 
Operating income decreased $40.1 million in fiscal 2024 as compared to fiscal 2023, primarily as a result of a decrease in net sales and an increase in S&A, partially offset by a positive shift in customer mix and a decrease in fixed costs.
APAC. 
Operating income decreased $0.3 million in fiscal 2024 as compared to fiscal 2023, primarily as a result of a decrease in net sales, partially offset by a positive shift in customer mix.
EMEA. 
Operating income increased $11.8 million in fiscal 2024 as compared to fiscal 2023 primarily as a result of an increase in net sales and a positive shift in customer mix, partially offset by increased fixed costs and an increase in S&A.
Other expense.
 Other expense for fiscal 2024 increased $3.4 million as compared to fiscal 2023. The increase in other expense for fiscal 2024 was primarily driven by a decrease in other miscellaneous income of $4.9 million as prior year insurance recoveries did not recur and an increase in foreign exchange losses of $1.6 million, partially offset by a decrease in interest expense of $2.7 million due to lower borrowings on our credit facility. 
Income taxes.
 Income tax expense for fiscal 2024 was $17.7 million compared to $21.9 million for fiscal 2023. The decrease is primarily due to a decrease in pre-tax book income and the geographic distribution of worldwide earnings.
Our annual effective tax rate varies from the U.S. statutory rate of 21.0% primarily due to the geographic distribution of worldwide earnings as well as a tax holiday granted to a subsidiary located in the APAC segment where we derive a significant portion of our earnings. Our effective tax rate may also be impacted by disputes with taxing authorities, tax planning activities, adjustments to uncertain tax positions and changes in valuation allowances.
We have been granted a tax holiday for a foreign subsidiary operating in the APAC segment. This tax holiday will expire on December 31, 2034, and is subject to certain conditions. In fiscal 2024 and 2023, the holiday resulted in tax reductions, net of the impact of the GILTI provisions of the U.S. Tax Cuts and Jobs Act, of approximately $37.3 million ($1.36 per basic share, $1.34 per diluted share) and $25.9 million ($0.94 per basic share, $0.92 per diluted share), respectively.
See also Note 6, "Income Taxes," in Notes to Consolidated Financial Statements for additional information regarding our tax rate.
The annual effective tax rate for fiscal 2025 is expected to be approximately 14.0% to 16.0%.
Net income.
 Net income for fiscal 2024 decreased $27.3 million, or 19.6%, from fiscal 2023 to $111.8 million. Net income decreased primarily as a result of the decrease in operating income and the increase in other expense, partially offset by the decrease in tax expense as previously discussed.
Diluted earnings per share.
 Diluted earnings per share decreased to $4.01 in fiscal 2024 from $4.95 in fiscal 2023, primarily as a result of decreased net income due to the factors discussed above, partially offset by a reduction in diluted shares outstanding.
Return on Invested Capital ("ROIC") and economic return.
 We use a financial model that is aligned with our business strategy and includes an ROIC goal of 15% which would exceed our weighted average cost of capital ("WACC") by more than 500 basis points and represent positive economic return. Economic return is the amount our ROIC exceeds our WACC.
31
Table of Contents
Non-GAAP financial measures, including ROIC and economic return, are used for internal management goals and decision making because such measures provide management and investors additional insight into financial performance. In particular, we provide ROIC and economic return because we believe they offer insight into the metrics that are driving management decisions. We view ROIC and economic return as important measures in evaluating the efficiency and effectiveness of our long-term capital investments. We also use ROIC as a performance criteria in determining certain elements of compensation as well as economic return performance.
We define ROIC as tax-effected operating income before restructuring and other charges divided by average invested capital over a rolling five-quarter period for the fiscal year. Invested capital is defined as equity plus debt and operating lease liabilities, less cash and cash equivalents. Other companies may not define or calculate ROIC in the same way. ROIC and other non-GAAP financial measures should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").
We review our internal calculation of WACC annually. Our WACC was 8.2% for fiscal 2024 and 9.0% for fiscal 2023. By exercising discipline to generate ROIC in excess of our WACC, our goal is to create value for our shareholders. Fiscal 2024 ROIC of 11.8% reflects an economic return of 3.6%, based on our weighted average cost of capital of 8.2%, and fiscal 2023 ROIC of 13.4% reflects an economic return of 4.4%, based on our weighted average cost of capital of 9.0%.
For a reconciliation of ROIC, economic return and adjusted operating income (tax-effected) to our financial statements that were prepared using U.S. GAAP, see Exhibit 99.1 to this annual report on Form 10-K, which exhibit is incorporated herein by reference.
Refer to the table below, which includes the calculation of ROIC and economic return for the indicated fiscal years (dollars in millions):

2024
2023
Adjusted operating income (tax-effected)
$
168.0 
$
190.5 
Average invested capital
1,418.7 
1,425.6 
After-tax ROIC
11.8 
%
13.4 
%
WACC
8.2 
%
9.0 
%
Economic return
3.6 
%
4.4 
%
32
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents and restricted cash were $347.5 million as of September 28, 2024, as compared to $256.7 million as of September 30, 2023. 
As of September 28, 2024, 88% of our cash and cash equivalents balance was held outside of the U.S. by our foreign subsidiaries. Currently, we believe that our cash balance, together with cash available under our Credit Facility, will be sufficient to meet our liquidity needs and potential share repurchases, if any, for the next twelve months and for the foreseeable future.
Our future cash flows from operating activities will be reduced by $31.4 million due to cash payments for U.S. federal taxes on the deemed repatriation of undistributed foreign earnings that are payable over an eight year period that began in fiscal 2019 with the first payment. The table below provides the expected timing of these future cash outflows, in accordance with the following installment schedule for the remaining two years (in millions):
2025
$
14.2 
2026
17.2 
Total
$
31.4 
Cash Flows.
 The following table provides a summary of cash flows for fiscal 2024 and 2023 (in millions): 
2024
2023
Cash flows provided by operating activities
$
436.5 
$
165.8 
Cash flows used in investing activities
(94.9)
(93.3)
Cash flows used in financing activities
(255.6)
(92.7)
Effect of exchange rate changes on cash and cash equivalents
4.8 
1.4 
     Net increase (decrease) in cash and cash equivalents and restricted cash
$
90.8 
$
(18.8)
Operating Activities.
 Cash flows provided by operating activities were $436.5 million for fiscal 2024, as compared to $165.8 million for fiscal 2023. The increase was primarily due to cash flow improvements (reductions) of:
•
$(27.3) million decrease in net income. 
•
$213.7 million in inventory cash flows driven by a larger decrease in inventory in fiscal 2024 as compared to fiscal 2023 due to inventory reduction efforts.
•
$139.9 million in accounts payables cash flows primarily driven by the timing of materials procurement and payments to suppliers.
•
$24.8 million in contract assets cash flows driven by lower demand from over time customers.
•
$(34.1) million in advanced payments from customers cash flows driven by a larger decrease in advanced payments in fiscal 2024 as compared to fiscal 2023. 
•
$(36.5) million in accounts receivable cash flows driven by timing of shipments and mix of customer payment terms.
•
$(23.6) million in other current and non-current asset cash flows primarily driven by an increase in tax prepayments related to timing of payments and an increase in prepayments to suppliers in fiscal 2024 as compared to a decrease in fiscal 2023.
33
Table of Contents
The following table provides a summary of cash cycle days for the periods indicated (in days):
Three Months Ended
September 28,
2024
September 30,
2023
Days in accounts receivable
54
59
Days in contract assets
10
13
Days in inventory
127
154
Days in accounts payable
(59)
(64)
Days in advanced payments
(68)
(75)
Annualized cash cycle
64
87
We calculate days in accounts receivable and contract assets as each balance sheet item for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory, accounts payable and advanced payments as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate annualized cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.  
As of September 28, 2024, annualized cash cycle days decreased twenty-three days compared to September 30, 2023 due to the following:
Days in accounts receivable for the three months ended September 28, 2024 decreased five days compared to the three months ended September 30, 2023. The decrease is primarily attributable to the timing of customer shipments and payments as well as the mix of customer payment terms.
Days in contract assets for the three months ended September 28, 2024 decreased three days compared to the three months ended September 30, 2023. The decrease is primarily attributable to a decrease in demand from customers with arrangements requiring revenue to be recognized over time as products are produced.
Days in inventory for the three months ended September 28, 2024 decreased twenty-seven days compared to the three months ended September 30, 2023. The decrease is primarily due to inventory reduction efforts.
Days in accounts payable for the three months ended September 28, 2024 decreased five days compared to the three months ended September 30, 2023. The decrease is primarily attributable to timing of materials procurement and payments to suppliers.
Days in advanced payments for the three months ended September 28, 2024 decreased seven days compared to the three months ended September 30, 2023. The decrease was primarily attributable to a return of advanced payments to customers in line with lower inventory balances.
Free Cash Flow. 
We define free cash flow ("FCF"), a non-GAAP financial measure, as cash flow provided by operations less capital expenditures. FCF was $341.3 million for fiscal 2024 compared to $61.8 million for fiscal 2023, an increase of $279.5 million. The improvement in FCF was primarily due to inventory reduction efforts as well as lower working capital investments in inventory to support our customers.
Non-GAAP financial measures, including FCF, are used for internal management assessments because such measures provide additional insight to investors into ongoing financial performance. In particular, we provide FCF because we believe it offers insight into the metrics that are driving management decisions. We view FCF as an important financial metric as it demonstrates our ability to generate cash and can allow us to pursue opportunities that enhance shareholder value. FCF is a non-GAAP financial measure that should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with GAAP.
34
Table of Contents
A reconciliation of FCF to our financial statements that were prepared using GAAP as follows (in millions):
2024
2023
Cash flows provided by operating activities
$
436.5 
$
165.8 
Payments for property, plant and equipment
(95.2)
(104.0)
Free cash flow
$
341.3 
$
61.8 
Investing Activities.
 Cash flows used in investing activities were $94.9 million for fiscal 2024 compared to $93.3 million for fiscal 2023. The increase in cash used in investing activities was due to $10.8 million from insurance proceeds in fiscal 2023, partially offset by an $8.9 million decrease in capital expenditures.
We utilized available cash and financing cash flows as the sources for funding our operating requirements during fiscal 2024. We currently estimate capital expenditures for fiscal 2025 will be approximately $120.0 million to $150.0 million to support new program ramps and replace older equipment. This estimate also includes $60.0 million related to the footprint expansion on the mainland of Penang, Malaysia.
Financing Activities.

Cash flows used in financing activities were $255.6 million for fiscal 2024 compared to $92.7 million for fiscal 2023. The increase was primarily attributable to net repayments on the credit facility in fiscal 2024 of $183.0 million compared to net repayments on the credit facility in 2023 of $30.0 million as well as an increase of $14.7 million in cash used to repurchase our common stock.
On August 18, 2022, the Board of Directors approved a share repurchase program under which we are authorized to repurchase up to $50.0 million of our common stock (the "2023 Program"). During fiscal 2024 and 2023, we completed the 2023 Program by repurchasing 59,277 and 425,746 shares under this program for $5.7 million and $40.9 million at an average price of $95.59 and $95.96 per share, respectively. 
On January 16, 2024, the Company announced a share repurchase program authorized by the Board of Directors under which we were authorized to repurchase up to $50.0 million of our common stock (the "2024 Program"). The 2024 Program commenced upon completion of the 2023 Program. During fiscal 2024, we completed the 2024 Program by repurchasing 477,012 shares under this program for $50.0 million at an average price of $104.82 per share. 
On August 14, 2024, the Board of Directors approved a share repurchase program under which we are authorized to repurchase up to $50.0 million of our common stock (the "2025 Program"). The 2025 Program commenced upon completion of the 2024 Program, and has no expiration. During fiscal 2024, we purchased 151 shares under this program for less than $0.1 million at an average price of $131.78 per share. As of September 28, 2024, $49.9 million of authority remained under the 2025 Program. 
All shares repurchased under the aforementioned programs were recorded as treasury stock.
On June 15, 2018, we entered into a Note Purchase Agreement (the “2018 NPA”) pursuant to which we issued an aggregate of $150.0 million in principal amount of unsecured senior notes, consisting of $100.0 million in principal amount 4.05% Series A Senior Notes, due on June 15, 2025, and $50.0 million in principal amount of 4.22% Series B Senior Notes, due on June 15, 2028 (collectively, the “2018 Notes”), in a private placement. The 2018 NPA includes customary operational and financial covenants with which we are required to comply, including, among others, maintenance of certain financial ratios such as a total leverage ratio and a minimum interest coverage ratio. The 2018 Notes may be prepaid in whole or in part at any time, subject to payment of a make-whole amount; interest on the 2018 Notes is payable semiannually. As of September 28, 2024, we were in compliance with the covenants under the 2018 NPA.
On June 9, 2022, we refinanced our then-existing senior unsecured revolving credit facility (as amended by that certain Amendment No. 1 to Credit Agreement dated April 29, 2020, the "Prior Credit Facility") by entering into a new 5-year revolving credit facility (collectively with the Prior Credit Facility, referred to as the "Credit Facility"), which expanded the maximum commitment from $350.0 million to $500.0 million and extended the maturity from May 15, 2024 to June 9, 2027. The maximum commitment under the Credit Facility may be further increased to $750.0 million, generally by mutual agreement of the lenders and us, subject to certain customary conditions. During fiscal 2024, the highest daily borrowing was $376.0 million; the average daily balance was $257.8 million. We borrowed $550.5 million and repaid $733.5 million of revolving borrowings ("revolving commitment") under the Credit Facility during fiscal 2024. As of September 28, 2024, we were in compliance with all financial covenants relating to the Credit Facility, which are generally consistent with those in the 2018 NPA discussed above. We are required to pay a commitment fee on the daily unused credit facility based on our leverage ratio; the fee was 0.100% as of September 28, 2024.
35
Table of Contents
The Credit Facility and the 2018 NPA allow for the future payment of cash dividends or the repurchase of shares provided that no event of default (including any failure to comply with a financial covenant) exists at the time of, or would be caused by, the dividend payment or the share repurchases. We have not paid cash dividends in the past. However, we evaluate from time to time potential uses of excess cash, which in the future may include share repurchases above those already authorized, a special dividend or recurring dividends.
We have Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which we may elect to sell receivables, at a discount. These facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA as of September 28, 2024 is $340.0 million. The maximum facility amount under the HSBC RPA as of September 28, 2024 is $70.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed. 
We sold $854.7 million and $834.5 million of trade accounts receivable under these programs during fiscal 2024 and 2023, respectively, in exchange for cash proceeds of $844.6 million and $824.6 million, respectively. As of September 28, 2024 and September 30, 2023, $220.2 million and $220.5 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by us remained outstanding and had not yet been collected. 
In all cases, the sale discount was recorded within "Miscellaneous, net" in the Consolidated Statements of Comprehensive Income in the period of the sale. For further information regarding the receivable sale programs, see Note 14, "Trade Accounts Receivable Sale Programs," in Notes to Consolidated Financial Statements.
Based on current expectations, we believe that our projected cash flows provided by operations, available cash and cash equivalents, potential borrowings under the Credit Facility and our leasing capabilities should be sufficient to meet our working capital and fixed capital requirements, as well as execution upon our share repurchase authorizations as management deems appropriate, for the next twelve months. We believe our balance sheet is positioned to support the potential future challenges presented by macroeconomic factors including increased working capital requirements associated with longer lead-times for components, increased component and labor costs, and operating inefficiencies due to supply chain constraints. As of the end of fiscal 2024, cash and cash equivalents and restricted cash were $347 million, while debt, finance lease and other financing obligations were $247 million. If our future financing needs increase, then we may need to arrange additional debt or equity financing. Accordingly, we evaluate and consider from time to time various financing alternatives to supplement our financial resources. However, we cannot be assured that we will be able to make any such arrangements on acceptable terms or at all.
36
Table of Contents
CONTRACTUAL OBLIGATIONS, COMMITMENTS AND OFF-BALANCE SHEET OBLIGATIONS
Our disclosures regarding contractual obligations and commercial commitments are located in various parts of our regulatory filings. Information in the following table provides a summary of our contractual obligations and commercial commitments as of September 28, 2024 (dollars in millions):
Payments Due by Fiscal Year
Contractual Obligations
Total
2025
2026-2027
2028-2029
2030 and thereafter
Debt Obligations (1)
$
212.5 
$
156.2 
$
4.2 
$
52.1 
$
— 
Finance Lease Obligations
110.1 
9.9 
24.5 
10.4 
65.3 
Operating Lease Obligations
53.2 
16.1 
15.3 
8.2 
13.6 
Purchase Obligations (2)
1,144.1 
1,080.7 
61.0 
1.3 
1.1 
Repatriation Tax on Undistributed Foreign Earnings (3)
31.3 
14.1 
17.2 
— 
— 
Other Liabilities on the Balance Sheet (4)
22.6 
3.9 
3.6 
2.0 
13.1 
Other Liabilities not on the Balance Sheet (5)
10.2 
5.1 
1.4 
0.1 
3.6 
Total Contractual Cash Obligations
$
1,584.0 
$
1,286.0 
$
127.2 
$
74.1 
$
96.7 
1)
Debt obligations includes $150.0 million in principal amount of 2018 Notes and $50.0 million of borrowings on the revolving commitment of the Credit Facility, as well as interest. 
2)
Purchase obligations consist primarily of purchases of inventory and equipment in the ordinary course of business.
3)
Repatriation tax on undistributed foreign earnings consists of U.S. federal income taxes on the deemed repatriation of undistributed foreign earnings due to U.S. Tax Reform. Refer to "Liquidity and Capital Resources" above for further detail. 
4)
Other obligations on the balance sheet included deferred compensation obligations to certain of our former and current executive officers, as well as other key employees, other financing obligations arising from information technology maintenance agreements and asset retirement obligations related to our buildings. We have excluded from the above table the impact of approximately $19.6 million, as of September 28, 2024, related to unrecognized income tax benefits. We cannot make reliable estimates of the future cash flows by period related to these obligations.
5)
Other obligations not on the balance sheet consist of guarantees and a commitment for salary continuation and certain benefits in the event employment of one executive officer is terminated without cause. Excluded from the amounts disclosed are certain bonus and incentive compensation amounts, which would be paid on a prorated basis in the year of termination.
37
Table of Contents
DISCLOSURE ABOUT CRITICAL ACCOUNTING ESTIMATES
Our accounting policies are disclosed in Note 1 "Description of Business and Significant Accounting Policies" of Notes to Consolidated Financial Statements. During fiscal 2024 there were no material changes to these policies. Our critical accounting estimates are described below:
Revenue Recognition:
 Revenue is recognized over time for arrangements with customers for which: (i) our performance does not create an asset with an alternative use to us, and (ii) we have an enforceable right to payment, including reasonable profit margin, for performance completed to date. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.
For contracts requiring over time revenue recognition, we calculate the revenue to recognize using the costs incurred to date plus a reasonable profit margin. We use historical information to estimate the profit margin associated with the performance obligation that is satisfied over time. We reevaluate our estimate of profit margins on a quarterly basis. While experience has shown that trends in profit margins are not volatile, changes in pricing or cost efficiencies could create significant fluctuations for certain performance obligations. As actual experience becomes available, we use the data to update the historical averages and compare the results to estimates. Based on review of profits margins we update our estimate to the model as necessary. 
See Note 15 "Revenue from Contracts with Customers" of Notes to Consolidated Financial Statements for further information on our revenue recognition policies. 
Income Taxes:
 Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We maintain valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is required, we take into account such factors as:
•
Prior earnings history
. A pattern of recent financial reporting losses in a jurisdiction is heavily weighted as a source of negative evidence. We also consider the strength and trend of earnings, as well as other relevant factors. In certain circumstances, historical earnings may not be as relevant due to changes in our business operations;
•
Expected future earnings.
 Future reversals of existing temporary differences are heavily weighted sources of objectively verifiable positive evidence.

Projections of future taxable income exclusive of reversing temporary differences are an additional source of positive evidence;
•
Tax planning strategies
. If necessary and available, tax planning strategies would be implemented to accelerate taxable amounts to utilize expiring carryforwards. These strategies would be a source of additional positive evidence.
See Note 6 "Income Taxes" of Notes to Consolidated Financial Statements for further information on our income tax policies. 
NEW ACCOUNTING PRONOUNCEMENTS
See Note 1, "Description of Business and Significant Accounting Policies," in Notes to Consolidated Financial Statements regarding recent accounting pronouncements.

38
Table of Contents
ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk from changes in foreign exchange and interest rates. We selectively use financial instruments to reduce such risks. We do not use derivative financial instruments for speculative purposes. 
Foreign Currency Risk
Our international operations create potential foreign exchange risk. Our policy is to selectively hedge our foreign currency denominated transactions in a manner that partially offsets the effects of changes in foreign currency exchange rates. We typically use foreign currency contracts to hedge only those currency exposures associated with certain assets and liabilities denominated in non-functional currencies. Corresponding gains and losses on the underlying transaction generally offset the gains and losses on these foreign currency hedges. We cannot predict changes in currency rates, nor the degree to which we will be able to manage the impacts of currency exchange rate changes. Such changes could have a material effect on our business, results of operations and financial condition.
Our percentages of transactions denominated in currencies other than the U.S. dollar for the indicated fiscal years were as follows:

2024
2023
Net Sales
11%
8%
Total Costs
17%
16%
We have evaluated the potential foreign currency exchange rate risk on transactions denominated in currencies other than the U.S. dollar for the periods presented above. Based on our overall currency exposure, as of September 28, 2024, a 10.0% change in the value of the U.S. dollar relative to our other transactional currencies would not have a material effect on our financial position, results of operations, or cash flows.
Interest Rate Risk
We have financial instruments, including cash equivalents and debt, which are sensitive to changes in interest rates. The primary objective of our investment activities is to preserve principal while maximizing yields without significantly increasing market risk. To achieve this, we limit the amount of principal exposure to any one issuer. 
As of September 28, 2024, our only material interest rate risk was associated with our Credit Facility. Borrowings under the Credit Facility bear interest, at the Company's option, at (a)(1) for borrowings denominated in U.S. dollars, the Term Secured Overnight Financing Rate ("SOFR"), (2) for borrowings denominated in pounds sterling, the Daily Simple Risk-Free Rate, plus, in each case of (a)(1) and (2), 10 basis points, (b) for borrowings denominated in euros, the EURIBOR Rate plus a statutory reserve rate, or (c) an Alternate Base Rate equal to the highest of (i) 100 basis points per annum, (ii) the prime rate last quoted by The Wall Street Journal (or, if not quoted, as otherwise provided in the Credit Facility), (iii) the greater of the federal funds effective rate and the overnight bank funding rate in effect on such day plus, in each case, 50 basis points per annum (or, if neither are available, as otherwise provided in the Credit Facility), and (iv) Term SOFR for a one month interest period on such day plus 110 basis points, plus, in each case of (a), (b), and (c), an applicable interest rate margin based on the Company's then current consolidated total indebtedness (minus certain unrestricted cash and cash equivalents in an amount not to exceed $100 million) to consolidated EBITDA. As of September 28, 2024, the borrowing rate under the Credit Facility was SOFR plus 1.00%. Borrowings under the 2018 NPA are based on a fixed interest rate, thus mitigating much of our interest rate risk. Based on our overall interest rate exposure, as of September 28, 2024, a 10.0% change in interest rates would not have a material effect on our financial position, results of operations, or cash flows. 
39
Table of Contents
ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
PLEXUS CORP.
List of Financial Statements and Financial Statement Schedule
September 28, 2024

Contents
Pages
Report of Independent Registered Public Accounting Firm
41
Consolidated Financial Statements:
Consolidated Statements of Comprehensive Income for the fiscal years ended 
Se
ptember 28, 2024, 
September 30, 2023

and 
October 1, 2022
43
Consolidated Balance Sheets as of 
September 28, 2024 and 
September 30, 2023
44
Consolidated Statements of Shareholders’ Equity for the fiscal years ended 
September 28, 2024, 
September 30, 2023

and 
October 1, 2022
45
Consolidated Statements of Cash Flows for the fiscal years ended 
September 28, 2024
, 
September 30, 2023
 and
 October 1, 2022
46
Notes to Consolidated Financial Statements
47
Financial Statement Schedule:
Schedule II - Valuation and Qualifying Accounts for the fiscal years ended 
September 28, 2024, 
September 30, 2023
 and
 October 1, 2022
80
NOTE: All other financial statement schedules are omitted because they are not applicable or the required information is included in the Consolidated Financial Statements or notes thereto.
40
Table of Contents
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Plexus Corp.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Plexus Corp. and its subsidiaries (the “Company”) as of September 28, 2024 and September 30, 2023, and the related consolidated statements of comprehensive income, of shareholders' equity and of cash flows for each of the three years in the period ended September 28, 2024, including the related notes and financial statement schedule listed in the accompanying index (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of September 28, 2024, based on criteria established in 
Internal Control - Integrated Framework 
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 28, 2024 and September 30, 2023, and the results of its operations and its cash flows for each of the three years in the period ended September 28, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 28, 2024, based on criteria established in 
Internal Control - Integrated Framework
 (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
41
Table of Contents
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Revenue Recognition
As described in Notes 1 and 15 to the consolidated financial statements, revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement. For the year ended September 28, 2024, the Company's net sales were $3.96 billion.
The principal consideration for our determination that performing procedures relating to revenue recognition is a critical audit matter is a high degree of auditor effort in performing procedures related to the Company's revenue recognition. 
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process. These procedures also included, among others (i) testing the completeness, accuracy, and occurrence of revenue recognized for a sample of revenue transactions by obtaining and inspecting source documents, such as purchase orders, invoices, proof of shipment, and cash receipts; (ii) confirming a sample of outstanding customer invoice balances as of September 28, 2024, and for confirmations not returned, obtaining and inspecting source documents, such as purchase orders, invoices, proof of shipment, and subsequent cash receipts; (iii) testing the accuracy and timing of revenue recognized as of period end for a sample of arrangements with customers that meet the conditions for over time revenue recognition by obtaining and inspecting source documents, such as master services agreements, purchase orders, inventory balances as of period end, and estimated profit margin support which includes historical results; and (iv) testing the completeness and accuracy of the data used by management to calculate the revenue recognized over time.
/s/ 
PricewaterhouseCoopers LLP
Milwaukee, Wisconsin
November 15, 2024
We have served as the Company’s auditor since at least 1985. We have not been able to determine the specific year we began serving as auditor of the Company.
42
Table of Contents
PLEXUS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
for the fiscal years ended September 28, 2024, September 30, 2023 and October 1, 2022 
(in thousands, except per share data)
2024
2023
2022
Net sales
$
3,960,827

$
4,210,305

$
3,811,368

Cost of sales
3,582,297

3,815,751

3,464,139

Gross profit
378,530

394,554

347,229

Selling and administrative expenses
190,541

175,640

167,023

Restructuring and other charges, net
20,257

23,094

2,021

Operating income
167,732

195,820

178,185

Other income (expense):
Interest expense
(
28,876
)
(
31,542
)
(
15,858
)
Interest income
3,860

3,138

1,305

Miscellaneous, net
(
13,184
)
(
6,403
)
(
5,329
)
Income before income taxes
129,532

161,013

158,303

Income tax expense
17,717

21,919

20,060

Net income
$
111,815

$
139,094

$
138,243

Earnings per share:
Basic
$
4.08

$
5.04

$
4.96

Diluted
$
4.01

$
4.95

$
4.86

Weighted average shares outstanding:
Basic
27,397

27,582

27,862

Diluted
27,909

28,114

28,439

Comprehensive income:
Net income
$
111,815

$
139,094

$
138,243

Other comprehensive income (loss):
Derivative instrument and other fair value adjustments
15,936

1,197

(
5,201
)
     Foreign currency translation adjustments
19,008

10,501

(
27,843
)
          Other comprehensive income (loss)
34,944

11,698

(
33,044
)
Total comprehensive income
$
146,759

$
150,792

$
105,199

The accompanying notes are an integral part of these consolidated financial statements.
43
Table of Contents
PLEXUS CORP. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
as of September 28, 2024 and September 30, 2023
(in thousands, except per share data)
2024
2023
ASSETS
Current assets:
Cash and cash equivalents
$
345,109

$
256,233

Restricted cash
2,353

421

Accounts receivable, net of allowances of $
3,189
 and $
1,914
, respectively
622,366

661,542

Contract assets
120,560

142,297

Inventories
1,311,434

1,562,037

Prepaid expenses and other
75,328

49,693

Total current assets
2,477,150

2,672,223

Property, plant and equipment, net
501,112

492,036

Operating lease right-of-use assets
74,360

69,363

Deferred income taxes
73,919

62,590

Other assets
27,280

24,960

Total non-current assets
676,671

648,949

Total assets
$
3,153,821

$
3,321,172

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations
$
157,325

$
240,205

Accounts payable
606,378

646,610

Advanced payments from customers
709,152

760,351

Accrued salaries and wages
94,448

94,099

Other accrued liabilities
75,991

71,402

Total current liabilities
1,643,294

1,812,667

Long-term debt and finance lease obligations, net of current portion
89,993

190,853

Accrued income taxes payable
17,198

31,382

Long-term operating lease liabilities
32,275

38,552

Deferred income taxes 
8,234

4,350

Other liabilities
38,002

28,986

Total non-current liabilities
185,702

294,123

Total liabilities
1,828,996

2,106,790

Commitments and contingencies
Shareholders’ equity:
Preferred stock, $
0.01
 par value, 
5,000
 shares authorized, 
none
 issued or outstanding
—

—

Common stock, $
0.01
 par value, 
200,000
 shares authorized, 
54,489
 and 
54,297
 shares issued, respectively, and 
27,122
 and 
27,466
 shares outstanding, respectively
545

543

Additional paid-in capital
680,638

661,270

Common stock held in treasury, at cost, 
27,367
 and 
26,831
 shares, respectively
(
1,190,115
)
(
1,134,429
)
Retained earnings
1,823,143

1,711,328

Accumulated other comprehensive income (loss)
10,614

(
24,330
)
Total shareholders’ equity
1,324,825

1,214,382

Total liabilities and shareholders’ equity
$
3,153,821

$
3,321,172

The accompanying notes are an integral part of these consolidated financial statements.
44
Table of Contents
PLEXUS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
for the fiscal years ended September 28, 2024, September 30, 2023 and October 1, 2022 
(in thousands)
2024
2023
2022
Common stock - shares outstanding
Beginning of period
27,466

27,679

28,047

Exercise of stock options and vesting of other share-based awards
192

212

235

Treasury shares purchased
(
536
)
(
425
)
(
603
)
End of period
27,122

27,466

27,679

Total stockholders' equity, beginning of period
$
1,214,382

$
1,095,731

$
1,028,232

Common stock - par value
Beginning of period
543

541

538

Exercise of stock options and vesting of other share-based awards
2

2

3

End of period
545

543

541

Additional paid-in capital
Beginning of period
661,270

652,467

639,778

Share-based compensation expense
30,314

21,300

23,377

Exercise of stock options and vesting of other share-based awards, including tax withholding
(
10,946
)
(
12,497
)
(
10,688
)
End of period
680,638

661,270

652,467

Treasury stock
Beginning of period
(
1,134,429
)
(
1,093,483
)
(
1,043,091
)
Treasury shares purchased
(
55,686
)
(
40,946
)
(
50,392
)
End of period
(
1,190,115
)
(
1,134,429
)
(
1,093,483
)
Retained earnings
Beginning of period
1,711,328

1,572,234

1,433,991

Net income
111,815

139,094

138,243

End of period
1,823,143

1,711,328

1,572,234

Accumulated other comprehensive income (loss)
Beginning of period
(
24,330
)
(
36,028
)
(
2,984
)
Other comprehensive income (loss)
34,944

11,698

(
33,044
)
End of period
10,614

(
24,330
)
(
36,028
)
Total stockholders' equity, end of period
$
1,324,825

$
1,214,382

$
1,095,731

The accompanying notes are an integral part of these consolidated financial statements.
45
Table of Contents
PLEXUS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
for the fiscal years ended September 28, 2024, September 30, 2023 and October 1, 2022 
(in thousands) 
2024
2023
2022
Cash flows from operating activities
Net income
$
111,815

$
139,094

$
138,243

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization
77,847

69,758

62,689

Share-based compensation expense and related charges
30,314

21,300

23,336

Asset impairment charges
4,736

—

—

Deferred income tax benefit
(
7,099
)
(
22,438
)
(
10,800
)
Other, net
(
5,709
)
(
579
)
972

Changes in operating assets and liabilities, excluding impacts of currency:
Accounts receivable
44,995

81,542

(
230,022
)
Contract assets
21,652

(
3,169
)
(
23,445
)
Inventories
262,266

48,613

(
652,989
)
Other current and non-current assets
(
14,463
)
9,162

(
1,212
)
Accrued income taxes payable
(
18,147
)
(
5,745
)
(
713
)
Accounts payable
(
30,829
)
(
170,685
)
176,037

Advanced payments from customers
(
55,865
)
(
21,775
)
479,734

Other current and non-current liabilities
14,989

20,744

11,930

Cash flows provided by (used in) operating activities
436,502

165,822

(
26,240
)
Cash flows from investing activities
Payments for property, plant and equipment
(
95,182
)
(
104,049
)
(
101,612
)
Proceeds from insurance
—

10,790

—

Other, net
235

(
45
)
51

Cash flows used in investing activities
(
94,947
)
(
93,304
)
(
101,561
)
Cash flows from financing activities
Borrowings under debt agreements
550,500

748,500

758,000

Payments on debt and finance lease obligations
(
739,456
)
(
787,785
)
(
556,726
)
Debt issuance costs
—

—

(
898
)
Repurchases of common stock
(
55,686
)
(
40,946
)
(
50,392
)
Proceeds from exercise of stock options
210

8

480

Payments related to tax withholding for share-based compensation
(
11,154
)
(
12,502
)
(
11,169
)
Cash flows (used in) provided by financing activities
(
255,586
)
(
92,725
)
139,295

Effect of exchange rate changes on cash and cash equivalents
4,839

1,391

(
6,537
)
Net increase (decrease) in cash and cash equivalents and restricted cash
90,808

(
18,816
)
4,957

Cash and cash equivalents and restricted cash:
Beginning of period
256,654

275,470

270,513

End of period
$
347,462

$
256,654

$
275,470

Supplemental disclosure information:
Interest paid
$
29,519

$
32,785

$
15,293

Income taxes paid
$
46,223

$
43,568

$
16,916

The accompanying notes are an integral part of these consolidated financial statements.
46
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
1.    
Description of Business and Significant Accounting Policies
Description of Business: 
Plexus Corp. and its subsidiaries (together "Plexus," the "Company," or "we") help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. Our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial market sectors supported by a global team of over 
20,000
 members across our 
26
 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. 
Significant Accounting Policies
Consolidation Principles and Basis of Presentation:
 The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and include the accounts of Plexus Corp. and its subsidiaries. All intercompany transactions have been eliminated. 
The Company’s fiscal year ends on the Saturday closest to September 30. The Company also uses a "4-4-5" weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. Fiscal 2024, fiscal 2023 and fiscal 2022 each included 52 weeks.
The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and notes thereto. The full extent to which current global events and economic conditions will impact the Company's business and operating results will depend on future developments that are highly uncertain and cannot be accurately predicted. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.

Cash and Cash Equivalents and Restricted Cash:
 Cash equivalents include short-term highly liquid investments and are classified as Level 1 in the fair value hierarchy described below. Cash equivalents of $
60.9
 million and $
33.5
 million at September 28, 2024 and September 30, 2023, respectively, consisted primarily of time deposits with initial maturities of less than three months. Restricted cash represents cash received from customers to settle invoices sold under accounts receivable purchase agreements that the Company continues servicing and is contractually required to be set aside. The restrictions will lapse when the cash is remitted to the purchaser of the receivables. Restricted cash is also classified as Level 1 in the fair value hierarchy described below.
Inventories:

Inventories are valued at the lower of cost or net realizable value. Cost is determined by the first-in, first-out ("FIFO") method. Valuing inventories at the lower of cost or net realizable value requires the use of estimates and judgment. Customers may cancel their orders, change production quantities or delay production for a number of reasons that are beyond the Company’s control. Any of these, or certain additional actions, could impact the valuation of inventory. Any actions taken by the Company’s customers that could impact the value of its inventory are considered when determining the lower of cost or net realizable value. 
In certain instances, in accordance with contractual terms, the Company receives advanced payments from customers to offset inventory risks.
Property, Plant and Equipment and Depreciation:
 Property, plant and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets. 
Estimated useful lives for major classes of depreciable assets are generally as follows:

Buildings and improvements
5
-
39
 years
Machinery and equipment
3
-
7
 years
Computer hardware and software
3
-
10
 years
47
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Certain facilities and equipment held under finance leases are classified as property, plant and equipment and amortized using the straight-line method over the term of the lease and the related obligations are recorded as liabilities. Amortization of assets held under finance leases is included in depreciation expense (see Note 3, "Property, Plant and Equipment") and the financing component of the lease payments is classified as interest expense. Maintenance and repairs are expensed as incurred. 
The Company capitalizes significant costs incurred in the acquisition or development of software for internal use. This includes costs of the software, consulting services and compensation costs for employees directly involved in developing internal use computer software.

Impairment of Long-Lived Assets: 
Long-lived assets, including property, plant and equipment, operating lease right-of-use assets and intangible assets with finite lives are reviewed for impairment and written down to fair value when facts and circumstances indicate that the carrying value of long-lived assets or asset groups may not be recoverable through estimated future undiscounted cash flows. If an impairment has occurred, a write-down to estimated fair value is made and the impairment loss is recognized as a charge against current operations. The impairment analysis is based on management’s assumptions, including future revenue and cash flow projections. Circumstances that may lead to impairment of property, plant and equipment, operating lease right-of-use assets and intangible assets with finite lives include reduced expectations for future performance or industry demand and possible further restructurings, among others.
Revenue Recognition:
 Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.
The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.
The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations. Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.
The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract-by-contract basis.
If an enforceable right to payment for work-in-process does not exist, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contract.
For contracts requiring over time revenue recognition, the selection of the method to measure progress toward completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress towards completion is measured based on the costs incurred to date.
Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.
48
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales. 
Net sales from engineering design and development services, which are generally performed under contracts with a duration of twelve months or less, are typically recognized as program costs incurred by utilizing the proportional performance model. The completed performance model is used if certain customer acceptance criteria exist. Any losses are recognized when anticipated. Net sales from engineering design and development services were less than 
5
% of consolidated net sales for each of fiscal 2024, 2023 and 2022.
Income Taxes:
 Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is required, the Company takes into account such factors as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.

Foreign Currency Translation & Transactions: 
The Company translates assets and liabilities of subsidiaries operating outside of the U.S. with a functional currency other than the U.S. dollar into U.S. dollars using exchange rates in effect at the relevant balance sheet date and net sales, expenses and cash flows at the average exchange rates during the respective periods. Adjustments resulting from the translation of the financial statements are recorded as a component of "Accumulated other comprehensive income (loss)." Exchange gains and losses arising from transactions denominated in a currency other than the functional currency of the entity involved and remeasurement adjustments for foreign operations where the U.S. dollar is the functional currency are included in the Consolidated Statements of Comprehensive Income as a component of "Miscellaneous, net." Exchange losses on foreign currency transactions were $
3.4
 million, $
1.8
 million and $
0.7
 million for fiscal 2024, 2023 and 2022, respectively. These amounts include the amount of gain recognized in income during each fiscal year due to forward currency exchange contracts entered into to hedge recognized assets or liabilities ("non-designated hedges") the Company entered into during each respective year. Refer to Note 5, "Derivatives and Fair Value Measurements," for further details on derivatives.
Derivatives:
 All derivatives are recognized on the balance sheets at fair value. The Company periodically enters into forward currency exchange contracts and interest rate swaps. On the date a derivative contract is entered into, the Company designates the derivative as a non-designated hedge or a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (a "cash flow" hedge). The Company does not enter into derivatives for speculative purposes. Changes in the fair value of non-designated derivatives are recorded in earnings as are the gains or losses related to the hedged asset or liability. Changes in the fair value of a derivative that qualifies as a cash flow hedge are recorded in "Accumulated other comprehensive income (loss)" within shareholders' equity until earnings are affected by the variability of cash flows. Certain forward currency exchange contracts are treated as cash flow hedges and, therefore, $
16.1
 million, $
1.1
 million and $(
5.0
) million was recorded in "Accumulated other comprehensive income (loss)" for fiscal 2024, 2023 and 2022, respectively. See Note 5, "Derivatives and Fair Value Measurements," for further information.

Earnings Per Share:
 The computation of basic earnings per common share is based upon the weighted average number of common shares outstanding and net income. The computation of diluted earnings per common share reflects additional dilution from share-based awards, excluding any with an antidilutive effect. See Note 7, "Earnings Per Share," for further information.
Share-based Compensation:
 The Company measures all grants of share-based payments to employees, including grants of employee stock options, at fair value and expenses them in the Consolidated Statements of Comprehensive Income over the service period (generally the vesting period) of the grant. See Note 9, "Benefit Plans," for further information.
Comprehensive Income (Loss): 
The Company follows the established standards for reporting comprehensive income (loss), which is defined as the changes in equity of an enterprise except those resulting from shareholder transactions.
49
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Accumulated other comprehensive income (loss) consists of the following as of September 28, 2024 and September 30, 2023 (in thousands):

2024
2023
Foreign currency translation adjustments
$
(
1,594
)
$
(
20,602
)
Cumulative derivative instrument fair value adjustments
11,378

(
4,699
)
Other fair value adjustments
830

971

Accumulated other comprehensive income (loss)
$
10,614

$
(
24,330
)
Refer to Note 5, "Derivatives and Fair Value Measurements," for further explanation regarding the change in fair value of derivative instruments that is recorded to "Accumulated other comprehensive income (loss)."
Use of Estimates:
 The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Fair Value of Financial Instruments:
 The Company holds financial instruments consisting of cash and cash equivalents, restricted cash, accounts receivable, certain deferred compensation assets held under trust arrangements, accounts payable, debt, derivatives and finance and operating lease obligations. The carrying values of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and finance and operating lease obligations as reported in the consolidated financial statements approximate fair value. Derivatives and certain deferred compensation assets held under trust arrangements are recorded at fair value. Accounts receivable are reflected at net realizable value based on anticipated losses due to potentially uncollectible balances. Anticipated losses are based on management’s analysis of historical losses and changes in customers’ credit status. The fair value of the Company’s debt excluding finance lease and other financing obligations was $
197.8
 million and $
374.3
 million as of September 28, 2024 and September 30, 2023, respectively. The carrying value of the Company's debt was $
200.0
 million and $
383.0
 million as of September 28, 2024 and September 30, 2023, respectively. The Company uses quoted market prices when available or discounted cash flows to calculate fair value. If measured at fair value in the financial statements, long-term debt (including the current portion) would be classified as Level 2 in the fair value hierarchy described below. The fair values of the Company’s derivatives are disclosed in Note 5, "Derivatives and Fair Value Measurements." The fair values of the deferred compensation assets held under trust arrangements are discussed in Note 9, "Benefit Plans."
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
Business and Credit Concentrations: 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, trade accounts receivable and derivative instruments, specifically related to counterparties. In accordance with the Company’s investment policy, the Company’s cash, cash equivalents and derivative instruments were placed with recognized financial institutions. The Company’s investment policy limits the amount of credit exposure in any one issue and the maturity date of the investment securities that typically comprise investment grade short-term debt instruments. Concentrations of credit risk in accounts receivable resulting from sales to major customers are discussed in Note 11, "Reportable Segments, Geographic Information and Major Customers". The Company, at times, requires cash deposits for services performed. The Company also closely monitors extensions of credit.
50
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Recently Adopted Accounting Pronouncements: 
In September 2022, the FASB issued ASU 2022-04 Supplier Finance Programs (Subtopic 405-50), which requires enhanced disclosures about supplier finance programs. The Company adopted this guidance during the first quarter of fiscal 2024 with no material impact to the Company's Consolidated Financial Statements.
Recently Issued Accounting Pronouncements Not Yet Adopted: 
In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280), which requires enhanced disclosures for segment reporting. The guidance is effective for the Company beginning in the fourth quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures. 
In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740), which requires enhanced disclosures for income taxes. The guidance is effective for the Company beginning in the first quarter of fiscal 2026. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures. 
In March 2024, the SEC adopted final rules to require registrants to disclose certain climate-related information in registration statements and annual reports. The SEC stayed its climate disclosure rules to facilitate the orderly judicial resolution of pending legal challenges. We are currently evaluating the impacts that the SEC's rule will have on our financial statement disclosures. 
In November 2024, the FASB issued ASU 2024-03 Disaggregation of Income Statement Expense (Subtopic 220-40), which requires disaggregated information about certain income statement expense line items. The guidance is effective for the Company beginning in fiscal 2028. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures.
The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements or apply to its operations.
2.    
Inventories
Inventories as of September 28, 2024 and September 30, 2023 consisted of the following (in thousands):
2024
2023
Raw materials
$
1,184,222

$
1,409,638

Work-in-process
49,513

66,340

Finished goods
77,699

86,059

Total inventories
$
1,311,434

$
1,562,037

In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within advanced payments from customers on the accompanying Consolidated Balance Sheets as of September 28, 2024 and September 30, 2023 w
as $
536.2
 million a
nd $
590.2
 million, respectively.

3.    
Property, Plant and Equipment
Property, plant and equipment as of September 28, 2024 and September 30, 2023 consisted of the following (in thousands):
2024
2023
Land, buildings and improvements
$
424,453

$
406,326

Machinery and equipment
508,051

468,904

Computer hardware and software
178,835

171,003

Capital assets in progress
23,868

28,875

Total property, plant and equipment, gross
1,135,207

1,075,108

Less: accumulated depreciation
(
634,095
)
(
583,072
)
Total property, plant and equipment, net
$
501,112

$
492,036

51
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Assets held under finance leases and included in property, plant and equipment as of September 28, 2024 and September 30, 2023 consisted of the following (in thousands):

2024
2023
Buildings and improvements
$
37,771

$
37,771

Machinery and equipment
2,868

2,008

Computer hardware and software
13,426

15,042

Total property, plant and equipment held under finance leases, gross
54,065

54,821

Less: accumulated amortization
(
18,212
)
(
17,430
)
Total property, plant and equipment held under finance leases, net
$
35,853

$
37,391

As of September 28, 2024, September 30, 2023 and October 1, 2022, accounts payable included approximately $
29.7
 million, $
28.9
 million and $
25.4
 million, respectively, related to the purchase of property, plant and equipment, which have been treated as non-cash transactions for purposes of the Consolidated Statements of Cash Flows.
4.

Debt, Finance Lease and Other Financing Obligations
Debt and finance lease obligations as of September 28, 2024 and September 30, 2023, consisted of the following (in thousands):
2024
2023
4.05
% Senior Notes, due June 15, 2025
$
100,000

$
100,000

4.22
% Senior Notes, due June 15, 2028
50,000

50,000

Borrowings under the Credit Facility
50,000

233,000

Finance lease and other financing obligations
48,142

49,233

Unamortized deferred financing fees
(
824
)
(
1,175
)
Total obligations
247,318

431,058

Less: current portion
(
157,325
)
(
240,205
)
Long-term debt, finance lease and other financing obligations, net of current portion
$
89,993

$
190,853

On June 15, 2018, the Company entered into a Note Purchase Agreement (the “2018 NPA”) pursuant to which it issued an aggregate of $
150.0
 million in principal amount of unsecured senior notes, consisting of $
100.0
 million in principal amount of 
4.05
% Series A Senior Notes, due on June 15, 2025, and $
50.0
 million in principal amount of 
4.22
% Series B Senior Notes, due on June 15, 2028 (collectively, the “2018 Notes”), in a private placement. The 2018 NPA includes customary operational and financial covenants with which the Company is required to comply, including, among others, maintenance of certain financial ratios such as a total leverage ratio and a minimum interest coverage ratio. The 2018 Notes may be prepaid in whole or in part at any time, subject to payment of a make-whole amount; interest on the 2018 Notes is payable semiannually. As of September 28, 2024, the Company was in compliance with the covenants under the 2018 NPA.
On June 9, 2022, the Company refinanced its then-existing senior unsecured revolving credit facility (as amended by that certain Amendment No. 1 to Credit Agreement dated April 29, 2020, the "Prior Credit Facility") by entering into a new 
5
-year revolving credit facility (collectively with the Prior Credit Facility, referred to as the "Credit Facility"), which expanded the maximum commitment from $
350.0
 million to $
500.0
 million and extended the maturity from May 15, 2024 to June 9, 2027. The maximum commitment under the Credit Facility may be further increased to $
750.0
 million, generally by mutual agreement of the Company and the lenders, subject to certain customary conditions. During fiscal 2024, the highest daily borrowing was $
376.0
 million; the average daily balance was $
257.8
 million. The Company borrowed $
550.5
 million and repaid $
733.5
 million of revolving borrowings ("revolving commitment") under the Credit Facility during fiscal 2024. As of September 28, 2024, the Company was in compliance with all financial covenants relating to the Credit Facility, which are generally consistent with those in the 2018 NPA discussed above. The Company is required to pay a commitment fee on the daily unused credit facility based on the Company's leverage ratio; the fee was 
0.100
% as of September 28, 2024.
52
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The aggregate scheduled maturities of the Company’s debt obligations as of September 28, 2024, are as follows (in thousands):
2025
$
150,000

2026
—

2027
—

2028
50,000

2029
—

Total
$
200,000

The aggregate scheduled maturities of the Company’s finance leases and other financing obligations as of September 28, 2024, are as follows (in thousands):
2025
$
7,325

2026
3,377

2027
13,437

2028
2,046

2029
828

Thereafter
21,129

Total
$
48,142

The Company's weighted average interest rate on finance lease obligatio
ns 
was 
16.7
% as of September 28, 2024 and September 30, 2023.

5.    
Derivatives and Fair Value Measurements
All derivatives are recognized in the accompanying Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes. 
The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive income (loss)" in the accompanying Consolidated Bala
nce Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates t
hat $
11.3
 million of unrealized gains, net of tax, related to cash flow hedges will be reclassified from other comprehensive income (loss) into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Consolidated Statements of Comprehensive Income.
The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of $
186.5
 million as of September 28, 2024, and a notional value of $
215.4
 million as of September 30, 2023. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a $
11.3
 million asset as of September 28, 2024, and a $
5.0
 million liability as of September 30, 2023.
The Company had additional forward currency exchange contracts outstanding with a notional value of $
144.0
 million as of September 28, 2024, and a notional value of $
145.5
 million as of September 30, 2023. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Consolidated Statements of Comprehensive Income. The total fair value of these derivatives was a $
2.7
 million asset as of September 28, 2024, and a $
1.3
 million liability as of September 30, 2023.
53
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Consolidated Financial Statements:
Fair Values of Derivative Instruments (in thousands)

Derivative Assets
Derivative Liabilities

September 28,
2024
September 30,
2023

September 28,
2024
September 30,
2023
Derivatives designated as hedging instruments
Balance sheet
classification
Fair Value
Fair Value
Balance sheet
classification
Fair Value
Fair Value
Foreign currency forward contracts
Prepaid expenses and other
$
16,294

$
2,610

Other accrued liabilities
$
5,020

$
7,590

Fair Values of Derivative Instruments (in thousands)

Derivative Assets
Derivative Liabilities

September 28,
2024
September 30,
2023

September 28,
2024
September 30,
2023
Derivatives not designated as hedging instruments
Balance sheet
classification
Fair Value
Fair Value
Balance sheet
classification
Fair Value
Fair Value
Foreign currency forward contracts
Prepaid expenses and other
$
3,868

$
1,337

Other accrued liabilities
$
1,125

$
2,669

The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) ("OCI")  (in thousands)
for the Twelve Months Ended
Derivatives in cash flow hedging relationships
Amount of Gain (Loss) Recognized in OCI on Derivatives
September 28, 2024
September 30, 2023
October 1, 2022
Foreign currency forward contracts
$
11,879

$
2,181

$
(
7,637
)
Derivative Impact on (Loss) Gain Recognized in Consolidated Statements of Comprehensive Income (Loss) (in thousands)
for the Twelve Months Ended
Derivatives in cash flow hedging relationships
Classification of (Loss) Gain Reclassified from Accumulated OCI into Income
Amount of (Loss) Gain Reclassified from Accumulated OCI into Income 
September 28, 2024
September 30, 2023
October 1, 2022
Foreign currency forward contracts
Cost of sales
$
(
4,142
)
$
1,002

$
(
2,459
)
Foreign currency forward contracts
Selling and administrative expenses
(
233
)
127

(
189
)
Derivatives not designated as hedging instruments
Location of Gain (Loss) Recognized on Derivatives in Income
Amount of Gain (Loss) on Derivatives Recognized in Income
September 28, 2024
September 30, 2023
October 1, 2022
Foreign currency forward contracts
Miscellaneous, net
$
1,949

$
(
1,285
)
$
(
1,181
)
Fair Value Measurements:
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
54
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The following table lists the fair values of the Company’s derivatives as of September 28, 2024 and September 30, 2023, by input level:
Fair Value Measurements Using Input Levels Asset (Liability) (in thousands)
Fiscal year ended September 28, 2024
Level 1
Level 2
Level 3
Total
Derivatives

Foreign currency forward contracts
$
—

$
14,017

$
—

$
14,017

Fiscal year ended September 30, 2023
Derivatives
Foreign currency forward contracts
$
—

$
(
6,312
)
$
—

$
(
6,312
)
The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.
6.    
Income Taxes
The domestic and foreign components of income (loss) before income tax expense for fiscal 2024, 2023 and 2022 were as follows (in thousands):

2024
2023
2022
U.S.
$
(
114,757
)
$
(
84,557
)
$
(
64,267
)
Foreign
244,289

245,570

222,570

$
129,532

$
161,013

$
158,303

Income tax expense (benefit) for fiscal 2024, 2023 and 2022 were as follows (in thousands):

2024
2023
2022
Current:
Federal
$
2,849

$
24,779

$
12,506

State
(
26
)
302

386

Foreign
21,993

19,276

17,968

24,816

44,357

30,860

Deferred:
Federal
(
9,343
)
(
21,098
)
(
9,931
)
State
(
1,045
)
(
1,371
)
(
315
)
Foreign
3,289

31

(
554
)
(
7,099
)
(
22,438
)
(
10,800
)
$
17,717

$
21,919

$
20,060

55
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The following is a reconciliation of the federal statutory income tax rate to the effective income tax rates reflected in the Consolidated Statements of Comprehensive Income for fiscal 2024, 2023 and 2022:

2024
2023
2022
Federal statutory income tax rate
21.0

%
21.0

%
21.0

%
(Decrease) increase resulting from:
Foreign tax rate differences
(
30.0
)
(
23.8
)
(
23.2
)
Withholding tax on dividends
6.2

1.2

2.4

Permanent differences
(
1.7
)
(
1.3
)
(
0.8
)
Excess tax benefits related to share-based compensation
(
0.8
)
(
1.1
)
(
1.4
)
Global intangible low-taxed income ("GILTI")
12.8

13.1

10.4

Audit settlements
(
0.2
)
—

3.7

Non-deductible compensation
3.9

2.8

2.5

Valuation allowances
2.0

3.5

(
1.7
)
Tax credits, net
(
1.8
)
(
2.1
)
(
1.9
)
Other, net
2.3

0.3

1.7

Effective income tax rate
13.7

%
13.6

%
12.7

%
The effective tax rate for fiscal 2024 was largely consistent with the effective tax rate for fiscal 2023.

During fiscal 2024, the company recognized a benefit of approximately $
6.9
 million as a result of making a U.S. method change impacting the timing of income recognition for advanced payments.

This benefit was largely offset by a $
4.0
 million withholding tax accrual under the indefinite reinvestment assertion for one of its APAC subsidiaries. The effective tax rate for fiscal 2023 was higher than the effective tax rate for fiscal 2022 primarily due to the GILTI impact of the research and development capitalization requirement and the geographic distribution of worldwide earnings. 
During fiscal 2024, the Company recorded a $
2.7
 million increase to its valuation allowance due to continuing losses in various jurisdictions in all operating segments.
During fiscal 2023, the Company recorded a $
5.7
 million increase to its valuation allowance due to continuing losses in various jurisdictions in all operating segments. 
During fiscal 2022, the Company recorded a $
2.8
 million decrease to its valuation allowance primarily due to a net decrease of the valuation allowance in the EMEA segment driven by the release of the valuation allowance against the net deferred tax assets of a foreign subsidiary. This is partially offset by continuing losses in certain jurisdictions within the AMER segment.
56
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The components of the net deferred income tax assets as of September 28, 2024 and September 30, 2023, were as follows (in thousands):
2024
2023
Deferred income tax assets:
Loss/credit carryforwards
$
32,998

$
27,810

Inventories
17,537

24,183

Accrued employee benefits
16,805

14,548

Advanced payments from customers
31,445

25,291

Lease obligations
16,497

17,520

Research and development capitalization
14,521

8,602

Other
6,545

8,556

Total gross deferred income tax assets
136,348

126,510

Less valuation allowances
(
35,641
)
(
31,949
)
Deferred income tax assets
100,707

94,561

Deferred income tax liabilities:
Property, plant and equipment
18,206

21,931

Right-of-use assets
8,956

10,539

Tax on unremitted earnings
7,860

3,851

Deferred income tax liabilities
35,022

36,321

 Net deferred income tax assets
$
65,685

$
58,240

During fiscal 2024, the Company’s valuation allowance increased by $
3.7
 million, including the impact of foreign exchange movement. This increase is the result of increases to the valuation allowances against the net deferred tax assets in the EMEA, AMER, and APAC regions of $
2.0
 million, $
0.4
 million and $
1.3
 million, respectively. 
As of September 28, 2024, the Company had approximately $
230.9
 million of pre-tax state net operating loss carryforwards that expire between fiscal 2025 and 2045. Certain state net operating losses have a full valuation allowance against them. The Company also had approximately $
73.8
 million of pre-tax foreign net operating loss carryforwards that expire between fiscal 2027 and 2034 or are indefinitely carried forward. Certain foreign net operating losses have a full valuation allowance against them. 
The Company has been granted a tax holiday for a foreign subsidiary in the APAC segment. This tax holiday will expire on December 31, 2034, and is subject to certain conditions. During fiscal 2024, 2023 and 2022, the tax holiday resulted in tax reductions, net of the impact of the GILTI provisions of U.S. Tax Reform, of approximately $
37.3
 million ($
1.36
 per basic share, $
1.34
 per diluted share), $
25.9
 million ($
0.94
 per basic share, $
0.92
 per diluted share) and $
35.3
 million ($
1.27
 per basic share, $
1.24
 per diluted share), respectively.
The Company does not provide for taxes that would be payable if certain undistributed earnings of foreign subsidiaries were remitted because the Company considers these earnings to be permanently reinvested. The deferred tax liability that has not been recorded for these earnings was approximately $
11.4
 million as of September 28, 2024. 
The Company has approximately $
19.6
 million of unrecognized tax benefits as of September 28, 2024. The Company has classified these amounts in the Consolidated Balance Sheets as "Other liabilities" (non-current) in the amount of $
19.2
 million and an offset to "Deferred income taxes" (non-current asset) in the amount of $
0.4
 million as the payment is not anticipated within one year. 
57
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The following is a reconciliation of the beginning and ending amounts of gross unrecognized tax benefits, excluding interest and penalties, for the indicated fiscal years (in thousands):
2024
2023
2022
Balance at beginning of fiscal year
$
13,950

$
8,998

$
4,635

Gross increases for tax positions of prior years
1,284

3,778

2,421

Gross increases for tax positions of the current year
3,922

2,105

2,531

Gross decreases for tax positions of prior years
(
1,385
)
(
931
)
(
589
)
Balance at end of fiscal year
$
17,771

$
13,950

$
8,998

The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate is $
19.2
 million and $
13.6
 million for the fiscal years ended September 28, 2024 and September 30, 2023, respectively.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The total accrued penalties and net accrued interest with respect to income taxes was approximately $
1.8
 million as of September 28, 2024, approximately $
1.1
 million as of September 30, 2023 and approximately $
0.5
 million as of October 1, 2022. The Company recognized $
0.7
 million of expense for accrued penalties and net accrued interest in the Consolidated Statements of Comprehensive Income for fiscal 2024, $
0.6
 million for fiscal 2023 and less than $
0.3
 million in fiscal 2022. 
Within the next 12 months, it is reasonably possible that federal, state and foreign tax audit resolutions could reduce unrecognized tax benefits by approximately $
8.6
 million, either because the Company’s tax positions are sustained on audit, the Company agrees to their disallowance or the statute of limitations closes.

The Company files income tax returns, including returns for its subsidiaries, with federal, state, local and foreign taxing jurisdictions. The following tax years remain subject to examination by the respective major tax jurisdictions:
Jurisdiction

Fiscal Years
China
2020-2024
Germany
2019-2024
Malaysia
2020-2024
Mexico
2020-2024
Romania
2023-2024
Thailand
2021-2024
United Kingdom
2021-2024
United States
  Federal
2015, 2017-2024
  State
2004-2006, 2009-2024
7.    
Earnings Per Share
The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for fiscal 2024, 2023 and 2022 (in thousands, except per share amounts): 

2024
2023
2022
Net income
$
111,815

$
139,094

$
138,243

Basic weighted average common shares outstanding
27,397

27,582

27,862

Dilutive effect of share-based awards and options outstanding
512

532

577

Diluted weighted average shares outstanding
27,909

28,114

28,439

Earnings per share:
Basic
$
4.08

$
5.04

$
4.96

Diluted
$
4.01

$
4.95

$
4.86

In each year of fiscal 2024, 2023 and 2022, share-based awards for less than 
0.1
 million shares were not included in the computation of diluted earnings per share as they were antidilutive.
58
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
8.    
Leases
The Company’s lease portfolio includes both real estate and non-real estate type leases which are accounted for as either finance or operating leases. Real estate leases generally include office, warehouse and manufacturing facilities and non-real estate leases generally include equipment and vehicles. The Company determines if a contract is or contains a lease at inception. The Company’s leases have remaining lease terms of less than 
1
 year to 
60
 years. Renewal options that are deemed reasonably certain are included as part of the lease term for purposes of calculating the right-of-use (“ROU”) asset and lease liability. Variable lease payments are generally expensed as incurred and include certain index-based changes in rent, certain nonlease components, such as maintenance and other services provided by the lessor, and other charges included in the lease. The Company elected the practical expedient to not separate lease and nonlease components, as such nonlease components are included in the calculation of the ROU asset and lease liability and included in the lease expense over the term of the lease. The Company uses a discount rate to calculate the ROU asset and lease liability. When the implicit rate is known or provided in the lease documents, the Company is required to use this rate. In cases in which the implicit rate is not known, the Company uses an estimated incremental borrowing rate.
Operating lease ROU assets and lease liabilities are recorded on the date the Company takes possession of the leased assets with expense recognized on a straight-line basis over the lease term. Leases with an estimated total term of 12 months or less are not recorded on the balance sheet and the lease expense is recognized on a straight-line basis over the lease term. Generally, the Company's lease agreements do not contain material residual value guarantees or material restrictive covenants.
The components of lease expense for fiscal years indicated were as follows (in thousands):
2024
2023
2022
Finance lease expense:
   Amortization of right-of-use assets
$
5,930

$
6,903

$
6,478

   Interest on lease liabilities
5,340

5,132

4,927

Operating lease expense
10,493

10,783

11,278

Other lease expense
6,807

8,280

6,185

Total
$
28,570

$
31,098

$
28,868

Based on the nature of the ROU asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance lease liabilities is recorded within interest expense on the Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.
59
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Consolidated Balance Sheets (in thousands):
Financial Statement Line Item
2024
2023
ASSETS
   Finance lease assets
Property, plant and equipment, net
$
35,853

$
37,391

   Operating lease assets
Operating lease right-of-use assets
74,360

69,363

      Total lease assets
$
110,213

$
106,754

LIABILITIES AND SHAREHOLDERS' EQUITY
Current

Finance lease liabilities
Current portion of long-term debt and finance lease obligations
$
4,717

$
4,034

Operating lease liabilities
Other accrued liabilities
14,697

8,363

Non-current

Finance lease liabilities
Long-term debt and finance lease obligations, net of current portion
38,756

39,271

  Operating lease liabilities
Long-term operating lease liabilities
32,275

38,552

        Total lease liabilities
$
90,445

$
90,220

Other information related to the Company’s leases was as follows: 
2024
2023
Weighted-average remaining lease term (in years)
   Finance leases
9.8
10.6
   Operating leases
25.4
16.0
Weighted-average discount rate
   Finance leases
16.7

%
16.7

%
   Operating leases
3.7

%
3.7

%
2024
2023
2022
Cash paid for amounts included in the measurement of lease liabilities (in thousands)
   Operating cash flows used in finance leases
$
5,035

$
4,823

$
4,630

   Operating cash flows used in operating leases
18,993

10,114

10,278

   Finance cash flows used in finance leases
4,342

8,375

6,148

ROU assets obtained in exchange for lease liabilities (in thousands)
   Operating leases
$
15,716

$
13,102

$
4,710

   Finance leases
5,021

4,811

7,851

60
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Future minimum lease payments required under finance and operating leases as of September 28, 2024, were as follows (in thousands):
Operating leases
Finance leases
2025
$
16,092

$
9,882

2026
8,529

7,329

2027
6,777

17,209

2028
4,949

5,430

2029
3,265

4,914

Thereafter
13,623

65,316

Total minimum lease payments
53,235

110,080

   Less: imputed interest
(
6,263
)
(
66,607
)
Present value of lease liabilities
$
46,972

$
43,473

As of September 28, 2024, the Company’s future operating leases that have not yet commenced are immaterial.

9.    
Benefit Plans
Share-based Compensation Plans:
 During fiscal 2024, the Company’s shareholders approved the Plexus Corp. 2024 Omnibus Incentive Plan (the “2024 Plan”). The 2024 Plan is a stock and cash-based incentive plan, and includes provisions by which the Company may grant executive officers, employees and directors stock options, stock appreciation rights ("SARs"), restricted stock (including restricted stock units ("RSUs"), performance stock awards (including performance stock units ("PSUs"), other stock awards and cash incentive awards.  Similar awards were offered under its predecessor, the Plexus Corp. 2016 Omnibus Incentive Plan (the "2016 Plan"), which is no longer being used for grants of new awards; however, outstanding awards granted under the 2016 Plan and its predecessors continue until vesting, exercise, forfeiture or expiration.  
The maximum number of shares of Plexus common stock that may be issued pursuant to the 2024 Plan is 
0.8
 million shares. The Compensation and Leadership Development Committee (the "Committee") of the Board of Directors may establish a term and vesting period for awards under the 2024 Plan as well as accelerate the vesting of such awards. RSUs granted to executive officers, other officers and key employees generally vest on the 
3
 year anniversary of the grant date (assuming continued employment), which is also the date as of which the underlying shares will be issued. 
PSUs are payable in shares of the Company's common stock and have a performance period of 
three years
. For PSUs, approximately 
50
% vest based on the relative total shareholder return ("TSR") of the Company's common stock as compared to the companies in the S&P 400 Index for grants issued. The remaining approximately 
50
% of PSUs vest based upon a 
three
-point annual average of the Company's absolute economic return, a performance condition, with grants being subject to an individual year minimum and maximum absolute economic return. For PSUs based on TSR, the vesting and payout of awards will range between 
0
% and 
150
% of shares granted. For PSUs based on absolute economic return, the vesting and payout of awards will range between 
0
% and 
200
% of shares granted. Payout at target, 
100
% of the shares granted, will occur if the TSR of Plexus stock is at the 
50
th percentile of companies in the S&P 400 Index during the performance period and if a 
2.5
% average economic return is achieved over the performance period of 
three years
. The Company uses the Monte Carlo valuation model to value performance stock units with market conditions and the share price on the date of the grant for performance stock units that vest based on non-market-based performance conditions. The number of shares that may be issued pursuant to PSUs ranges from 
zero
 to 
0.5
 million and is dependent upon the Company's TSR and economic return performance over the applicable performance periods. The Committee also grants RSUs to non-employee directors, which generally fully vest on the first anniversary of the grant date, which is also the date the underlying shares are issued (unless further deferred). 
The Company recognizes stock-based compensation expense, reduced for estimated forfeitures, primarily in selling and administrative expenses on the Consolidated Statement of Comprehensive Income. The Company recognized $
30.3
 million, $
21.3
 million and $
23.3
 million of compensation expense associated with share-based awards in fiscal 2024, 2023 and 2022, respectively. Included in the $
30.3
 million of total stock-based compensation expense for the year ended September 28, 2024, was $
5.1
 million related to modifications of awards from executive retirement agreements. The award modifications were the result of accelerated vesting of previously unvested awards upon their retirements.
61
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
A summary of the Company’s PSU and RSU activity follows:
Number of Shares (in thousands)
Weighted Average Fair Value at Date of Grant
Aggregate Intrinsic Value (in thousands)
Units outstanding as of October 2, 2021
861

$
72.38

Granted
328

75.39

Canceled
(
35
)
76.68

Vested
(
356
)
58.76

Units outstanding as of October 1, 2022
798

$
79.57

Granted
371

91.73

Canceled
(
28
)
83.97

Vested
(
339
)
80.85

Units outstanding as of September 30, 2023
802

$
84.50

Granted
367

92.29

Canceled
(
14
)
88.86

Vested
(
302
)
81.84

Units outstanding as of September 28, 2024
853

$
88.72

$
116,445

The Company uses the fair value at the date of grant to value RSUs. As of September 28, 2024, there was $
24.3
 million of unrecognized compensation expense related to RSUs that is expected to be recognized over a weighted average period of 
1.4
 years.
The Company recognizes share-based compensation expense over the vesting period of PSUs. During the fiscal year ended September 28, 2024, the 
0.1
 million PSUs granted in fiscal 2021 vested at a 
116
% payout based upon the TSR performance achieved during the performance period and 
153
% payout based upon economic return performance achieved during the performance period. There were 
0.1
 million PSUs granted during each of fiscal years 2024, 2023 and 2022.
As of September 28, 2024, at the target achievement level, there was $
8.7
 million of unrecognized compensation expense related to PSUs that is expected to be recognized over a weighted average period of 
1.8
 years.
401(k) Savings Plan:
 The Company’s 401(k) Retirement Plan covers all eligible U.S. employees. The Company matches employee contributions up to 
4.0
% of eligible earnings. The Company’s contributions for fiscal 2024, 2023 and 2022 totaled $
9.6
 million, $
9.8
 million and $
9.3
 million, respectively.
Supplemental Executive Retirement Plan (Deferred Compensation Arrangement):
 The Company maintains a supplemental executive retirement plan (the "SERP") as a deferred compensation plan for executive officers. Under the SERP, a covered executive may elect to defer some or all of the participant’s compensation into the plan, and the Company may credit the participant’s account with a discretionary employer contribution. Participants are entitled to payment of deferred amounts and any related earnings upon termination or retirement from Plexus.
The SERP allows investment of deferred compensation into individual accounts and, within these accounts, into one or more designated investments. Investment choices do not include Plexus stock. During fiscal 2024, 2023 and 2022, the Company made contributions to the participants’ SERP accounts in the amount of $
1.0
 million, $
0.9
 million and $
0.8
 million, respectively.
As of September 28, 2024 and September 30, 2023, the SERP assets held in the trust totaled $
15.4
 million and $
12.4
 million, respectively, and the related liability to the participants totaled approximately $
15.4
 million and $
12.4
 million, respectively. As of September 28, 2024 and September 30, 2023, the SERP assets held in the trust were recorded at fair value on a recurring basis, and were classified as Level 2 in the fair value hierarchy discussed in Note 1, "Description of Business and Significant Accounting Policies."
The trust assets are subject to the claims of the Company’s creditors. The trust assets and the related liabilities to the participants are included in non-current "Other assets" and non-current "Other liabilities," respectively, in the accompanying Consolidated Balance Sheets.
62
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
10.    
Litigation
The Company is party to lawsuits in the ordinary course of business. We record provisions in the consolidated financial statements for pending legal matters when we determine that an unfavorable outcome is probable, and the amount of the loss can be reasonably estimated.
During fiscal 2023, the Company paid a one-time, non-recurring payment of $
15.8
 million related to an arbitration decision in Norway regarding a contractual matter concluded in May 2023. This payment resulted in a $
14.2
 million one-time, non-recurring charge, net of insurance recoveries and amounts previously accrued. During fiscal 2024, the Company received $
2.3
 million of additional insurance proceeds related to this decision. The Company no longer provides services for this customer. Refer to Note 16, "Restructuring and Non-recurring Charges," for information regarding total charges. The Company does not expect further charges relating to this matter.
Management does not believe that any other such proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could involve substantial fines, civil or criminal penalties, and other expenditures.
11.    
Reportable Segments, Geographic Information and Major Customers
Reportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income. A segment’s operating income includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any, such as the $
20.3
 million, $
23.1
 million and $
2.0
 million of restructuring and other charges in fiscal 2024, 2023 and 2022, respectively.  These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.
63
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Information about the Company’s 
three
 reportable segments for fiscal 2024, 2023 and 2022 is as follows (in thousands):

2024
2023
2022
Net sales:
AMER
$
1,323,428

$
1,558,230

$
1,310,687

APAC
2,213,111

2,358,390

2,300,640

EMEA
541,610

403,040

316,315

Elimination of inter-segment sales
(
117,322
)
(
109,355
)
(
116,274
)
$
3,960,827

$
4,210,305

$
3,811,368

Operating income:
AMER
$
39,603

$
79,678

$
44,741

APAC
289,300

289,556

267,253

EMEA
13,416

1,576

8,018

Corporate and other costs
(
174,587
)
(
174,990
)
(
141,827
)
$
167,732

$
195,820

$
178,185

Other income (expense):
Interest expense
$
(
28,876
)
$
(
31,542
)
$
(
15,858
)
Interest income
3,860

3,138

1,305

Miscellaneous, net
(
13,184
)
(
6,403
)
(
5,329
)
Income before income taxes
$
129,532

$
161,013

$
158,303

2024
2023
2022
Depreciation:
AMER
$
23,544

$
23,560

$
23,482

APAC
32,270

29,218

23,547

EMEA
11,005

6,281

5,861

Corporate
9,843

9,513

8,613

$
76,662

$
68,572

$
61,503

Capital expenditures:
   AMER
$
18,392

$
23,880

$
20,024

   APAC
29,664

45,923

73,758

EMEA
38,820

23,120

2,617

Corporate
8,306

11,126

5,213

$
95,182

$
104,049

$
101,612

September 28,
2024
September 30,
2023

Total assets:
AMER
$
937,409

$
1,124,555

APAC
1,608,377

1,696,795

EMEA
443,514

462,199

Corporate and eliminations
164,521

37,623

$
3,153,821

$
3,321,172

64
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The following information is provided in accordance with the required segment disclosures for fiscal 2024, 2023 and 2022. Net sales were based on the Company’s location providing the product or service (in thousands):
2024
2023
2022
Net sales:
United States
$
817,454

$
1,001,697

$
869,144

Malaysia
1,756,747

1,886,970

1,846,086

Mexico
505,973

556,532

441,543

Romania
422,756

297,969

217,052

China
384,493

456,443

453,591

United Kingdom
115,688

98,314

91,137

Thailand
71,871

14,978

963

Germany
3,167

6,757

8,126

Elimination of inter-country sales
(
117,322
)
(
109,355
)
(
116,274
)
$
3,960,827

$
4,210,305

$
3,811,368

September 28,
2024
September 30,
2023

Long-lived assets:
United States
$
96,956

$
107,392

Malaysia
173,139

159,182

Mexico
74,158

77,757

Romania
56,877

51,653

Thailand
56,415

58,009

China
40,254

44,068

Poland
13,594

—

United Kingdom
12,689

8,234

Other Foreign
—

2,767

Corporate
51,390

52,337

$
575,472

$
561,399

As the Company operates flexible manufacturing facilities and processes designed to accommodate customers with multiple product lines and configurations, it is impracticable to report net sales for individual products or services or groups of similar products and services. 
Long-lived assets as of September 28, 2024 and September 30, 2023 exclude other long-term assets, deferred income tax assets and intangible assets, which totaled $
101.2
 million and $
87.6
 million, respectively.
As a percentage of consolidated net sales, there were no customers representing 10.0% or more of consolidated net sales for fiscal 2024. Net sales attributable to customers representing 10.0% or more of consolidated net sales for fiscal 2023 and 2022 were as follows:

2023
2022
GE Healthcare Technologies, Inc. ("GEHC")
10.3
%
*
General Electric Company ("GE")
*
12.9
%
 * Net sales attributable to the customer were less than 10.0% of consolidated net sales for the period
During fiscal 2023, GE completed the separation of its healthcare business, GEHC, as a stand-alone company. During fiscal 2023 and 2022, net sales attributable to GEHC and GE, respectively, were reported in all 
three
 reportable segments.

65
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
12.    
Guarantees
The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.
In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 
12
 months to 
24
 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.
The Company provides for an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
Below is a table summarizing the activity related to the Company’s limited warranty liability for fiscal 2024, 2023 and 2022 (in thousands):
Limited warranty liability, as of October 2, 2021
$
6,645

Accruals for warranties issued during the period
2,786

Settlements (in cash or in kind) during the period
(
2,506
)
Limited warranty liability, as of October 1, 2022
6,925

Accruals for warranties issued during the period
2,954

Settlements (in cash or in kind) during the period
(
4,058
)
Limited warranty liability, as of September 30, 2023
5,821

Accruals for warranties issued during the period
3,344

Settlements (in cash or in kind) during the period
(
2,413
)
Limited warranty liability, as of September 28, 2024
$
6,752

13.    
Shareholders' Equity
On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $
50.0
 million of its common stock (the "2023 Program"). During fiscal 2024 and 2023, the Company completed the 2023 Program by repurchasing 
59,277
 and  
425,746
 shares under this program for $
5.7
 million and $
40.9
 million at an average price of $
95.59
 and $
95.96
 per share, respectively. 
On January 16, 2024, the Company announced a share repurchase program authorized by the Board of Directors under which the Company is authorized to repurchase up to $
50.0
 million of its common stock (the "2024 Program"). The 2024 Program commenced upon completion of the 2023 Program. During fiscal 2024, the Company completed the 2024 Program by repurchasing 
477,012
 shares under this program for $
50.0
 million at an average price of $
104.82
 per share. 
66
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
On August 14, 2024, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $
50.0
 million of its common stock (the "2025 Program"). The 2025 Program became effective upon completion of the 2024 Program, and has no expiration. During fiscal 2024, the Company repurchased 
151
 shares under this program for less than $
0.1
 million at an average price of $
131.78
 per share. As of September 28, 2024, $
49.9
 million of authority remained under the 2025 Program. 
All shares repurchased under the aforementioned programs were recorded as treasury stock.
14.    
Trade Accounts Receivable Sale Programs
The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell receivables; at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG R
PA is 
$
340.0
 million
. The maximum facility amount under the HSBC RPA is $
70.0
 million.
 The MUFG RPA will be automatically extended each year unless any party gives no less than 
10
 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA.
Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during fiscal 
2024
, 
2023
 and 
2022
 were not material.
The Company sold $
854.7
 million, $
834.5
 million
 and $
787.5
 million of trade accounts receivable under these programs, or their predecessors, during fiscal 2024, 2023 and 2022, respectively, in exchange for cash proceeds
 of $
844.6
 million
, 
$
824.6
 million and $
783.1
 million, respectively. As of 
September 28, 2024
 and September 30, 2023, $
220.2
 million and $
220.5
 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been collected.

15.    
Revenue from Contracts with Customers
Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.
The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.  
The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.
Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.
67
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract-by-contract basis.
Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.
The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.
Contract Costs
For contracts requiring over time revenue recognition, the selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress toward completion is measured based on the costs incurred to date. 
There were no other costs to obtain or fulfill customer contracts. 
Disaggregated Revenue
The table below includes the Company’s revenue for the fiscal years indicated disaggregated by geographic reportable segment and market sector (in thousands):
2024
Reportable Segment:
AMER
APAC
EMEA
Total
Market Sector:
Aerospace/Defense
$
329,602

$
271,906

$
96,926

$
698,434

Healthcare/Life Sciences
674,202

655,284

225,330

1,554,816

Industrial
303,277

1,189,846

214,454

1,707,577

     External revenue
1,307,081

2,117,036

536,710

3,960,827

Inter-segment sales
16,347

96,075

4,900

117,322

    Segment revenue
$
1,323,428

$
2,213,111

$
541,610

$
4,078,149

2023
Reportable Segment:
AMER
APAC
EMEA
Total
Market Sector:
Aerospace/Defense
$
281,632

$
212,336

$
85,038

$
579,006

Healthcare/Life Sciences
862,767

809,165

202,842

1,874,774

Industrial
398,120

1,248,016

110,389

1,756,525

     External revenue
1,542,519

2,269,517

398,269

4,210,305

Inter-segment sales
15,711

88,873

4,771

109,355

    Segment revenue
$
1,558,230

$
2,358,390

$
403,040

$
4,319,660

68
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
2022
Reportable Segment:
AMER
APAC
EMEA
Total
Market Sector:
Aerospace/Defense
$
255,779

$
165,432

$
71,668

$
492,879

Healthcare/Life Sciences
645,881

744,216

175,674

1,565,771

Industrial
398,743

1,288,577

65,398

1,752,718

     External revenue
1,300,403

2,198,225

312,740

3,811,368

Inter-segment sales
10,284

102,415

3,575

116,274

    Segment revenue
$
1,310,687

$
2,300,640

$
316,315

$
3,927,642

For fiscal 
2024
 approximately 
83
% of the Company's revenue was recognized as products and services transferred over time. For fiscal 
2023 and 
2022 approximately 
82
% and 
84
% of the Company's revenue was recognized as products and services  transferred over time.
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Consolidated Balance Sheets.
Contract Assets
: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the recognition of contract assets. 
The following table summarizes the activity in the Company's contract assets during fiscal 2024 and 2023 (in thousands):
2024
2023
Contract assets, beginning of period
$
142,297

$
138,540

Revenue recognized during the period
3,275,226

3,450,570

Amounts collected or invoiced during the period
(
3,296,963
)
(
3,446,813
)
Contract assets, end of period
$
120,560

$
142,297

Deferred Revenue
: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in advanced payments from customers on Consolidated Balance Sheets. As of 
September 28, 2024
 and September 30, 2023 the balance of advance payments from customers attributable to deferred revenue was $
154.7
 million and $
158.7
 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping terms.
16.    
Restructuring and Non-recurring Charges
Restructuring and non-recurring charges are recorded within restructuring and other charges on the Consolidated Statements of Comprehensive Income. Restructuring liabilities are primarily recorded within other accrued liabilities on the Consolidated Balance Sheets.
During fiscal 2024, the Company incurred restructuring and other charges of $
20.3
 million, which consisted of severance from the reduction of the Company's workforce and associated site closure costs in the AMER region and EMEA region. 
During fiscal 2023, the Company incurred restructuring and other charge of $
8.9
 million, which consisted of severance from the reduction of the Company's workforce and a lease agreement termination. 
69
Table of Contents
Plexus Corp.
Notes to Consolidated Financial Statements
Additionally during fiscal 2023, the Company incurred a one-time, non-recurring charge of $
14.2
 million relating to an arbitration decision in Norway regarding a contractual matter. During fiscal 2024, the Company received $
2.3
 million of insurance proceeds related to this decision. The Company no longer provides services for this customer. 
During fiscal 2022, the Company recorded $
2.0
 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment. 
The Company recognized a tax benefit of $
2.1
 million, $
1.9
 million and $
0.2
 million related to restructuring and other charges in fiscal 2024, 2023 and 2022, respectively.  
The Company's restructuring accrual activity for fiscal 2024, 2023 and 2022 is included in the table below (in thousands):
Termination and Severance Costs
Fixed Asset and Operating ROU Asset Impairment
Arbitration Recovery
Total
Accrual balance, as of October 2, 2021
$
71

$
—

$
—

$
71

Restructuring and impairment costs
1,766

255

—

2,021

Amounts utilized
(
1,725
)
(
255
)
—

(
1,980
)
Accrual balance, as of October 1, 2022
112

—

—

112

Restructuring and impairment costs
8,865

—

14,229

23,094

Amounts utilized
(
8,355
)
—

(
14,229
)
(
22,584
)
Accrual balance, as of September 30, 2023
622

—

—

622

Restructuring and other charges
14,130

8,377

(
2,250
)
20,257

Amounts utilized
(
13,256
)
(
7,268
)
2,250

(
18,274
)
Accrual balance, as of September 28, 2024
$
1,496

$
1,109

$
—

$
2,605

The accrual balances outstanding as of October 1, 2022 and September 30, 2023 were fully utilized as of September 28, 2024.
70
Table of Contents
ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.

ITEM 9A.    CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures designed to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission ("SEC") is recorded, processed, summarized and reported on a timely basis. The Company’s President and Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") have reviewed and evaluated, with the participation of the Company’s management, the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") as of the end of the period covered by this report. Based on such evaluation, the CEO and CFO have concluded that, as of September 28, 2024, the Company’s disclosure controls and procedures are effective, at the reasonable assurance level, (a) in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act, and (b) in assuring that information is accumulated and communicated to the Company’s management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Management’s Annual Report on Internal Control Over Financial Reporting
Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Management of the Company, including its CEO and CFO, has assessed the effectiveness of its internal control over financial reporting as of September 28, 2024, based on the criteria established in "Internal Control - Integrated Framework" issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") (2013). Based on its assessment and those criteria, management has reached the conclusion that the Company's internal control over financial reporting was effective as of September 28, 2024.
The independent registered public accounting firm of PricewaterhouseCoopers LLP has audited the Company’s internal control over financial reporting as of September 28, 2024, as stated in its report included herein.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Limitations on the Effectiveness of Controls
Our management, including our CEO and CFO, does not expect that our disclosure controls and internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Notwithstanding the foregoing limitations on the effectiveness of controls, we have nonetheless reached the conclusion that the Company's disclosure controls and procedures and internal control over financial reporting are effective.
71
Table of Contents
ITEM 9B.    OTHER INFORMATION
On 
August 16, 2024
, 
Todd P. Kelsey
, 
President and Chief Executive Officer
, 
adopted
 a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 
26,158
 shares of the Company's common stock through 
November 19, 2025
.

There were no other directors or Section 16 officers that 
adopted
 or 
terminated
 a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408(a) of Regulation S-K) during the three months ended September 28, 2024.
ITEM 9C.    DISCLOSURES REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable. 
PART III
ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information in response to this item is incorporated herein by reference to "Election of Directors" and "Corporate Governance" in the Company’s Proxy Statement for its 2025 Annual Meeting of Shareholders ("2025 Proxy Statement"), which will be filed within 120 days of the end of the Company's fiscal year.
Our Code of Conduct and Business Ethics is posted on our website at www.plexus.com. You may access the Code of Conduct and Business Ethics by following the links under "Investors" and then "Corporate Governance" at our website. Plexus’ Code of Conduct and Business Ethics applies to all members of the board of directors, officers and employees; and includes provisions related to accounting and financial matters that apply to the Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Controller. 

Plexus also has an Insider Trading Policy governing the purchase, sale and/or other dispositions of our securities by our directors, officers, employees, and related persons that we believe is reasonably designed to promote compliance with insider trading laws, rules and regulations, and the exchange listing standards applicable to us. A copy of our Insider Trading Policy, as amended to date, is filed as Exhibit 19 to this Annual Report on Form 10-K. 
Information about our Executive Officers
The following table sets forth our executive officers, their ages as of November 15, 2024, and the positions held by each person:
Name
Age
Position
Todd P. Kelsey
59
President and Chief Executive Officer
Patrick J. Jermain
58
Executive Vice President and Chief Financial Officer
Oliver K. Mihm
52
Executive Vice President and Chief Operating Officer
Angelo M. Ninivaggi
57
Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
Michael J. Running
49
Regional President – AMER
Victor Tan
60
Regional President – APAC
Frank Zycinski
56
Regional President – EMEA
Todd P. Kelsey
 joined Plexus in 1994 and has served as Chief Executive Officer since 2016. In 2024, Mr. Kelsey resumed the office of President. He previously served as President from 2016 to 2022.  Previously, Mr. Kelsey served as Executive Vice President and Chief Operating Officer since 2013 and as Executive Vice President – Global Customer Services since 2011 and as Senior Vice President prior thereto.
Patrick J. Jermain
 joined Plexus in 2010 and has served as Chief Financial Officer since 2014; he was named a Senior Vice President in 2015 and Executive Vice President in 2019. Previously, Mr. Jermain served as Treasurer and Vice President of Finance since 2013 and as Corporate Controller since 2010. 
72
Table of Contents
Oliver K. Mihm 
joined Plexus in 2000 and has served as Executive Vice President and Chief Operating Officer since 2022. Prior thereto, he served as Executive Vice President – Global Supply Chain and Operational Solutions, previously serving as Executive Vice President Supply Chain since 2019. From 2015 to 2019, Mr. Mihm served as Regional President – EMEA. Prior to that, Mr. Mihm was Industrial Market Sector Vice President, led our Global Engineering Solutions and held various leadership roles within our Engineering Solutions organization. 
Angelo M. Ninivaggi
 joined Plexus in 2002 and has served as Chief Administrative Officer since 2013. Mr. Ninivaggi has also served as Vice President, General Counsel and Secretary since 2006, was named a Senior Vice President in 2011 and Executive Vice President in 2019. Mr. Ninivaggi also served as Corporate Compliance Officer from 2007 to 2013.
Michael J. Running 
joined Plexus in 1997 and has served as Regional President – AMER since 2023. Previously, Mr. Running served as Senior Vice President of Quality and Regulatory and Senior Vice President of Engineering since 2022. He was promoted to Senior Vice President of Global Engineering Solutions in AMER in 2016 and has held various leadership roles within our Engineering Solutions organization.  
Victor Tan 
joined Plexus in 2007 and has served as Regional President – APAC since 2020. Previously, Mr. Tan served as Senior Vice President of Global Operations since 2019. In 2010, he was promoted to Vice President of Customer Management in APAC, later appointed to lead all Penang operations and support functions in the region in 2013 and further expanded to lead APAC operations in 2018. Prior thereto, he served as the General Manager for Plexus' Penang-Hillside site in Malaysia.
Frank Zycinski 
joined Plexus in 2012 and has served as Regional President  – EMEA since 2023. Previously, Mr. Zycinski served as Vice President of Regional Operations - EMEA from 2014 to 2018 before he departed from Plexus. In 2021 he rejoined as Market Sector Vice President. 
ITEM 11.    EXECUTIVE COMPENSATION
Incorporated herein by reference to "Corporate Governance – Board and Committee Responsibilities – Compensation & Leadership Development Committee," "Director Compensation for Fiscal 2024," "Compensation Discussion & Analysis," "Executive Compensation" and "Compensation Committee Report" in the 2025 Proxy Statement.
ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Incorporated herein by reference to "Security Ownership of Certain Beneficial Owners and Management" in the 2025 Proxy Statement.  
Equity Compensation Plan Information
The following table chart gives aggregate information regarding grants under all Plexus equity compensation plans through September 28, 2024:
Plan category
Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)
Weighted-average exercise price of outstanding options, warrants and rights (2)
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in 1
st
 column)
Equity compensation plans approved by security holders
853,452 
$
— 
$
870,085 
Equity compensation plans not approved by security holders
— 
n/a
— 
Total
853,452 
$
— 
$
870,085 
(1) Represents options, stock-settled SARs, PSUs and RSUs granted under the 2024 Omnibus Incentive Plan, the 2016 Omnibus Incentive Plan and the 2008 Long-Term Incentive Plan, all of which were approved by shareholders. No further awards may be made under the 2008 Long-Term Incentive Plan or the 2016 Omnibus Incentive Plan.
(2) The weighted average exercise prices exclude PSUs and RSUs. There are no outstanding options, warrants or rights as of September 28, 2024.
73
Table of Contents
ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Incorporated herein by reference to "Corporate Governance – Director Independence" and "Certain Transactions" in the 2025 Proxy Statement.
ITEM 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES
Our independent registered public accounting firm is 
PricewaterhouseCoopers LLP
, 
Milwaukee, Wisconsin
, Auditor Firm ID: 
238
. Incorporated herein by reference to the subheading "Ratify Independent Auditors - Fees and Services" in the 2025 Proxy Statement.

74
Table of Contents
PART IV
ITEM 15.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a)

Documents filed

Financial Statements and Financial Statement Schedule. See the list of Financial Statements and Financial Statement Schedule in Item 8.
(b)

Exhibits. The list of exhibits is included below:
Incorporate by Reference Herein
Exhibit 
No.

Exhibit
Form
Exhibit
Filing Date
3(i)
Restated Articles of Incorporation of Plexus Corp.

10-Q
3.1
5/14/2004
3(ii)

Amended and Restated Bylaws of Plexus Corp., as amended through February 14, 2024
8-K
3.1
2/15/2024
4.1
Description of Common Stock
10-K
4.3
11/19/2021
10.1 (a)

Credit Agreement, dated as of May 15, 2019, among Plexus Corp., the banks, financial institutions and other institutional lenders listed on the signature pages thereto, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association, as syndication agent, PNC Bank, National Association, Bank of America, N.A., MUFG Bank, Ltd., HSBC Bank USA, N.A., Bank of the West and Wells Fargo Bank, National Association, as co-documentation agents, and JPMorgan Chase Bank, N.A. and U.S. Bank National Association, as joint lead arrangers and joint book runners (including the related subsidiary guaranty).
8-K
10.1
5/15/2019
10.1 (b)
Amendment No. 1 to Credit Agreement, dated as of April 29, 2020, among Plexus Corp., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.

8-K
10.1
4/30/2020
10.1 (c)
Amended and Restated Credit Agreement, dated June 9, 2022, by and among Plexus Corp., certain of its subsidiaries from time to time party thereto as borrowers, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent.
8-K
10.1
6/13/2022
10.2 (a)

Note Purchase Agreement, dated as of June 15, 2018, between Plexus Corp. and the Purchasers named therein relating to an aggregate of $150,000,000 in principal amount of 4.05% Series A Senior Notes, due June 15, 2025, and 4.22% Series B Senior Notes, due June 15, 2028.
8-K
10.1
6/18/2018
10.2 (b)
First Amendment, dated as of June 25, 2019, to the Note Purchase Agreement, dated as of June 15, 2018, between Plexus Corp. and the Noteholders named therein relating to an aggregate of $150,000,000 in principal amount of 4.05% Series A Senior Notes, due June 15, 2025, and 4.22% Series B Senior Notes, due June 15, 2028.
10-Q
10.1
8/2/2019
10.3 (a)
Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser, dated as of October 4, 2016.
8-K
10.1
10/7/2016
10.3 (b)
Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser, dated as of December 14, 2016.
10-Q
10.2
2/3/2017
75
Table of Contents
10.3 (c)
Amendment No. 3 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser, dated as of March 28, 2017.
10-Q
10.1
5/5/2017
10.3 (d)
Amendment No. 4 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser, dated as of September 11, 2017.
10-K
10.3(d)
11/16/2018
10.3 (e)
Amendment No. 5 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser, dated as of October 19, 2017.

10-K
10.3(d)
11/17/2017
10.3 (f)
Amendment No. 6 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of May 4, 2018.

10-Q
10.1
8/3/2018
10.3 (g)
Amendment No. 7 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of September 19, 2018.

10-K
10.3(g)
11/16/2018
10.3 (h)
Amendment No. 8 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of March 20, 2019.

10-Q
10.1
5/3/2019
10.3 (i)
Amendment No.9 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of June 21, 2019.

10-Q
10.2
8/2/2019
76
Table of Contents
10.3 (j)
Amendment No.10 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of December 23, 2019.
10-Q
10.1
2/7/2020
10.3 (k)
Amendment No.11 to Amended and Restated Master Accounts Receivable Purchase Agreement between Plexus Corp. and Plexus Manufacturing Sdn. Bhd., Plexus Intl. Sales & Logistics, LLC, Plexus Services Ro SRL, Plexus Corp. (UK) Limited and each additional seller party thereto from time to time as the Sellers, Plexus Corp., as Seller Representative, and MUFG Bank Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Purchaser, dated as of September 10, 2020.
10-K
10.3(k)
11/20/2020
10.4
Retirement and Transition Agreement, dated August 17, 2016, by and between Plexus Corp. and Dean A. Foate.*
8-K
10.1
8/19/2016
10.5
Retirement and Transition Agreement, dated May 31, 2024, by and between Plexus Corp. and Steven J. Frisch.*
8-K
10.1
6/5/2024
10.6
Employment Agreement, dated August 17, 2016, by and between Plexus Corp. and Todd P. Kelsey.*
8-K
10.2
8/19/2016
10.7
Form of Change of Control Agreement with executive officers.*
8-K
10.2
5/21/2008
10.8
Summary of Directors' Compensation (1/22).*
10-Q
10.2
2/4/2022
10.9 (a)
Plexus Corp. Executive Deferred Compensation Plan.*

10-K
10.17
12/19/2000
10.9 (b)

Plexus Corp Executive Deferred Compensation Plan Trust dated April 1, 2003 between Plexus Corp. and Bankers Trust Company.*
10-K
10.14
12/15/2003
10.10
Plexus Corp. Non-employee Directors Deferred Compensation Plan.*

10-K
10.10
11/19/2012
10.11 (a)
Plexus Corp. 2024 Omnibus Incentive Plan.*
8-K
10.1
2/14/2024
10.11 (b)
Forms of award agreements thereunder*
(i) Form of Performance Stock Unit Agreement (Economic Return).
10-Q
10.1
8/2/2024
(ii) Form of Performance Stock Unit Agreement (Total Shareholder Return).
10-Q
10.2
8/2/2024
(iii) Form of Restricted Stock Unit Agreement.
10-Q
10.3
8/2/2024
(iv) Form of Restricted Stock Unit Award Agreement for Directors.
10-Q
10.4
8/2/2024
10.12 (a)

Amended and Restated Plexus Corp. 2016 Omnibus Incentive Plan.*
(superseded except as to outstanding awards).
10-Q
10.2
5/5/2017
10.12 (b)
Forms of award agreements thereunder*
(i) Form of Performance Stock Unit Agreement.
10-Q
10.1
2/5/2021
(ii) Form of Performance Stock Unit Agreement (Economic Return).
10-Q
10.1
2/3/2023
(iii) Form of Performance Stock Unit Agreement (Total Shareholder Return).
10-Q
10.2
2/3/2023
77
Table of Contents
(iv) Form of Restricted Stock Unit Award.
10-Q
10.2
8/8/2016
(v) Form of Restricted Stock Unit Award Agreement for Directors.
10-Q
10.1
2/3/2017
(vi) Form of Stock Option Agreement.
10-Q
10.1
8/8/2016
(vii) Form of Stock Appreciation Rights Agreement.

10-Q
10.3
8/8/2016
(viii) Form of Plexus Corp. Variable Incentive Compensation Plan - Plexus Leadership Team.
10-K
10.1(b)(vi)
11/17/2017
10.13 (a)
Amended and Restated Plexus Corp. 2008 Long-Term Incentive Plan*
(superseded except as to outstanding awards).
10-Q
10.3
5/5/2017
10.13 (b)
Forms of award agreements thereunder*
Form of Restricted Stock Unit Award.
10-Q
10.5(b)
5/8/2008
19**
Insider Trading and Related Policies.
21**
List of Subsidiaries.
23**
Consent of PricewaterhouseCoopers LLP.
24**
Power of Attorney
 (see signature page).
31.1**
Certification of President and Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
31.2**
Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
32.1**
Certification of the CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification of the CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1**
Reconciliation of ROIC to GAAP and Economic Return Financial Statements.
101
The following materials from Plexus Corp.’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, formatted in Inline Extensible Business Reporting Language ("XBRL"): (i) the Consolidated Statements of Comprehensive Income, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Shareholders’ Equity, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.
101.INS
Inline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document).
101.SCH
Inline XBRL Taxonomy Extension Schema Document.
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document.
78
Table of Contents
104
The cover page from the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, formatted in Inline XBRL and contained in Exhibit 101.
*
Designates management compensatory plans or agreements.
**
Filed or furnished herewith.
ITEM 16.    FORM 10-K SUMMARY
None.
79
Table of Contents
Plexus Corp. and Subsidiaries
Schedule II – Valuation and Qualifying Accounts
For fiscal 2024, 2023 and 2022 (in thousands):
Descriptions
Balance at beginning of period
Additions charged to costs and expenses
Additions charged to other accounts
Deductions
Balance at end of period
Fiscal Year 2024:
Allowance for losses on accounts receivable (deducted from the asset to which it relates)
$
1,914

$
2,607

$
—

$
(
1,332
)
$
3,189

Valuation allowance on deferred income tax assets (deducted from the asset to which it relates)
$
31,949

$
3,728

$
—

$
(
36
)
$
35,641

Fiscal Year 2023:
Allowance for losses on accounts receivable (deducted from the asset to which it relates)
$
1,961

$
2,197

$
—

$
(
2,244
)
$
1,914

Valuation allowance on deferred income tax assets (deducted from the asset to which it relates)
$
25,562

$
6,425

$
—

$
(
38
)
$
31,949

Fiscal Year 2022:
Allowance for losses on accounts receivable (deducted from the asset to which it relates)
$
1,188

$
2,117

$
—

$
(
1,344
)
$
1,961

Valuation allowance on deferred income tax assets (deducted from the asset to which it relates)
$
30,321

$
1,338

$
—

$
(
6,097
)
$
25,562

80
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Plexus Corp.
Registrant
Date:
November 15, 2024
/s/ Todd P. Kelsey

Todd P. Kelsey
President and Chief Executive Officer
81
Table of Contents
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Todd P. Kelsey, Patrick J. Jermain and Angelo M. Ninivaggi, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and any other regulatory authority, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirement of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the date indicated.*
SIGNATURE AND TITLE

/s/ Todd P. Kelsey
/s/ Randy J. Martinez
Todd P. Kelsey, President and Chief Executive Officer (Principal Executive Officer) and Director
Randy J. Martinez, Director
/s/ Patrick J. Jermain
/s/ Joel Quadracci
Patrick J. Jermain, Executive Vice President and Chief
Financial Officer (Principal Financial Officer and
Principal Accounting Officer)
Joel Quadracci, Director
/s/ Dean A. Foate
/s/ Karen M. Rapp
Dean A. Foate, Chairman
Karen M. Rapp, Director
/s/ Joann M. Eisenhart
/s/ Paul A. Rooke
Joann M. Eisenhart, Director
Paul A. Rooke, Director
/s/ Rainer Jueckstock
/s/ Michael V. Schrock
Rainer Jueckstock, Director
Michael V. Schrock, Director
/s/ Jennifer Wuamett
Jennifer Wuamett, Director
*Each of the above signatures is affixed as of November 15, 2024.
82